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There is increasing evidence to suggest that the normal non-pathogenic
commensal flora, of the healthy individual, may act as a reservoir of antibiotic
resistant determinants. In order to investigate this potential gene pool further,
three commensal faecal flora surveys examining three separate populations
have been completed. Firstly, 100 faecal specimens were obtained from healthy
members of the community in Edinburgh and were examined for the presence of
antibiotic resistant determinants amongst the lactose-fermenting, aerobic faecal
bacteria. A further 100 faecal specimens, which had been submitted to clinical
diagnostic laboratories from general practitioners in Edinburgh and found not
to contain any pathogens, were investigated as before. In developing countries,
the carriage of antibiotic resistance amongst pathogens has been reported as
being significantly higher than in the developed countries. Consequently, to
make such a comparison about non-pathogenic commensal faecal flora, the third
survey was carried out in the black communities of South Africa; 361 faecal
specimens were obtained and examined for the presence of antibiotic resistant
faecal flora.
The ampicillin resistant bacteria, from each survey, were purified and
investigated further. Conjugation experiments identified the transferability of
the resistance determinants. In those strains able to transfer the antibiotic
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resistance genes, plasmid preparations and restriction profiles were prepared.
From such work, the presence of single or epidemic plasmids within the given
community could be identified. The causative P-lactamase mediating resistance
within this population was thus determined.
A follow up survey was carried out in Edinburgh approximately two years after
the initial survey. Faecal specimens were obtained from five people who had
participated in the "healthy" commensal flora survey. Previously, their
specimens were found to harbour transferable ampicillin resistant
determinants; the responsible plasmids were isolated and identified. Whether or
not ampicillin resistant bacteria had been maintained was assessed prior to
investigation of the resistance mechanism employed; persistence of a single
plasmid type was sought.
The TEM-1 P-lactamase, present on a wide variety of plasmids, was ubiquitous
amongst the ampicillin resistant strains isolated from the three surveys.
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"Science is built up of facts, as a house is built up of stones; but
an accumulation of facts is no more a science than
a heap of stones is a house."
Henri Poincare
(1854 - 1912)
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The ability to control infections with antibiotics has revolutionised the practice
of medicine. Early considerations of the nature of infectious disease were made
by Fracastoro (1546) but it was not until the publications of Henle (1840) and
then Koch (1876) that the first evidence that a specific micro-organism could
cause a specific disease in an animal, became apparent. Control of disease was
initiated with the use of various antiseptics and disinfectants (Semmelweis,
1850; Lister, 1867). It was, however, with the development of chemotherapy that
great advances were made in the treatment of infections.
The term chemotherapy expressed the belief of Paul Ehrlich that infectious
disease could be combated by treatment with synthetic chemicals. Indeed, as a
result of his extensive screening of dyes, the first man-made compound
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recognised as being able to produce a curative effect, Trypan Red, was found in
1904. This was followed by the examination of organochemical compounds and
the discovery of salvarsan (Ehrlich, 1913) which, together with its derivative
neo-salvarsan, became the standard treatment for syphilis at that time.
However, this arsenical-based compound was not very selective. Further
progress in the therapy of bacterial infections was slow until Domagk (1935)
reported that Prontosil rubrum was active against infections; the effective
antibacterial agent was subsequently identified as sulphanilamide (Trefouel,
1935). The sulphonamides were enormously successful drugs which enjoyed
widespread clinical use (Greenwood, 1983). Their success stimulated interest in
bacterial chemotherapy and in the work performed a few years earlier on
penicillin by Fleming.
Interest in penicillin was initiated when the antibacterial action of a Penicillium and
its potential importance was recognised by Fleming (1929). He serendipitously,
observed the inhibitory effect of Penicillium notatum on a Staphylococcus plate.
However, a considerable period of time elapsed before the responsible active
substance, penicillin, was extracted (Chain et al., 1940). The initial clinical trials
(Abraham et al., 1941), which have since been recounted (Fletcher, 1984), revealed
the clinical usefulness of penicillin in man. An extensive screening of the soil for
micro-organisms which might produce other antibacterial agents followed which led
to the identification of streptomycin and neomycin (Waksman and Lechevalier, 1949).
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In 1945, Brotzu isolated an antibiotic producing strain of Cephalosporium
acremonium mould from a sewage outfall (Kuemmerle et al., 1983). Seven antibiotics
were isolated from the culture, namely cephalosporin PI, P2, P3, P4, P5 (Burton
and Abraham, 1951), cephalosporin N (Newton and Abraham, 1954) and later
cephalosporin C. The isolation of the cephalosporin C (Newton and Abraham,
1955) was a significant event as this antibiotic was found to have a wide
antibacterial activity. In addition, it was found to be equally effective against
penicillin sensitive staphylococci and also against the penicillin resistant
staphylococci which had emerged at that time. Penicillin resistant strains of
Staphylococcus aureus were noted within a few years of the introduction of
penicillin and, unfortunately, these resistant strains soon became a major
clinical problem. Penicillinase ((3-lactamase), the hydrolytic enzyme mediating
resistance, predates the introduction of penicillin into widespread clinical use.
The first identification of this enzyme was from a strain of Escherichia coli
(Abraham and Chain, 1940) and only later were these enzymes found in
strains of S. aureus, the bacteria actually being treated with the antibiotic
(Kirby, 1944).
The appearance of antibiotic resistant bacteria encouraged firstly, the
development of the semi-synthetic penicillins, with either an increased spectrum
of bacterial activity or with modifications rendering them stable to resistant
strains, and secondly, a continued progress in the discovery of natural, novel
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P-lactam products (Kuemmerle et al., 1983). Many (3-lactam antibiotics have been
listed to date although only approximately 50 of them have clinical use (Hood,
1991). Although not discussed here, bacterial resistance has also developed to the
other classes of antimicrobial agents (Amyes and Gemmell, 1992).
1.2. Development of (3-Lactam Antibiotics
1.2.1. Semi-Synthetic Penicillins
Although the original penicillin F and its replacement, penicillin G
(benzylpenicillin) were both clinically successful products, variants were sought.
Penicillin V (phenoxymethyl penicillin), an early derivative of penicillin G, was
obtained in 1948. This agent was available in 1954 for oral administration as it
was resistant to hydrolysis by gastric enzymes (Selwyn, 1980).
Many semi-synthetic derivatives of penicillin have been developed as a direct
result of the isolation, in 1957, of the penicillin "nucleus" (6-aminopenicillanic
acid, or 6-APA) (Figure 1), which was biosynthesised in large quantities by
Beecham Research Laboratories (Batchelor et al., 1959).
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Figure 1 & 2. Basic penam (left) and cephem (right) nuclei with R and S
positions in which modifications are possible (Pickering
and Murray, 1984a).
Figure 1. Figure 2.
Dihydrothiazine
ring
This molecule consists of the P-lactam ring attached to a five member
thiazolidine ring (Greenwood, 1983) and although alone it is virtually devoid of
antibacterial action, simple acylation substitutions on the nucleus with different
carboxylic acids, chlorides or mixed anhydrides have created compounds with
important pharmacological and antibacterial differences (Pickering and Murray,
1984a).
The first semi-synthetic penicillin to be employed in clinical practice, methicillin
(Rolinson et al., 1960), was active against the penicillin-resistant staphylococci.
Similar derivatives, oxacillin and cloxacillin (Doyle et al., 1961; Knudsen et al., 1962)
followed but although they were resistant to staphylococcal penicillinases, they have
little antibacterial activity against Gram-negative bacteria (Pickering and
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Murray, 1984a). The fact that there is only one site for chemical modification on
the penicillin molecule (C6), limits the possibilities for both broad spectrum
activity and for penicillinase stability. The development of ampicillin was,
therefore, of particular interest on account of its broad spectrum activity against
Gram-positive and Gram-negative organisms (Rolinson and Stevens, 1961).
Further to this, carbenicillin, ticarcillin and piperacillin were developed
specifically with antipseudomonal activity (Selwyn, 1982).
1.2.2. Ampicillin
Ampicillin, 6-D(-)aminophenylacetamidopenicillanic acid (Figure 3), was
introduced in 1961 (Rolinson and Stevens, 1961). It is more effective against
Gram-negative bacteria such as E. coli, Shigella spp., Salmonella spp., and
Proteus mirabilis than penicillin G since it is able to penetrate the outer
membrane with greater efficiency (Neu, 1979). Ampicillin was
created as a result of an insertion of an amino group in the opposition of the
benzylpenicillin side chain (Rolinson and Stevens, 1961). In 1972, an insertion
of a hydroxyl group in the ampicillin molecule at the para position of the benzyl
side chain resulted in the formation of amoxycillin (Sutherland et al., 1972).
Although ampicillin and amoxycillin share the same spectrum of bacterial
activity, (Neu, 1974; Neu, 1979; Neu, 1986) the additional hydroxyl group in
amoxycillin alters the ability of the drug to be absorbed from the gastrointestinal
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tract; between 40-60% of ampicillin given orally is absorbed compared with 70%
of amoxycillin given orally (Pickering and Murray, 1984a).
Figure 3. Structure of ampicillin
1.2.3. Semi-Synthetic Cephalosporins
Similarly, many semi-synthetic cephalosporins have now been marketed. While
cephalosporin C possesses a P-lactam ring it is attached to a six membered
dihydrothiazine ring (Figure 2) (Newton and Abraham, 1955). In contrast to the
penam nucleus, the 7-aminocephalosporanic acid or 7-ACA nucleus is not a
naturally occurring substance; it is only obtained from the side chain of
cephalosporin C (Rolinson, 1988). Advantageously, it has several sites for
modifications and, as a result, thousands of cephalosporin antibiotics have
been produced (Chauvette et al., 1962; Muggleton et al., 1964).
Therapeutically important modifications have been made at the sulphur atom
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at position 1, the acyl group attached to C7 (Rl), C7 itself and the moiety
attached to C3 (R2) (Donowitz and Mandell, 1988).
The first derivatives of cephalosporin C included cephalothin (Chauvette et al.,
1962) which became available in the United States in 1964. This was followed
quickly with the introduction of cephaloridine by Glaxo in the United Kingdom
(Muggleton et al., 1964). The success of these early cephalosporins was,
however, jeopardized by P-lactamases. Consequently, new cephalosporins, with
increased P-lactamase stability and an expanded spectrum of antibacterial
activity eg. cefuroxime (O'Callaghan et al., 1976; Brogden et al., 1979), were
developed, mainly as a result of modifications to the 7-beta-acyl position.
Similarly, in order to combat increasing resistance, ceftizoxime, cefmenoxime
and cefodizime were all launched (reviewed by Hoover, 1983). Finally the latest
cephalosporins, such as cefotaxime, ceftazidime and ceftriaxone, exhibited a
much higher antibacterial activity over an even broader range of bacterial
species. The major advantages of this newest group are the P-lactamase
stability and more favourable pharmacological properties (Pickering and
Murrray, 1984b). The release of ceftazidime, in particular, by Glaxo in 1981
(Muggleton, 1981) was considered a major breakthrough; the antimicrobial was
resistant to most of the P-lactamases which had been identified at that time
(Simpson et al., 1982) and Pseudomonas aeruginosa was included in its range of
activity (Klingeren, 1981; Labia et al., 1981).
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1.3. Mechanism of Action of (3-Lactams
p-lactam antibiotics have a bactericidal mode of action. They bind to and inactivate
penicillin binding proteins (PBPs) which lie on the inner surface of the bacterial
cell membrane (Spratt, 1975;1980; Tomasz, 1986). The PBPs, which are
transpeptidases, carboxypeptidases and endopeptidases, catalyse the cross linking
of the cell wall polymer, peptidoglycan. The function of peptidoglycan is to
maintain the strength of the bacterial cell wall which it is able to do because it
possesses a mesh structure of polysaccharide strands which are cross-linked by
peptide bonds (Donowitz and Mandell, 1988; Livermore, 1991). The P-lactams
inhibit the formation of these bonds, weakening the wall (Tipper and Strominger,
1965) and are able to inactivate endogenous inhibitors of bacterial autolysins (Holtje
and Tomasz, 1975). Consequently, P-lactams can cause bacterial lysis. Different
P-lactams have different affinities for the various PBPs; binding with some specific
PBPs causes a more detrimental effect than with others. While inactivation of
PBPs 4, 5, and 6 by P-lactams is not lethal to bacteria, as these particular PBPs are
not essential for bacterial viability, binding with PBPs la and lb will result in cell
death (Tomasz, 1986; Donowitz and Mandell, 1988). If low dose or long periods of
intermittent penicillin therapy are given, the effect of the antibiotic is quite
different; the autolytic system is inhibited with the result that, while cells divide,
they cannot separate and so form long filaments (Lorian and Sabath, 1972).
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1.4. Mechanisms of Resistance to (3-Lactams
It is estimated that the introduction of antibiotics added 10 years to the life
expectancy of Americans (Donowitz and Mandell, 1988); however, they are not
the panacea they once promised to be. Each drug has the potential to create
adverse reactions in the recipient (Murray and Moellering, 1978) and bacteria
have responded to the challenge of antibiotics by developing various
mechanisms of resistance (Amyes and Gemmell, 1992). Such adaptations have
complicated the treatment of infections as resistant bacteria are indeed
associated with increased risk of morbidity and mortality (Holmberg et al.,
1987; Murray, 1991; Sanders and Sanders, 1992). The problem of resistance has,
in some cases, forced the clinician to select the more toxic or the more expensive
alternative drug (Jacoby and Archer, 1991). Three mechanisms of resistance
have developed to p-lactam antibiotics:
1.4.1. Impermeability
The presence of a cell envelope, consisting of exopolysaccharide, in some
bacteria may act as a primary barrier to the penetration of P-lactam antibiotics
(Piddock and Wise, 1985). Gram-negative bacteria possess an outer membrane
which provides the next obstacle to the entrance of antibiotics. P-lactams
14
traverse this outer membrane layer through the water filled protein porin
channels (Jaffe et al., 1982; Hancock, 1988a). The size, charge and hydrophobicity
of the agent will determine the ease of passage through the membrane (Nikaido
et al., 1983). However, alterations in the porins, by mutation, can prevent [3-lactams
from penetrating the outer membrane and ultimately reaching the target PBPs
on the inner membrane (Livermore, 1991). Amongst Enterobacteria, a
simultaneous consequence of such adaptations is difficulty in nutrient uptake
and, on some occasions, difficulty in attaching to mammalian cells as a result of
the altered surface (Nikaido, 1989; Livermore, 1991). Ps. aeruginosa has a high
intrinsic resistance to most commonly used antibiotics owing to their low rate of
permeation across the outer membrane; permeation is 12-100 fold lower than
permeation of the same compound in E. coli (Hancock, 1988b).
1.4.2. Altered Target
Resistance may arise as a result ofmutations which are responsible for the lack
of affinity between a P-lactam and its target PBPs (Hedge and Spratt, 1985).
Often metabolically important PBPs are selected for modification (Piddock and
Wise, 1985). Alternatively, there may be the acquisition of supplementary PBPs
which are not associated with sensitive strains and are incompatible for binding
the P-lactam drug (Hartman and Tomasz, 1984; Ubukata et al., 1985).
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1.4.3. Production of P-Lactamases
The production of [3-lactamase is the most important mechanism of resistance to
(3-lactam drugs (Hamilton-Miller, 1982; Medeiros, 1984; Pratt, 1989). (3-lactamases
hydrolyse the cyclic amide bond of (3-lactam antibiotics (Figure 4) resulting in a
product which is antibiotically inactive.
Figure 4. Action of [3-lactamases (Sykes, 1982)
Essentially (3-lactamases act by firstly, binding to the (3-lactam substrate in a
noncovalent Michaelis complex. The enzyme/substrate complex may at this stage,
dissociate or alternatively commit itself to a hydrolytic reaction. With most
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clinically important (3-lactamases, the latter procedure involves acylation of the
complex in which the carboxyl of the opened [3-lactam ring is linked to the
hydroxyl group on the serine side chain. This reaction is then terminated with the
deacylation of this covalent complex with the release of ring-open product
(Livermore, 1993). The products of penicillin hydrolysis are penicilloates which are
stable and easily recognised compounds. In contrast, the products of cephalosporin
hydrolysis are cephalosporoates which are unstable and differ depending on the
nature of the C-3 substitute (Sykes, 1982). The (3-lactam antibiotics may also
experience the removal of acyl side-chains by amino acid acylases (Figure 4). This
enzymatic degradation of (3-lactam antibiotics is, however, of little importance in
antibiotic resistance. These antibiotics may act as substrates for a number of other
hydrolytic enzymes but none of which, particularly in the clinical situation, are as
significant as (3-lactamases (Sykes, 1982).
The three major factors of rate of penetration of drug into the cell, interaction of
drug with (3-lactamase in the periplasmic space and the ability of the drug to
bind to and inactivate the target PBPs, all determine the susceptibility of Gram-
negative bacteria to any given (3-lactam antibiotic. Each of the three factors are,
none the less, interdependent upon the others (Sanders and Wiedemann, 1988).
As the production of (3-lactamases is the most important mechanism of




1.5.1. Origin of P-Lactamases
It had been suggested that p-lactamases arose from penicillin-sensitive D-alanyl-
D-alanine peptidases involved in bacterial wall peptidoglycan metabolism (Kelly
et al., 1986). This would not be altogether surprising since both groups of
proteins interact with ^-lactam compounds in much the same way. P-lactamases
are unbound proteins which rapidly acylate and deacylate P-lactams. This
results in a hydrolysed drug and the regeneration of a free, active enzyme. PBPs
meanwhile, are membrane bound proteins that rapidly acylate but only slowly
deacylate P-lactams resulting in hydrolysed drug bound covalently to the PBP,
which is itself inactivated (Spratt, 1980). Therefore, while the activity of the
P-lactamase represents drug resistance, the affinity of the P-lactam for PBPs
determines drug susceptibility. The proposal that a PBP mutated to a free
unbound form many millennia ago and then mutated to a form that rapidly
hydrolysed P-lactams is not so unlikely (Sanders and Wiedemann, 1988).
1.5.2. Classification of P-Lactamases
Classification of P-lactamases was initiated in the early 1960's when penicillin
inactivating enzymes were divided into two broad groups, the penicillinases and
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the amidases (Ayliffe, 1963). Some years later, the classification scheme was
developed and the P-lactamases were classified on the basis of their "substrate
profile" ie. the spectrum of hydrolytic activity against a range of (3-lactam
substrates (Sawai et al., 1968). A further modification was made, still dividing
the enzymes into groups according to substrate profile, but in addition
parameters such as antisera, enzyme inhibition with p-chloromercuribenzoic
acid (pCMB) and cloxacillin, and electrophoretic mobility were included (Jack
and Richmond, 1970). As subsequent P-lactamases were discovered, this
classification scheme did not provide sufficient discrimination of the enzymes.
Consequently, the system was adapted further (Richmond and Sykes, 1973) to
produce the first classification to be recognised and extensively used. The
P-lactamases were classified by the following criteria: substrate and inhibitor
profiles, genetic locus (plasmid or chromosomally mediated) and nature of
enzyme expression (constitutive or inducible).
When detailed guidelines for the detection and assay of P-lactamases (Sykes and
Matthew, 1976) were applied, a large number of new enzymes were identified.
This did, however, result in great confusion as far as the classification schemes
were concerned. The limitations of the available scheme included the
heterogeneity among enzymes in the same class, the difficulty in classifying an
enzyme if the genetic locus implicated had not been localised and finally the
difficulty in determining inhibitor profiles under certain conditions (Medeiros,
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1984). In 1980, a completely new classification scheme was created (Ambler,
1980) which was based on the molecular characteristics of the proteins or the
genes coding for them. Three groups were established, Class A, B and C. Since
then two additional groups, Class D and E have been added (Bicknell et al.,
1985; Huovinen et al., 1988a). The latest classification scheme is based
primarily on biochemical characteristics employing substrate and inhibitor
profiles in addition to physical data (Bush, 1988a; 1989a; 1989b; 1989c). The
intention of the new system was to allow meaningful comparison between well
established P-lactamases and those recently identified.
Changes in medical practice resulting in the appearance of new P-lactamases,
the continued discovery and synthesis of p-lactamase substrates and inhibitors
and in addition, the development of sophisticated technology such as isoelectric
focusing and amino acid analysis, have necessitated the need for the
modifications in the classification systems (Sykes, 1982; Bauernfeind, 1986).
A crude distinguishing factor in classification systems is the position of the
genetic locus; the genes controlling the production of P-lactamases may be either
chromosomally or plasmid encoded:
1.5.3. Chromosomal (3-Lactamases
Virtually all Gram-negative bacteria have a chromosomal gene called amp C
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that encodes a P-lactamase more active in hydrolysing cephalosporins than
penicillins (Medeiros, 1984). These chromosomal P-lactamases are species
specific but nevertheless, they may resemble one another closely. However, the
manner in which they are produced varies considerably and is reflected in their
ability to confer resistance (Livermore, 1987). While the production of
chromosomal P-lactamase is usually under low level constitutive control iriE. coli
with little contribution to P-lactam resistance, some clinical isolates possessing
the ability to make large amounts of chromosomal enzyme, have been identified
(Lindberg and Normark, 1986; Korfmann and Wiedemann, 1988). This
hyperproduction, which is extremely high but rather unstable, may result from
an alteration in the promoter for am.p C allowing more efficient expression
(Jacoby and Archer, 1991).
A variety of nonfastid ious Gram-negative bacilli produce chromosomal enzymes
which are characteristically inducible (Sanders and Sanders, 1985; 1986).
P-lactamase induction may simply be described as a transient elevation in
P-lactamase synthesis which occurs when a P-lactam drug is present. The
synthesis of the enzyme returns to a low level when the inducer is removed
(Livermore, 1987). P-lactamases may be induced by one of two mechanisms
(Sanders, 1983; Sanders and Sanders, 1986); either there might be a
spontaneous mutation of the wild type organism to a stably derepressed state
(Gwynn and Rolinson, 1983; Curtis et al., 1986). Such mutants may be termed
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"constitutive", "stably derepressed" or "enzyme hyperproducers" or alternatively,
high level (3-lactamase formation might be a result of reversible derepression of
the (3-lactamase in response to a p-lactam inducer (Sanders, 1983). Following
derepression, it has been speculated that these enzymes may mediate resistance
by a non-hydrolytic mechanism (Sanders, 1984; Livermore, 1985).
1.5.4. Plasmid (3-Lactamases
The concept of transferable, extrachromosomal elements that contain antibiotic
resistance genes, R-plasmids, was first recognised in Japan (see Watanabe et al.,
1963). At that time, the impact of such plasmids was not fully appreciated but it
was not long before their potential to facilitate widespread antibiotic resistance
was realized (Murray and Moellering, 1978); in E. coli, the production of
plasmid-determined p-lactamases is the most important cause of resistance to
P-lactam antibiotics (Roy et al., 1989). Although the massive use of antibiotics
from the 1940's onwards encouraged the selection and dissemination of
R-plasmids, it did not create them; a tetracycline-streptomycin R-plasmid in
an E. coli was found prior to the clinical introduction of these drugs (Smith,
1967). R-plasmids have now been identified in almost all bacteria (Murray and
Moellering, 1978).
The first plasmid-mediated resistance reported to the P-lactam agents was
transmissible ampicillin resistance identified in a strain of Salmonella
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typhimurium (Anderson and Datta, 1965). The synthesis of penicillinase by
cultures carrying the R-plasmid was shown to be under direct control of those
R-plasmids (Datta and Kontomichalou, 1965). Plasmid-mediated P-lactamases
are commonly expressed constitutively (Medeiros, 1984) and may be divided
into two groups:
1.5.4.1. Broad-Spectrum P-Lactamases
The most prevalent type of plasmid-mediated P-lactamase in Gram-negative
bacilli, is the TEM P-lactamase. Two evolutionary variants of this P-lactamase,
designated TEM-1 (pi 5.4) and TEM-2 (pi 5.6) have been distinguished by
analytical isoelectric focusing (Matthew et al., 1975). They differ from each
other by a single amino acid as determined by amino acid and DNA sequencing
(Ambler, 1980); there is a substitution of glutamine for lysine at position 39
following Ambler notation (Ambler et al., 1991). TEM P-lactamases have been
identified on plasmids with a wide variety of incompatibility properties and
from a broad taxonomic range of bacteria isolated from various continents
(Hedges et al., 1974; Medeiros, 1984; Simpson et al., 1986; Sousa et al., 1991;
Roy et al., 1992). The ubiquity of the TEM structural gene, named TnA for
Transposon-ampicillin, results from firstly, the success of the coded enzymes,
which may be described as fully efficient (Christensen et al., 1990) and secondly
from the ability of the gene to transpose (Hedges and Jacob, 1974; Rubens et al.,
1976; Heffron et al., 1977); transposition, thought to be non site specific
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(Wiedemann, 1986), may be from plasmid to plasmid, from plasmid to
chromosome and then again from chromosome to plasmid. While the transposon
TnA includes Tnl, Tn2 and Tn3, the TEM-1 P-lactamase is encoded by the
blaTEM-1 gene that is present on Tn2 and Tn3 specifically, whereas TEM-2 is
encoded by Tnl (Sutcliffe, 1978; Chen and Clowes, 1987).
The nucleotide sequence of the ampicillin resistant (TEM) gene in E. coli has
been determined and a 27000 dalton protein of 286 amino acids identified,
although the first 23 amino acids are involved in signalling for secretion and do
not appear in the mature enzyme (Ambler and Scott, 1978; Sutcliffe, 1978).
Furthermore, the crystalline structure of TEM-1 has recently been elucidated
providing an insight into structure-function relationships (Jelsch et al., 1992).
SHV-1 is a broad spectrum P-lactamase also isolated with some regularity. It
shares 68% sequence homology with TEM-1 (Sutcliffe, 1978; Barthelemy et al.,
1988a). It is thought that SHV-1 P-lactamase gene evolved as a chromosomal gene
in Klebsiella spp. and was later incorporated into a plasmid (Medeiros, 1984). It is
mainly detected in Klebsiella spp. (Shannon et al., 1990b; Reig et al., 1993). Other
broad-spectrum plasmid-mediated P-lactamases have been found only on isolated
occasions and cannot be considered to be major mediators ofP-lactam resistance.
While considered to be broad-spectrum P-lactamase because they hydrolyse both
penicillins and cephalosporins, none of these P-lactamases are capable of
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hydrolysing the extended-spectrum (3-lactam drugs such as cefotaxime or
ceftazidime. This might be expected when it is considered that extended-
spectrum antibiotics were developed in part because of their resistance to the
common plasmid-mediated broad-spectrum enzymes such as TEM-1 (Palzkill
and Botstein, 1992a).
1.5.4.2. Extended-Spectrum p-Lactamases
By the mid 1980s resistance to the extended-spectrum antibiotics had been
reported (Knothe et al., 1983; Kliebe et al., 1985). Transferable resistance to
extended-spectrum P-lactams arose from subtle amino acid changes in the
common plasmid-mediated Ambler Group A P-lactamases, namely TEM-1,
TEM-2 and SHV-1 (Philippon et al., 1989; Payne and Amyes, 1991; Sanders and
Sanders, 1992). For example, analysis of the nucleotide sequence of the bla T-3
gene, which mediates the production of the TEM-3 P-lactamase, revealed
differences in two positions from that of the TEM-2 P-lactamase; lysine (TEM-3)
for glutamic acid (TEM-2) at position 164 and serine (TEM-3) for glycine (TEM-2)
at position 238 (Ambler notation) (Sougakoff et al., 1988a). The P-lactamases
designated TEM-3 to TEM-7 all share the same phenotype (exhibiting activity
against cefotaxime) and DNA-DNA hybridisation has indicated they are all
variants of the TEM structural gene (Sougakoff et al., 1988b). The first p-lactamase
to appear, conferring resistance to cefotaxime, was recognised as being a
modification of SHV-1 (Knothe et al., 1983). This enzyme was named SHV-2 as it
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was closely related to SHV-1 (Korfmann et al., 1986). SHV-2 differs from the
amino acid sequence of SHV-1 (Barthelemy et al., 1988b) at position 238 (Ambler
notation) where glycine is replaced by serine.
The earliest known extended-spectrum (3-lactamase was a TEM-1 derived
(TEM-E2) enzyme identified from a strain of Klebsiella oxytoca in Liverpool in
1982 (Payne et al., 1990). The enzyme was unique in possessing the ability to
hydrolyse ceftazidime. Other "ceftazidimases" have been reported (Sirot et al.,
1987; Bauernfeind and Horl, 1987). The substitutions usually occur in the active
site pocket of the enzyme indicating that the newly introduced changes influence
the binding and catalysis of the antibiotics (Palzkill and Botstein, 1992b).
Mutagenesis experiments suggest the TEM-1 (3-lactamase does, however, exhibit
a high level of tolerance to amino acid substitutions; 44% ofmutants with random
substitutions retained some (3-lactamase activity (Palzkill and Botstein, 1992b). It is
clear that consequences for the interactions between the p-lactam and P-lactamases
are not the same for different substitutions (Collatz et al., 1990). The subsequent
expanded spectrum has been attained at a cost of reduced hydrolytic activity
against ampicillin (Bush and Singer, 1989).
Since the first emergence of TEM and SHV substituted P-lactamases, there has
been a proliferation of extended-spectrum P-lactamases, many of which have been
isolated in France (Philippon et al., 1989) where there is a higher usage of the
newer generation cephalosporins. However, many of the novel enzymes such as
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TEM-9 (Mabilat et al., 1990) have only been isolated in a single hospital at a
single time (Bush, 1989a). Epidemic spread throughout the bacterial populations
is not common except in a few isolated cases. In Clermont-Ferrand, France there
was "an epidemic of antibiotic multiply-resistant strains of K. pneumoniae
producing a new beta-lactamase" which was designated, CTX-1 (Sirot et al., 1987).
Recently, an outbreak of infections caused by an SHV-5 producing strain of
K. pneumoniae was reported (Bauernfeind et al., 1993). The spread of a single
extended-spectrum p-lactamase is dependent on the pathogenicity of the strain
carrying the plasmid, the stability of the plasmid concerned, the presence of other
influencing resistance markers on the plasmid and finally, the consistency of the
selective pressure to stabilise the resistant plasmid (Payne and Amyes, 1991).
The question has been raised as to whether certain plasmids have properties
that promote gene evolution (Jacoby and Sutton, 1991). As a single extended-
spectrum P-lactamase has not predominated in a similar fashion to TEM-1, a
pandemic strain carrying such an enzyme is highly unlikely. Variations in the
prevalence of the extended-spectrum P-lactamases must be related to local
epidemiological factors, general preventive methods and antibiotic policies
(Sirot et al., 1992). A number of surveys have assessed the prevalence of the
extended-spectrum P-lactamases in hospitals (Sirot et al., 1988; Jarlier et al.,
1988; Sirot et al., 1992). At present they are not a "major threat" to
antimicrobial chemotherapy but are more of a "minor inconvenience" (Payne
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and Amyes, 1991). The introduction of new oral cephalosporins is hoped to be a
viable option (Wise, 1992) particularly in the management of outpatient
infections (Cullmann, 1992). It has been stated that these new agents will not
enhance the selection pressure for extended-spectrum [3-lactamases directly as
they are highly stable to the 'classical (3-lactamases' (Cullmann, 1992). However,
it might be suggested that, on the contrary, an increased usage of these agents
in the community will certainly increase the selection pressure.
Recently, new enzymes, BIL-1 (Woodford et al., 1990; Payne et al., 1992) and MIR-1
(Papanicolaou et al., 1990) have been identified. These enzymes are resistant to
expanded-spectrum cephalosporins caused by plasmid-mediated (3-lactamases but
are not inhibited by clavulanic acid. These enzymes are Ambler class C
chromosomal (3-lactamases which have, for the first time, migrated onto plasmids
(Payne et al., 1992). Many other extended-spectrum (3-lactamases unrelated to
either TEM or SHV have been reported (Jacoby and Medeiros, 1991).
1.5.5. Epidemiology ofPlasmid-Mediated f3-Lactamases
A number of studies have been conducted to identify the (3-lactamases
contributing to (3-lactam resistance in clinical Gram-negative bacterial
populations (Simpson et al., 1986; Jouvenot et al., 1987; Reid et al., 1988; Redjeb
et al., 1988; Thomson et al., 1992b; Thomson and Amyes, 1993a). As a result of
such work, the clinical potential of any novel (3-lactam agents can be assessed
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(Simpson et al., 1980). Prior to the use of isoelectric focusing (Matthew et al.,
1975) P-lactamases were frequently divided into groups according to their
susceptibility to various (5-lactam drugs (Medeiros et al., 1974). Since the
detection method of P-lactamases has been improved (Matthew et al., 1975), the
characterisation and prevalence of the different enzymes involved in resistance
has been monitored and their epidemiology recorded (Matthew, 1979; Jacoby
and Sutton, 1985; Wiedemann et al., 1989). The distribution of plasmid-
mediated P-lactamases identified in various surveys is reflected in Figure 4.







Ln 3 n ll tQ. =JL
T I I I I I I I I I
^ ^ y# y^ ytf* y** ^ ^
K tA*1 K cA" K tA° K <A0 -s2, »cA" > tA° K cA*' K (A-' K cA°eS









Some clinical surveys have examined isolates by DNA hybridisation with a
TEM probe revealing TEM-1 to be the most prevalent P-lactamase (Huovinen et
al., 1988b; Cooksey et at., 1990; Burman et al., 1992). However, it should be
remembered that a complete TEM-1 gene probe is not discriminatory enough to
distinguish between TEM and TEM derived genes and therefore oligotyping
may be preferable for complete characterisation and molecular epidemiology of
P-lactamases (Mabilat and Courvalin, 1990).
The TEM-1 enzyme is not limited to E. coli. It has proliferated throughout all
Enterobacteriaceae and other species such as Vibrio spp. (Hedges et al., 1977)
and Pseudomonas spp. (Huovinen et al., 1988a). It was found to be the principal
mechanism of resistance in Haemophilus influenzae strains (Reid et al., 1987)
and in Neisseria gonorrhoeae (Elwell et al., 1977). The ubiquitous nature of the
TEM P-lactamase exemplifies the slow but efficient spread of the resistance
gene in the environment (Wiedemann et al., 1989) and reflects its widespread
success. The ubiquitous nature is of concern, however, as this enzyme exhibits a
remarkable capacity to overcome advances in antibiotic chemotherapy; the
TEM-1 P-lactamase is recognised as a progenitor of resistance to third
generation cephalosporins (Philippon et al., 1989; Payne and Amyes, 1991).
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1.6. Overcoming (3-Lactamase Resistance
There have been two main strategies employed to overcome resistance mediated
by P-lactamases. Firstly, the development of new P-lactam antibiotics which are
not hydrolysed by most P-lactamases as a result of modifications in the
structure. This has been discussed previously. As a result of the associated
clinical resistance problems, a second strategy became more attractive, namely
the use of P-lactamase inhibitors which, when co-administered with a P-lactam,
prevent inactivation by P-lactamases (Pratt, 1989; Sutherland, 1990; Thomson
and Amyes, 1992b; Moellering, 1993).
1.6.1. P-Lactamase Inhibitors
1.6.1.1. Olivanic Acids
In 1967, Beecham Pharmaceuticals initiated a screening programme of micro¬
organisms for the presence of P-lactamase inhibitors. The first likely
compounds were isolated from a strain of Streptomyces olivaceus (Brown et al.,
1976) and named olivanic acids. Unfortunately, although certain pathogens
such as K. pneumoniaz-and S. aureus could be rendered susceptible to
ampicillin or amoxycillin in the presence of the olivanic acids, there was little
effect against other pathogens because of poor penetration through the
bacterial cell wall and their rapid metabolism (Moellering, 1991).
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1.6.1.2. Clavulanic Acid
Further screening led to the discovery of clavulanic acid which was produced
from a strain of Streptomyces clavuligerius (Brown et al., 1976). While
clavulanic acid is a progressive potent inhibitor of P-lactamases, it has weak
antibacterial activity (Brogden, 1981; Selwyn, 1982). The structure is distinct
from penicillins and cephalosporins. It possesses an oxazolidine ring fused to
the P-lactam, it lacks an acylamino side-chain and it has an unusual
substituent, a (3-hydroxyethylidine group at C-2 (Brown, 1981).
Clavulanic acid binds with a p-lactamase resulting in the formation of the acyl
enzyme complex (Bush and Sykes, 1986; Bush, 1988b). The effectiveness of
clavulanic acid as a P-lactamase inhibitor depends on the P-lactamase involved
(Reading and Cole, 1977). Most constitutively produced plasmid- and
chromosomally-mediated enzymes are readily inhibited. These enzymes are
widespread in Enterobacteriaceae, P. aeruginosa and H. influenzae. In contrast,
inducible P-lactamases are less readily inhibited because the affinity between
enzyme and inhibitor is poor (Rolinson, 1991); such enzymes are produced by
Serratia spp., Enterobacter spp. and Citrobacter spp. (Brown, 1981). Clavulanic
acid itself is a weak inducer and had little activity against these Class 1
(Richmond and Sykes) P-lactamases (Moosdeenet al., 1986).
Clavulanic acid has been marketed in combination with amoxycillin
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(Augmentin) in an amoxycillin:clavulanic acid 2:1 ratio since 1981. Doses of
clavulanic acid exceeding 200mg are not well tolerated and so the formulation is
usually 250mg:125mg amoxycillin:clavulanic acid (Leigh et al., 1981). While
also available in a 5:1 ratio, this formulation is currently being reassessed.
Clavulanic acid may be associated with mild side effects such as diarrhoea.
A number of in vivo studies have been carried out in order to assess the efficacy of
this (3-lactam/p-lactamase inhibitor combination; early success was reported when
85% of patients made a complete recovery after treatment with the combination
against Gram-negative bacteria resistant to penicillin (Martinelli et al., 1981).
This success has continued (Cherubin et al., 1991; Cherubin, 1992; Barry et al.,
1993). In addition, in vitro studies report low levels of resistance (Martinez et al.,
1987; Williams et al., 1988; French and Ling, 1988; Thomson et al., 1992a).
Shortly after the introduction of "Augmentin", a formulation of potassium
clavulanate with ticarcillin (Timentin) was marketed by Beecham Laboratories
and has been evaluated (Labia et al., 1986). While clavulanic acid in
combination with amoxycillin is administered orally, in combination with
ticarcillin, administration is parenteral. It seems that there is also synergy
between clavulanic acid and the newest cephalosporins. This might be
promising in the therapy of serious infections caused by bacteria with multi-
resistance to P-lactam antibiotics (Redjeb et al., 1988).
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The effectiveness of clavulanic acid may relate to the moderate synergism when
combined with other p-lactam antibiotics or it may have a better penetration
rate than other inhibitors.
1.6.1.3. Sulbactam
Sulbactam (45,899) (English et al., 1978) is a penicillanic sulphone which has
been formulated with ampicillin and in some countries with cefoperazone. Like
clavulanate, sulbactam inhibits a wide range of p-lactamases but in general it is
less potent than clavulanate (Wise et al., 1980; Jacobs et al., 1986). When a
clinical study compared their activity in mixed infections of anaerobes and
aerobes, amoxycillin performed better in combination with clavulanic acid rather
than sulbactam (Gisby and Beale, 1988). The activity of sulbactam combinations
against E. coli isolates with known amounts of TEM-1 P-lactamase was found to
be very weak. The concentration of sulbactam needed to potentiate the P-lactam
did depend, however, on the amount of P-lactamase present (Livermore, 1993).
In common with clavulanate, sulbactam possesses a weak antibacterial activity
alone (Brown, 1981).
1.6.1.4. Tazobactam
Tazobactam (YTR 830) is an analogue of sulbactam with activity comparable with
clavulanate (Jacobs et al., 1989). It inhibits a wide range of commonly
encountered P-lactamases including plasmid-mediated types and limited Class I
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chromosomal enzymes (Aronoff et al., 1984; Gutmann et al., 1986; Moosdeen et al.,
1986; Bauernfeind, 1990; Livermore and Seetulsingh, 1991). In vitro activity
seems very promising for the clinical use of the combination piperacillin and
tazobactam (Kuck et al., 1989; Livermore and Seetulsingh, 1991). Indeed a recent
survey reported 89% of Enterobacteriaceae that were resistant to piperacillin,
were restored to susceptibility by tazobactam (Acar et al., 1993). Furthermore,
piperacillin/tazobactam exhibit comparable susceptibility rates to other p-lactam
agents with P-lactamase inhibitors against anaerobic bacteria (Appelbaum, 1993).
Recent investigations have suggested that inactivation of TEM-1 p-lactamase by
tazobactam may be pH dependent (Livermore and Corkill, 1992).
1.6.1.5. BRL 42715
BRL 42715 enhances the activity of the P-lactams in strains that constitutively
express Richmond and Sykes Class I P-lactamases and also in strains
expressing extended-spectrum plasmid-mediated P-lactamases (Piddock et al.,
1993). It is a potent inhibitor of both common chromosomal and plasmid-
mediated P-lactamase whatever the level of expression (Coleman et al., 1989).
This compound, a substituted penem, is a more potent P-lactamase inhibitor
than clavulanate, sulbactam or tazobactam (Rolinson, 1991; Livermore and
Seetulsingh, 1991 and Appelbaum et al., 1992). BRL 42715 is, however,
unstable (Piddock et al., 1993) and consequently is not being developed further
for clinical use (Appelbaum et al., 1992; Zhou et al., 1993).
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At present, inhibitors are only available in the combined form in the U.K. If the
new extended-spectrum P-lactamase enzymes become a clinical problem, the
case may arise for their use as individual agents, leaving the final choice of the
P-lactam to the clinician (Thomson and Amyes, 1992b). Analysis of therapy with
P-lactamase inhibitors has indicated that for clavulanic acid, single dose
therapy with a lower cost, better patient compliance, diminished pressure on
intestinal flora and fewer side effects is preferable (Raz et al., 1991). The
inhibitors seem to display an acceptable safety profile as determined in clinical
trials (Martinelli et al., 1981; Kuye et al., 1993).
1.6.2. Mechanism of Action
P-lactamase inhibitors may act in either a competitive or non-competitive
manner. If the former, the inhibitors may function in a reversible manner where
there is a non-chemical interaction between the substrate and inhibitor.
Consequently, if the inhibitor is removed, the enzyme may act on the substrate.
Alternatively, the inhibitor may function in an irreversible manner whereby the
enzyme is inactivated; the enzyme is incapable of catalysing the conversion of
substrate to product even after removal of excess inhibitor (Bush and Sykes,
1983). In this situation, the inhibitors inevitably destroy themselves and so the
term "suicide inhibitor" has been adopted (Wise, 1982). Time suicide inhibition
requires a branched reaction pathway whereby the covalent ester reacts either
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to yield hydrolysed inhibitor and reactivated enzyme or to give a permanently
inactivated product in which the inhibitor, or a fragment of it, remains
permanently attached to the (3-lactamase (Livermore, 1993). In contrast, in non¬
competitive inhibition, the enzyme will be bound at a point removed from the
catalytic site and so distort the enzyme rendering it non-functional (Wise, 1982).
1.6.3. Resistance to (3-Lactamase Inhibitors
Decreased susceptibility to (3-lactam/(3-lactamase inhibitor combinations such as
amoxycillin/clavulanate and ticarcillin/clavulanate have been reported
(Martinez et al., 1987; French and Ling, 1988). This may be attributed to either
an increased frequency in hyperproduction of TEM-1 (3-lactamase (Martinez et
al., 1987; Page et al., 1989; Shannon et al., 1990a) or, alternatively, as a result of
an enzyme mediating such resistance (Thomson and Amyes, 1992a; Vedel et al.,
1992). Examining each:
Irrespective of the (3-lactamase and inhibitor type, it is easier to protect a (3-lactam
antibiotic against the activity of a smaller rather than a larger amount of
(3-lactamase (Livermore, 1993). This fact is highlighted for E. coli strains that
produce TEM-1. The TEM-1 |3-lactamase is expressed constitutively but the
amount varies 100-fold amongst different strains. Amoxycillin/clavulanate
resistant E. coli were found to produce 3 times as much TEM-1 as the standard
sensitive strain (Williams et al., 1988). Clear correlations have been established
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between (3-lactamase quantity and levels of resistance to the (3-lactam inhibitor
combinations (Sanders et al., 1988; Thomson et al., 1990; Seetulsingh et al.,
1991). The exact mechanism involved in the hyperproduction of the TEM-1
(3-lactamase is unclear but several possibilities have been proposed. These
include plasmid copy number; plasmid rearrangement may produce small
multicopy plasmids and consequently gene duplication (Martinez et al., 1987;
Martinez et al., 1989; Shannon et al., 1990a; Nandivada et al., 1990; Reguera et
al., 1991). For example, amoxycillin/clavulanate resistant E. coli isolates from
Madrid were found to produce between 4 and 50 fold more TEM-1 than did a
control strain with a single copy of the TEM-1 gene (Martinez et al., 1987). The
degree of gene amplification within plasmids and also the promoter efficiency
may also be of some importance (Page et al., 1989; Seetulsingh et al., 1991). It is
not known whether strains displaying this mechanism of resistance arose as a
result of use of amoxycillin plus clavulanic acid or already existed in the
bacterial population before the introduction of inhibitor combinations (Page et
al., 1989; Thomson and Amyes, 1992b).
Increasing incidences of hyperproducing TEM-1 strains may be restricted to local
outbreaks caused by a ubiquitous strain or plasmid, since there has been no
increase in the frequency of such strains in clinical isolates (Seetulsingh et al.,
1991; Thomson and Amyes, 1993a). In addition, amoxycillin/clavulanate
resistant nosocomial E. coli which were analysed for hyperproduction may have
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comprised a single strain (Williams et al., 1988). Hyperproduction may be a
great energy drain on the cell and therefore tend to be an inefficient mechanism
of resistance.
As mentioned previously, lack of susceptibility of certain isolates eg. Serratia
marcescens, to a p-lactam plus a P-lactamase inhibitor may result from lack of
penetration of the antibiotic or the inhibitor into the cell. On the other hand, the
strains may produce an inducible cephalosporinase against which the
combination is relatively inactive (Bush et al., 1991). Occasional antagonism of
the (3-lactam activity has been attributed to the induction of chromosomal
cephalosporinases (Livermore et al., 1989). These features of induction are
further complicated if strains produce a second plasmid-mediated P-lactamase.
The success of therapy is uncertain when multiple |3-lactam antibiotics are used
in such situations (Bush et al., 1991).
It has been suggested that mutation to clavulanic acid resistance in the TEM-1
P-lactamase would deprive the enzyme of its catalytic ability to hydrolyse
P-lactam antibiotics (Thomson and Amyes, 1992b). However, such enzymes have
been selected in vitro (Manavathu et al., 1990; Bonomo et al., 1992). The
emergence of a clavulanic acid resistant TEM P-lactamase was first reported in
a clinical strain in Scotland (Thomson and Amyes, 1992a). The plasmid encoded
enzyme was named TRC-1: TEM resistant to clavulanate. The pi value of TRC-1
is lower than for TEM-1. While TRC-1 has a raised resistance to inhibition by
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clavulanic acid, as assessed by ID50 values, it is associated with only a moderate
increase in MIC to amoxycillin plus clavulanic acid. Interestingly, mutation of
TEM-1 to TRC-1 also appears to be accompanied by a decrease in resistance to
amoxycillin (Thomson and Amyes, 1993a). In addition a plasmid-mediated
enzyme, TRI (TEM resistant to P-lactamase inhibitors), has been isolated from
clinical strains in France and found to possess features comparable to TRC-1
(Vedel et al., 1992). The identification of a mutant derived from OHIO-1
(Bonomo et al., 1992) with increased inhibitor resistance, reveals that
mutations can occur amongst the SHV family of enzymes and are not restricted
to the TEM enzymes. Analysis of mutants resistant to inhibitors indicate that
this resistance is a result of an alteration in the amino acids at the active site;
the inhibitor is not able to acylate the P-lactamase irreversibly. The enzyme is
inactivated less efficiently, either as a result of decreased binding of the
inhibitor or, alternatively, the inhibitor is hydrolysed in a reaction yielding
product and free enzyme (Bonomo et al., 1992). It seems that the amino acids
methionine, at position 69, and arginine, at position 244, are crucial in the
inhibition pathway (Oliphant and Struhl, 1989; Belaaouaj et al., 1991; Delaire et al.,
1992). It is unclear if the emergence of these new enzymes will have a significant
impact in the clinical setting. At present they still appear to be rare.
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1.7. The Impact of Antibiotic Therapy
1.7.1. Acquisition of Resistant Determinants
The therapeutic use of antibiotics undoubtedly favours the selection of resistant
bacteria (Hamilton-Miller, 1990; Sanders and Sanders, 1992). It is evident,
however, that resistant determinants evolved before the advent of the antibiotic
era. A commensal flora study of people living in an "antibiotic-virgin"
community in North Borneo indicated this, as from four subjects six strains of
E. coli were found to possess transferable drug resistance (Davis and Anandan,
1970). In addition, a study of remote rural Xhosa communities in South Africa,
with minimal exposure to antibiotics, found that 19% of the coliform bacteria
examined, carried antibiotic resistant determinants (Burt and Woods, 1976).
1.7.2. Reservoirs ofAntibiotic Resistant
Determinants
E. coli is a ubiquitous micro-organism which is found in large numbers in the
gastrointestinal tract of every individual where it forms a part of the normal gut flora
(Turck et al., 1969). The potential exists for this E. coli to play a pathogenic role in
urinary tract infections (Turck et al., 1969; Bettelheim et al., 1971; MacGowan et al.,
1993) and other infections (Tullus et al., 1988). Indeed E. coli has remained the most
frequently isolated nosocomial pathogen in U.S. hospitals, accounting for
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approximately 18.6% of hospital acquired infections (Cooksey et al., 1990).
The normal human gastrointestinal microflora is a remarkably stable ecosystem
(Nord et al., 1993). However, changes in the microfora may occur if there are
physiological or ecological disturbances in the digestive tract. The most common
cause of disturbance is the administration of antimicrobial agents since the
antimicrobials might be incompletely absorbed if orally administered (Nord,
1990). In addition, they might be secreted in the saliva or bile or from the
intestinal mucosa (Nord and Heimdahl, 1986). The influence of an antimicrobial
agent on the normal microflora is mostly not beneficial to the patient as the
indigenous micro-organisms are suppressed, thereby, often permitting potential
pathogens to overgrow (Nord and Heimdahl, 1986; Nord et al., 1993).
Furthermore, the emergence of antimicrobial resistant strains is promoted
either through mutation or transfer of resistant factors between the bacteria
(Nord et al., 1993). It seems that whilst R-plasmid transfer may occur amongst
the faecal flora of subjects not taking antibiotics, transfer is much more likely
when antibiotics are being administered (Anderson et al., 1973a, 1973b;
Hawkey, 1986). While it was thought coliform flora of the gut return to a
predominantly sensitive state within 10 days or so of the end of treatment, it
now appears that, when treatment is terminated, any antibiotic resistant
strains may either rapidly disappear or alternatively, they may be maintained
for months (Hartley and Richmond, 1975). Persistence of antibiotic resistant
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microflora may be the result of an indiscriminate use of antibiotics in the
community. It has been suggested that the nature of the strain, rather than the
plasmid being carried, is of more influence in determining its survival. For
example, whether or not the strains possess the ability to stick to the intestinal
wall (Hartley and Richmond, 1975). However, it has become apparent that
plasmid carriage may impair bacterial function and, therefore, survival
(Anderson, 1974). The survival capacity of E. coli carrying R-plasmids is
uncertain. Both increased and decreased survival rates have been shown (Kelch
and Lee, 1978; Hartley and Richmond, 1975). The gastrointestinal tract is not
alone in containing bacteria that harbour antibiotic resistant determinants.
They have been detected in organisms from a number of skin sites in
hospitalised patients (Larson et al., 1986).
The acquisition of resistant bacteria may be achieved through the ingestion of
contaminated water (Young, 1993). The frequency of antibiotic resistant
determinants has been assessed in both non-polluted (Jones, 1986) and polluted
water (Al-Jebour and Al-Meshadani, 1985; Kaspar and Burgess, 1990). The
ingestion of contaminated food is another method of acquiring resistant
determinants (Levy, 1986). The flow of resistant genes from both animal to
animal and from animal to man has been extensively discussed (Smith, 1968;
Shooter et al., 1970; Anderson et al., 1975; Levy et al., 1976; Linton, 1977; Rowe
and Threlfall, 1984; Linton, 1986; Corpet, 1987).
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A number of specific reservoirs have been associated with the emergence and steady-
maintenance of antibiotic resistant bacteria and have been studied in some detail:
1.7.3. Clinical Practice
An enormous number of studies have been undertaken to assess the level of
antibiotic resistance in clinical practice (Ma et al., 1983; Mayer, 1986; Kresken
and Wiedemann, 1986; O'Brien et al., 1986). The carriage of resistance
determinants differs considerably, firstly amongst different bacterial species,
secondly with the type of antibiotics in use and thirdly, and most noticeably, it
differs in different countries.
1.7.3.1. Developing Countries
It is well established that the level of antibiotic resistance in the developing
countries is substantially higher than in developed countries (Farrar, 1985).
Ampicillin, in particular, will be considered in the following discussions of
surveys as firstly, it is the most widely used antibiotic in these countries and
indeed the world (Selwyn, 1982) on account of its relatively low cost following
the expiry of its patent (Young et al., 1989). Secondly, ampicillin resistance
among clinical isolates of E. coli is a useful indicator of resistance arising from
antibiotic selection of resistant strains among naturally susceptible species
(Sanders and Sanders, 1992).
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In South India in 1984, 82% of Enterobacteriaceae causing bacteriuria were
resistant to ampicillin (Young et al., 1989; Nandivada and Amyes, 1990). In a
study conducted in Northern India between 1984-86, 90% of the isolates
collected from man which were responsible for urinary tract infection were
resistant to one or more antimicrobial agents; 43.5% of isolates recovered from
both man and animals were resistant to ampicillin (Singh(b) et al., 1992).
Amongst children presenting with diarrhoea in the Sudan, 91% of the E. coli
isolated were resistant to ampicillin (Shears et al., 1987). Examination of
enteropathogenic E. coli strains from a nosocomial outbreak in Kenya revealed
ampicillin resistance to be 100% (Senerwa et al., 1991). Similarly, a high
incidence of ampicillin resistance (70.9%) was also found in northern Tanzania
(Gillespie et al., 1992). A survey of eight African countries reported 69% of the
E. coli were ampicillin resistant (Dowse and Prigent, 1991). Ampicillin
resistance was, however, reported to be surprisingly low in Zaire (38%), Peru
(37%) and Belize (0%) but high in Sudan (90%) (Shears et al., 1988a). As 20
individuals or less were included in each of these studies, the resistance levels
cannot be considered to be truly representative of the whole community. High
levels of antibiotic resistance in developing countries is promoted by "over the
counter" buying of drugs, indiscriminate use of antimicrobial agents and poor
sanitary conditions which facilitates the spread of resistant determinants
(Kunin et al., 1987; Shears et al., 1988a).
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1.7.3.2. Developed Countries
In comparison, in the United Kingdom, the prevalence of ampicillin resistance,
specifically, was much lower; it was found to be 18.8% in the Charing Cross
hospital in London and 24.1% in Nottingham (Simpson et al., 1980). A variation in
drug resistance in various cities was revealed in a large study of Gram-negative
isolates, mostly from urinary tract infections. In Glasgow, Dundee and Edinburgh,
71.9%, 45.2% and 48.5% of the isolates respectively, were resistant to ampicillin
(Reid et al., 1988). Two large surveys have been carried out in order to assess the
changes in the antibiotic sensitivities of urinary pathogens, firstly between 1971-
82 and secondly between 1971-89. During this period the resistance of E. coli to
ampicillin in general practice increased from 8.6% to 24.4% to 34.2% in 1971,
1981 and 1989 respectively. A similar pattern was observed in the hospital where
E. coli resistance to ampicillin increased from 15.6% to 35.7% to 43.1% in the
same years respectively (Griineberg, 1984; Griineberg, 1990). A recent
comprehensive study of general antibiotic resistance of clinical urinary isolates
reported ampicillin resistance to have in fact fallen from 48.5% to 33% in
Edinburgh and from 71.9% to 40.2% in Glasgow (Thomson et al., 1992a). In
contrast, a survey of E. coli. isolated from blood from 1969-91 indicated ampicillin
resistance to have increased from 22% to 40% (Shannon et al., 1992).
In the United States, a steady state of ampicillin resistance has been
maintained. During a 12 year survey, E. coli isolated from patients showed no
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significant change in resistance to ampicillin (25.8% mean) (Atkinson and
Lorian, 1984). A survey of Gram-negative bacteremia isolates examined a few
years later showed that ampicillin resistance (29.5% in community acquired
organisms and 37.3% in nosocomially acquired organisms) has only slightly
increased (McGowan et al., 1989).
A number of other studies have been carried out in other parts of the world. In a
university hospital and a general practice survey in Denmark the resistance
levels found in E. coli during a seven year period fluctuated only between 16-
19% suggesting little change in the selective pressure (Mpller, 1989). In a
European collaborative study, resistance in Gram-negative bacilli isolated from
blood indicated ampicillin resistance in E. coli to be slightly lower in northern
Europe (28%) than in south Europe (46%) (Dombusch et al., 1990). In an extensive
survey of Gram-negative bacteria isolated in Dutch hospitals, 42% of E. coli
were ampicillin resistant (Buirma et al., 1991). A higher level of resistance has
been observed to the aminopenicillins (55.3%) in pathogenic strains of E. coli
from Portugal (Sousa et al., 1991) while a decreasing susceptibility to ampicillin
of urinary isolates has been found in Israel; resistance ranging from 49% in
1981 to 72% in 1985 (Alon et al., 1987).
1.7.4. Farming Practice
The acquisition of antibiotic resistance may be associated with transfer of the
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determinants from animals to man (Levy, 1986). Therefore the presence of a
reservoir of antibiotic resistant determinants in animal practice is not
surprising (Levy et ai, 1987; Moellering, 1990). The development of antibiotic
resistance factors in animals has been encouraged through the use of antibiotics
in animal feeds (Smith, 1968). Such practice creates a selective pressure which,
although lower than that associated with drugs used in the treatment of clinical
disease, is of a longer duration. This exercise was mainly aimed at reducing
animal disease and also promoting animal growth. If, however, the Swann
report, produced in 1969, intended to reduce antibiotic resistance in E. coli in
the human populace by restricting the use of antibiotics in animal feed, it seems
to have failed (Richmond and Linton, 1980). Intensive farming practices
particularly allow the proliferation of resistant determinants.
1.7.5. Travel to Developing Countries
A number of studies have now been conducted which indicate that travel itself
(Levy, 1982) is associated with the acquisition of resistant E. coli. One such
study revealed the emergence of high level resistance to trimethoprim-
sulphamethoxazole: in strains of E. coli isolated from 95% of students from the
United States while either taking trimethoprim alone, or in combination with
sulphamethoxazole, for prophylaxis of travellers' diarrhoea while in Mexico
(Murray et al., 1982). This survey was of particular interest as approximately
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one third of travellers from the United states to the developing countries will
contract travellers' diarrhoea (Wanger et al., 1988). A second such study observed
the increase in resistance to mecillinam from 5% of pre-travel E. coli to 42.9% of
post-travel E. coli (Stenderup et al., 1983). The emergence of resistant faecal E. coli
in travellers not taking prophylactic antimicrobial treatment has also been shown.
After three weeks in Mexico, trimethoprim resistant E. coli in the faecal flora of
the individuals screened had risen from none to 57% (Murray et al., 1990).
1.7.6. Day Care Centres
An increasingly recognized reservoir of resistant determinants is that of day
care centres (Reves et al., 1987; Reves et al., 1990). A number of factors
contribute to promote the spread of resistant determinants in this reservoir
including ill children attending the centre (Goodman et al., 1984), the lower
standard of hygiene associated with children, the close contact between children
and the wide use of antibiotics amongst that age group (Singh et al., 1990). In
addition, the prophylactic use of antimicrobial agents in the community may
encourage the establishment of such reservoirs (Murray et al., 1982; Moellering,
1990). Although children are not representative of the community at large, they
may represent one avenue through which resistance determinants may spread
into the community.
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1.7.7. Epidemiology of Resistant Plasmids
Many studies have analysed the resistant strains isolated from the various
reservoirs and examined them for the presence of plasmids. Characterization of
the plasmids has established if common or epidemic plasmids are present in
given communities. In particular strains from the developing world have been
assessed (Crosa et al., 1977; Murray and Rensimer, 1983; Rudy and Murray,
1984; Levy et al., 1985; Shears et al., 1988a; 1988b; Shears et al., 1989). In
addition, much work had been carried out on the strains isolated from day care
centres (Gordillo et al., 1992; Singh(a) etal., 1992; Fornasini et al., 1992).
1.7.8. Commensal Flora Surveys
Non-pathogenic commensal flora of the healthy individual may act as a
reservoir of antibiotic resistant determinants (Gross et al., 1982; Hawkey, 1986;
Shears et al., 1988a). This is of considerable concern as firstly, enteric organisms
may cause either an endogenous infection, particularly in the urinary tract
(Brumfitt et al., 1971; Anderson et al., 1973a; Spgaard, 1975), or secondly, the
resistance determinants may transfer to any invading pathogens (Thomson et
al., 1993). Naturally the treatment of consequent infections will, therefore, be
complicated.
To date there has been a dearth of information in this particular field. Although a
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number of surveys have been conducted in order to establish the prevalence of
resistant strains in the gastrointestinal tract, few have taken advantage of recent
advances in molecular techniques to characterize the mechanisms of resistance
involved. The first survey of this kind was reported in 1966 (Smith and Halls,
1966). While 62% of the individuals studied carried resistant E. coli, 17% ofwhich
were resistant to ampicillin, unfortunately only 24 people were included in the
survey which, while providing some indication of resistance amongst commensals,
could not be referred to as a true representation of the community at large.
A number of surveys have sought to assess the carriage of antibiotic resistance
in the human gut by examining faecal specimens on admission to hospital. In a
study examining 100 patients on admission to hospital, E. coli resistant strains
were found in 52% of the patients, with 17% being resistant to ampicillin
(Datta, 1969). In Edinburgh, 36% of the volunteers, who were submitted for
chemotherapy treatment carried resistant coliforms in their faecal flora (Shaw
et al., 1973) while in Denmark, amongst 95 patients admitted to a male
urological ward, 67% contained resistant E. coli strains (Spgaard, 1975). Each of
these three studies assessed people without bacterial infection but whose
health was compromised in some other way; the connection with the hospital
naturally biases this group particularly as these participants may have received
other drug treatments which may have affected the normal gut flora.
The first comprehensive survey to examine truly healthy volunteers was
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conducted on 100 Irish infants. Resistant bacteria were isolated in 81% of the
cases with ampicillin resistant strains in 62% of them (Moorhouse, 1969). A
survey conducted in Sweden (Lidin-Janson et al., 1977) identified 102 out of 709
E. coli strains from children which were resistant to one or more antibacterial
agent. However, as these surveys only examined children, the results may not
be considered to be indicative of the whole community, especially as the spread
of resistant determinants through the faecal/oral route is higher in this group.
This point is clarified by a survey which examined intestinal coliform flora of
both healthy children and adults in an urban and rural community. A much
higher proportion of resistant strains was found in the former population (67%)
rather than the latter (46%) (Linton et al., 1972).
A further two studies have examined only children. Firstly, a study which
although interestingly spanned three continents, in addition to examining just
children, only a few numbers were included in the study so the results can not
be a true reflection of the total population in each area (Lester et al., 1990).
Secondly, assessment of faecal flora of children in day care centres was carried
out relatively recently (Reves et al., 1990). Although this study did not take the
whole community into consideration, it did however identify a new reservoir of
resistant determinants in its own right.
Two commensal flora studies have examined student populations. As students
only represent a small section of the community, it may be that their faecal flora
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is not representative of the total community. However, in the Netherlands, 76%
of the students contained flora resistant to ampicillin (Bonten et al., 1990) while
in Nigeria, where only trimethoprim resistance was assessed, 38.1% of the
strains were resistant to this antimicrobial (Lamikanra et al., 1989).
Another select population group examined was that of healthy staff at hospitals
in Germany, Amman, Mexico and Columbia. While the carriage rate of
ampicillin resistance was not reported, the [3-lactamases contributing to
ampicillin resistance were investigated (Simpson et al., 1986).
To date few surveys have overcome the problems of population selection. The
first study to examine a full cross section of the healthy community was carried
out amongst different age-groups in Dutch urban communities (Degener et al.,
1983). Of the specimens found to contain E. coli, 26% were resistant to
ampicillin. More recently, a study in Boston of both patients and ambulatory
volunteers found 34.9% of the latter population contained ampicillin resistant
flora (Levy et al., 1988). In a survey, carried out in South India, the highest
incidence of antibiotic resistance in any bacterial population was identified.
Nearly 100% of the samples contained strains resistant to both ampicillin and
trimethoprim (Amyes et al., 1992). A further study examined two different areas
in an industrialised country. High prevalence of resistance was found in both
populations, ranging from 28% for trimethoprim to 89% for ampicillin (Bonten
et al., 1992). The most recent survey to be conducted was based in Jeddah; 40.4%
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of the faecal bacteria from healthy urban and rural dwellers were resistant to
ampicillin (Ismaeel, 1993). It is, however, difficult to draw comparisons between
these surveys on account of differences in initial screening procedures and also in
the concentration of antibiotic employed to determine resistance.
Each of the studies discussed is associated with one or more of the following
complicating factors:
1) Biased study group - A number of the surveys examined selected groups
only, such as children (Moorhouse, 1969; Reves et al., 1990; Lester et al.,
1990), students (Lamikanra et al., 1989; Bonten et al., 1990), or patients
on admission to hospital (Datta, 1969; Shaw et al., 1973; Spgaard, 1975).
The implications of which have been discussed previously.
2) Small sample size - Insufficient sample numbers subtract from the
validity of some studies (Smith and Halls, 1966; Lester et al., 1990).
3) Lack of analysis - None of the conducted surveys have addressed themselves
to the responsible mechanism mediating resistance to ampicillin.
4) Lack of comparison - Only one research group (Lester et al., 1990)
examined the carriage of resistance in different parts of the world. This
is necessary for a true comparison.
As the healthy members of the community represent the largest reservoir of
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bacteria resistant to antimicrobial agents (Lester et al., 1990) accurate
information regarding the resistance levels within it will help in the choice of
antimicrobial regimens. Therefore, in order to establish the carriage of
resistance determinants in this particular reservoir, it is necessary for surveys
to be conducted by one team employing the same experimental procedure, in
both developing and developed countries. Furthermore, the biases associated
with the previous studies should be eliminated.
Aims
1) To establish the carriage of antibiotic resistance determinants in the aerobic
commensal flora of selected healthy populations in South Africa and in
Edinburgh.
2) To investigate the biochemical and molecular basis for the beta-lactam





The bacterial strains used were as follows:
Escherichia coli K12 J62-2 - pro" his* trp" lac' rif^ (Bachmann, 1972).
Pseudomonas aeruginosa - NCTC 10662.
Staphylococcus aureus - NCTC 6571.
Escherichia coli - NCTC 10418.
Standard (3-lactamase producing strains:
Escherichia coli K12 J53-2 containing plasmid R1 (TEM-1) (Hedges et al., 1974).
Escherichia coli K12 J53-2 containing plasmid RP4 (TEM-2) (Hedges et al., 1974).
Escherichia coli K12 J53-2 containing plasmid R1010 (SHV-1) (Petrocheilou
et al., 1977).
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Escherichia coli K12 J53-2 containing plasmid R455 (OXA-1) (Dale and
Smith, 1974).
All the stains were maintained at -70°C in nutrient broth with 10% glycerol v/v.
2.2. Media
2.2.1. Complex Media
The complex media used were Nutrient Broth No.2 (CM67), Columbia Base
Agar (CM331), Diagnostic Sensitivity Test Agar (CM261), Isosensitest Broth
(CM473), Isosensitest Agar (CM471), Agar Bacteriological No.l (Lll), and
MacConkey agar (CM7b) all from Oxoid, Basingstoke, Hants. Mueller Hinton
Broth was obtained from Difco, Michigan.
2.2.2. Minimal Media
Double strength minimal salts medium (DM) was prepared as described by Davis
and Mingioli (1950) (Table 1). Single strength minimal medium (DM) was prepared
by diluting double strength DM with an equal volume of distilled water prior to
autoclaving. Diluents were prepared by distributing single strength DM into 9.9ml
and 4.5ml aliquots and then autoclaving at 15psi for 15 minutes. Supplement
solutions for incorporation in the minimal medium are given in Table 2.
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These ingredients were all dissolved in a litre of distilled water in the order
given and then 50ml quantities were distributed and autoclaved at 15psi for 15
minutes.







D-glucose Sigma 200mg/ml 2.8mg/ml Autoclaving
L-proline BDH 5mg/ml 50pg/ml Steaming
L-histidine BDH 5mg/ml 50pg/ml Steaming
L-tryptophan BDH 2mg/ml 50pg/ml Steaming
Autoclaving was at 15psi for 15 minutes. Steaming was for 30 minutes.
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2.2.3. Preparation of Plates
2.2.3.1. Complex Media
Complex media were made up according to the manufacturer's instructions and
were autoclaved at 15psi for 15 minutes. With trimethoprim selection plates
(Amyes and Gould, 1984), the compounds listed in Table 3 were added to the
Agar No. 1 prior to autoclaving. The plates, each containing approximately
15mls of agar, were poured while the agar was still molten. With antimicrobial
drug sensitivity plates, the agar was allowed to cool to 50°C before the
appropriate antimicrobial drugs were added and the plates poured. After
setting, all the plates were dried, inverted at 55°C for 20 minutes.
Table 3. Preparation of Trimethoprim Selection Plates
Mueller Hinton Broth 21.0g
Lactose lO.Og
Bile salts 5.0g
Neutral red indicator 0.075g
Agar No. 1 12.Og
All the ingredients were added to 1L distilled water prior to autoclaving at
15psi for 15 minutes.
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2.2.3.2. Minimal Media
Minimal DM media plates were prepared as follows. The required amino acid
supplements (to give a final concentration of 50pg/ml), 1.4ml of 20% D-glucose
and the appropriate antimicrobial drugs were added, aseptically, to 50ml of
double strength DM media. Sterile distilled water was added to bring the total
volume up to 60mls. This mixture was added to 40mls of molten bacteriological
agar No.l and mixed gently before pouring.
2.3. Materials
2.3.1. Chemotherapeutic Drugs
The chemotherapeutic drugs used are listed in Table 4. Allowance was made for
the potency of those drugs combined with an inert base. All were supplied
sterile and prepared as indicated. Compounds were made up freshly as
required. In contrast, the non chemotherapeutic drug, nitrocephin (Glaxo), was
stored, in solution, in the dark at -20°C until required.
2.3.2. Buffers
Sodium phosphate buffers were prepared as described in Data for Biochemical
Research (Oxford University Press, 1974). The buffer used routinely for (3-lactamase
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Table 4. Chemotherapeutic drugs
Chemotherapeutic drug Method used to dissolve Supplier
Ampicillin (Sodium salt) HoO
























Amoxycillin (Sodium salt) sodium hydrogen carbonate SKB
HoO
(Sodium formaldehyde sulphoxylate)






















preparation and assay was 50mM sodium phosphate buffer, pH7.0.








3M sodium acetate - acetic acid








The standard molecular weight proteins used to calibrate Sephadex gel
filtration columns are shown in Table 5. For DNA gels, Lambda phage pre-cut
with restriction enzyme, Hin d III was employed.
Table 5. Proteins used as molecular weight markers









Between December 1990 and April 1991, a total of 100 faecal specimens were
collected from the "healthy" population in Edinburgh. Four separate population
groups participated in the survey including:-
(i) members of the Edinburgh University Catholic Chaplaincy Centre (33)
(ii) office workers in the city ofEdinburgh (9)
(iii) registered members of a general practice in Loanhead, Edinburgh (34)
(iv) medical students at the University ofEdinburgh (24)
The figure in parenthesis indicates the number of faecal specimens obtained
from the associated group. Candidates were excluded from the study if they had
received any medical treatment in the three weeks prior to sampling.
Information regarding the sex and age of the volunteer was requested.
2.4.1.2. Survey 2
Between November 1990 and February 1991, a total of 100 faecal specimens
were collected from the clinical diagnostic laboratories at the Medical School,
Edinburgh. The specimens had been submitted by general practitioners in the
Edinburgh region and were found not to contain any of the following pathogens:
Salmonella spp, Shigella spp, Campylobacter spp. or E. coli 0157.
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2.4.1.3. Survey 3
The survey was conducted between January and March 1992; a total of 361 faecal
specimens were obtained. Survey participants consisted of healthy volunteers
resident in the Transvaal, South Africa. The study examined eight separate
population groups from both urban and rural areas (Table 6). In the urban area,
the four groups comprised infants attending either a childminder or a creche in
South Western Townships (SOWETO), urban children and urban teenagers
attending a school in Kagiso, a town on the West Rand and urban adults who
resided in SOWETO. The rural population was composed of infants attending a
"well baby" clinic at Middleplaas in the KaNgwane district, rural children and
rural teenagers attending a school at Hekpoort in the Magaliesburg district and
lastly adults resident in KaNgwane district. Notably, the rural adults were all
associated with the hospital at Shongwe Mission and consequently were in
contact with patients. This specific population consisted of healthy mothers
feeding sick children, mothers attending a nutrition centre for children and finally
escorts to patients visiting the out patients department.
Candidates were excluded from the study if they had received any medical
treatment in the three weeks prior to sampling. Parental consent was obtained for
all persons involved of less than 18 years. A completed questionnaire (Figure 6)
accompanied each specimen.
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Have you been to hospital or a clinic in the last week? Yes/No
If yes, what was your reason for making the visit?
RECENT THERAPY






Do you eat meat?
If so, how often?
FAMILY
How many in the same family?
How many in the same house?
ANCILLARY QUESTIONS
Where do you get your water from?
Do you keep any animals?
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Rural Infants 0-5 Shongwe 50
Rural Children 6- 11 Hekpoort 47
Rural Teenagers 12 - 19 Hekpoort 36
Rural Adults >19 Shongwe 50
Urban Infants 0-5 SOWETO 45
Urban Children 6 - 11 Kagiso 42
Urban Teenagers 12 - 19 Kagiso 47
Urban Adults >19 SOWETO 44
2.4.2. Sample Processing
Rectal swabs or freshly passed faecal specimens were deposited in small plastic
containers for immediate transport to the laboratory. Following the protocol
established for such studies (Amyes et al., 1992), each faecal specimen was
streaked directly onto a series of Oxoid MacConkey Agar plates containing different
antibiotics as well as a control plate with no antibiotic. In addition, the
specimens were also plated onto Modified Difco Mueller Hinton Agar plates
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containing trimethoprim. The antibiotics employed differed in each of the
surveys (Table 7). The plates were incubated overnight at 37°C. Each plate
was scored for the presence or absence of bacterial colonies which were
subsequently classified as either lactose fermenters or lactose non-fermenters.
All non-mucoid lactose fermenters were purifed and kept for further study.
Non-mucoid strains were selected in an attempt to eliminate mucoidy as a
resistance mechanism and thus more readily identify the proportion of
plasmid-mediated resistance. Some Klebsiellae strains appeared mucoid on Iso-
sensitest agar but not on MacConkey medium. Therefore some of the non-
mucoid lactose-fermentors isolated were in fact Klebsiellae.
Table 7. Selective plates included in the surveys
Antibiotic Concentration Survey 1 Survey 2 Survey 3
pg/mL
Ampicillin 10 + + +
Cephaloridine 10 + + NT
Cefuroxime 4 + + NT
Ceftazidime 2 + + NT
Nalidixic acid 10 + + +
Ciprofloxacin 1 + + NT
Tetracycline 10 + + NT
Gentamicin 4 + + +
Trimethoprim 10 + + +
Chloramphenicol 10 NT NT +
+, tested NT, not tested
Survey 1 = Edinburgh healthy faecal flora survey
Survey 2 = Edinburgh diagnostic faecal flora survey
Survey 3 = South Africa healthy faecal flora survey
67
2.4.3. Water Sample Collection and Processing
(Survey 3 only)
From each study centre, except for Kagiso, a 100ml sample of the normal
drinking water was collected in a sterile bottle. After immediate transportation
to the laboratory, the water was filtered and the filter pad placed on an Oxoid
MacConkey agar plate containing no antibiotic. The plate was incubated
overnight at 37°C. Each plate was examined for the presence of bacterial
colonies which were subsequently identified.
2.4.4. Identification ofBacterial Species
Bacterial colonies were identified either by standard biochemical analysis as
described in Practical Medical Microbiology (Churchill Livingston, 1989).
Strains were allocated into one of four groups; E. coli, Klebsiella spp.,
Enterobacter spp., or other enterobacteria. Alternatively, the API 20E microtube
system (API System, France) was employed.
2.4.5. Plasmid Transfer
Isolates were tested for their ability to transfer their resistance determinants by
the method previously described (Amyes and Gould, 1984). The conjugation
experiments employed the rifampicin resistant E. coli K12 strain J62-2 as the
recipient. Donor and recipient strains were grown up statically overnight in
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4.5ml of nutrient broth at 37°C. After overnight growth, 0.1ml of the donor
culture and 1ml of the recipient culture were combined in 4.5ml of prewarmed
nutrient broth. The mixture was incubated at 37°C for 18 hours. Cells were
harvested by centrifugation at 4000g for 15 minutes (Heraeus Christ Bactifuge)
and resuspended in 5.6ml basal DM medium. The suspension was subsequently
diluted to 10"1, 10"2 and 10"4 in DM medium. 0.1ml of each of the dilutions and of
the neat culture was spread on minimal media DM containing rifampicin
(25mg/L) and either ampicillin (lOmg/L) or trimethoprim (lOmg/L) selective
plates. Such plates only allowed growth of a plasmid containing recipient strain.
The plates were incubated for 48 hours at 37°C after which the resultant single
colonies were purified on the same selective plates. The auxotrophic
requirements of the transconjugants were confirmed on selective DM plates,
lacking histidine. Controls consisted of spreading donor and recipient strains on
selective plates after centrifugation and resuspension in 4.5ml DM.
2.4.6. Minimum Inhibitory Concentration (MIC)
Determination on Solid Agar
A 4.5ml Isosensitest broth aliquot was inoculated with a culture from a fresh
Isosensitest Agar plate, and grown overnight at 37°C. Serial dilutions were
made with 1 in 100 dilution steps in single strength DM resulting in a 1 in 10-4
dilution. Of this suspension, 2f.il was spotted onto media containing varying
concentrations of the drug with a multipoint inoculator (Denley). All plates were
69
incubated at 37°C for 18 hours. The concentration of the drug increased by a
factor of two in the plates and the MIC was taken as the first concentration
permitting no visible growth. A control plate lacking any drug was used in each
case. In addition, NCTC strains, E. coli, S. aureus and Ps. aeruginosa were
included as control strains.
2.4.7. Antibiogram Determination
The protocol for MIC determination on solid agar as described was followed
except that 2pl of bacterial suspension was spotted onto a range of Isosensitest
agar plates containing a single antibiotic at a given breakpoint value (BSAC
guidelines). All plates were incubated at 37°C for 18 hours. As before, a control
plate and control strains were used in each case.
2.4.8. Isolation of Plasmid DNA
Isolation of plasmid DNA was by the method of Takahashi and Nagano (1984).
After 4.5ml nutrient broths were inoculated with a single bacterial colony and
grown, shaking overnight, at 37°C, the cells were harvested by centrifugation at
4000g for 15 minutes (Heraeus Christ Bactifuge). The procedure described by
the authors was then followed. A final volume of lOOpl plasmid DNA solution
was obtained. Plasmids were analysed by agarose gel electrophoresis.
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2.4.9. Preparation of DNA for Endonuclease
Restriction Digestion
Plasmid DNA for endonuclease restriction digestion was extracted as described
previously (Takahashi and Nagano, 1984).
A further 350pl Solution C buffer and 50pl Solution D buffer were added to lOOgl
plasmid DNA solution. This solution was inverted 5 times prior to precipitation
with 2 volumes of cold ethanol at -20°C for 10 minutes. The precipitate was
collected by centrifugation at 4°C for 10 minutes at high speed (MSE Micro
Centaur) after which the pellet was dried in a vacuum desiccator for 5 minutes.
The pellet was dissolved in 60pl of a RNAse solution (50mg/L) (Sigma) and
incubated at 65°C for 10 minutes.
The restriction endonuclease digest was carried out in a sterile eppendorf tube
in a 37°C water bath for 4 hours. The restriction digest mixture consisted of:-
- 18pl plasmid DNA solution
- 2pl restriction endonuclease buffer (10 times strength, NBL Enzymes)
- lpl restriction endonuclease (NBL)
Unless otherwise stated, restriction endonuclease Eco R1 in combination with
restriction buffer "React 3" (NBL) were employed. The reaction was terminated by
adding lOpl loading buffer (0.25% bromophenol blue, 0.25% xylene cyanol, 30%
glycerol in water). The sample was analysed by agarose gel electrophoresis.
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2.4.10. Agarose Gel Electrophoresis
Horizontal slab gel electophoresis was performed by the method of Meyers et al.
(1976). Plasmid DNA was electrophoresed overnight at 70V in a 0.7% (w/v) agarose
gel (Sigma) while restricted DNA was electrophoresed overnight at 60V in a 0.8%
(w/v) agarose gel. DNA was visualised by staining with ethidium bromide (0.5 mg
in 1L) and examination on a flat bed UV source. Agarose gels were photographed
with an IBI Polaroid Quick Shooter camera (Model NO. 46400) with a orange filter.
2.4.11. Large Scale p-Lactamase Preparation of
Crude Cell Extracts
P-lactamase extracts were prepared as described by Simpson et al. (1980).
Nutrient broth (1L) was inoculated with a bacterial colony and incubated,
shaking, at 37°C overnight. Cells were harvested at 6000g for 15 minutes at
4°C (Sorvall RC-5B Refrigerated Superspeed Centrifuge, Du Pont
Instruments). The pellet was resuspended in lOmls 50mM, pH7.0, sodium
phosphate buffer. A further pellet was obtained after centrifugation at 4000g
(Heraeus Christ Bactifuge) for 15 minutes. The final pellet was resuspended in
lml 50mM, pH7.0, sodium phosphate buffer. The cells were disrupted by
ultrasonication (8pm, 2 x 30 seconds separated with a 1 minute break) with
constant cooling (MSE Soniprep 150, MSE Instruments, Crawley). The cell
lysate was cleared by centrifugation at 32000g for 30 minutes at 4°C (Sorvall).
The supernatant crude enzyme preparation was stored at -20°C until required.
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2.4.12. Small Scale (3-Lactamase Preparation of
Crude Cell Extracts
A 10ml nutrient agar slope was inoculated with a bacterial culture and
incubated at 37°C overnight. The overnight growth was washed off the slope
with 1ml sodium phosphate buffer (50mM, pH7.0). The cells were disrupted by
ultrasonication (8pm, 2 x 15 seconds separated with a 30 second break,
Soniprep). The cell lysate was removed by centrifugation for 10 minutes at 4°C
at high speed (MSE Micro Centaur). The cleared lysate was transferred to a
fresh tube and stored at -20°C until required.
2.4.13. Assessment of P-Lactamase Activity in Small
Scale Preparations
In a microtitre plate (Sterilin), 30pl of crude (3-lactamase was added to lOOpl
nitrocephin solution (50pg/ml). The reaction time, or the time taken for a colour
change from yellow to red, was taken as an indication of the (5-lactamase
activity of the enzyme preparation (Simpson et al., 1980).
2.4.14. Analytical Isoelectric Focusing
Analytical isoelectric focusing (IEF) of P-lactamases was performed by the
method of Matthew et al., (1975). A glass plate was employed to support a thin
layer of polyacrylamide gel containing ampholines on which crude P-lactamases
73
were focused. The composition of the gel is described in Table 8. Standard crude
preparations of broad-spectrum [3-lactamases of known pi values were used as
controls.
Crude small scale (3-lactamase preparations were applied to the surface of the
gel at the anode end. A maximum of 12 (3-lactamase samples could be loaded to
each gel. The amount of enzyme loaded directly related to the enzyme activity
as determined by nitrocephin testing ie. time in seconds for colour change
equalled volume in f.il loaded up to a maximum volume of 30pl. Isoelectric
focusing was carried out at 4°C at 500V and 20mA, limited by constant power
set at 1W for 18 hours (LKB 10-2000V Power Pack).
Table 8. Composition of polyacrylamide gels for analytical isoelectric
focusing
Material Supplier Volume Final
Used Concentration
5% tetramethyl-ethylenediamine Sigma 0.2ml 0.25mg/L
(TEMED) in distilled water
40% ampholines w/v LKB 2.0ml 12%w/v
(pH 3.5-10 and pH 4-6)
Acrylamide (lOOg) plus BDH 9.0ml acrylamide 70mg/L
methylene bisacrylamide bisacrylamide 2mg/L
(2.7g) in water (300mls)
Distilled water 25.0ml
Riboflavin (20mg/L) Sigma 4.0ml 2mg/L
These ingredients were combined together immediately before the gel was poured.
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Bands of P-lactamase activity were detected by staining the polyacrylamide gels
with nitrocephin (500mg/L). A sheet of Whatman No.l paper, which had been
dipped in the solution of nitrocephin, was placed on the surface of the gel,
taking care not to trap any air bubbles. The focused bands of p-lactamase
activity appeared red on a yellow background.
The polyacrylamide gels were photographed on a light box employing an IBI
Polaroid Quick Shooter camera (Model No. 46400) with a green filter.
2.4.15. Gel Filtration
An LKB (Bromma, Sweden) column (90 x 2cm2) filled with sephadex G75
(Pharmacia, Uppsala, Sweden) was maintained at 4°C in an LKB mini cold lab.
A peristaltic pump (LKB) controlled the flow rate of the column buffer, sodium
phosphate buffer (50mM, pH7.0), at 2ml per 10 minutes.
Samples for separation (1 - 2ml) were applied to the bottom of the column and eluted
with sodium phosphate buffer. Fractions were collected with an LKB Ultrorac fraction
collector. Elution was continued until a volume of buffer equivalent to the total column
volume had passed through (180mls). The column was washed with sodium phosphate
buffer for 12 hours between each run. Fractions containing (3-lactamases activity were
determined by testing samples with nitrocephin spotting solution (50mg/L); fractions
with peak P-lactamase activity were pooled for further analysis.
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2.4.16. Enzyme MolecularWeight Determinations
Calibration of the Sephadex column was based on the method of Andrews
(1964). Standard proteins (Table 5), at a concentration of 5mg, were dissolved in
2ml 50mM sodium phosphate buffer (pH7.0) and applied to the Sephadex
column. After elution and collection of the fractions, the position of the protein
peaks was determined by measuring the absorbance of the fractions at 280nm.
2.4.17. Protein Estimations
Protein estimations were determined according to the method of Waddell (1956).
All samples were suitably diluted in sterile water and the absorbance measured
at 215 and 225nm. The protein concentration (mg/L), which was correlated with
a standard curve of bovine serum albumin concentrations in a Perkin-Elmer
Lambda 2 spectrophotometer, could then be calculated with the formula:
(215nm - 225nm) x 165
2.4.18. Assays of (3-Lactamase Activity
The ultraviolet absorption spectrum of penicillins and cephalosporins is altered
if the cyclic amide bond in the P-lactam ring is hydrolysed. The wavelength at
which maximum decrease in absorption occurs following hydrolysis is termed X max.
The rate of substrate hydrolysis is assessed by measuring the rate of decrease in
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optical density (OD) at A. max (Reid, 1986). The wavelength employed therefore
varied with the different P-lactams (Table 9).






P-lactamase activity was measured by spectrophotometric assay following the
method of O'Callaghan et al. (1969). The assays were performed in a Perkin
Elmer Lambda 2 spectrophotometer at 37°C. Penicillin and cephalosporin
substrates were prepared at 10-'2M and KHM respectively in 50mM sodium
phosphate buffer (pH7.0). Test and blank cuvettes were prepared and
equilibrated at 37°C. The test cuvette contained the following:
- 0.3ml substrate
- 2.6ml sodium phosphate buffer (50mM, pH7.0)
- 0.1ml P-lactamase preparation
The blank cuvette contained 2.9ml buffer but no substrate. The initial linear part
of the reaction curve was used to obtain a value for change in OD per minute.
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Calculation: R = OD x N x enzyme dilution
OD1 x time
where
R = pmoles of substrate hydrolysed per minute per ml enzyme
OD = change in optical density
N = jjmoles substrate in cuvette
(0.3 for cephalosporins, 3.0 for penicillins)
OD1 = optical density of intact substrate
2.4.19. Inhibition of (3-Lactamase Activity
The effect of (3-lactamase inhibitors on specific (3-lactamases was determined
employing the spectrophotometry assay (O'Callaghan et al., 1969). In each assay,
nitrocephin was employed as the substrate. After the (3-lactamase inhibitor was
added to the cuvette, the mixture was pre-incubated at 37°C for 5 minutes prior
to the start of the assay. A range of inhibitor concentrations was employed in
order to determine the concentration required for 50% inhibition (ID50) of
enzyme activity.
2.4.20. Mutation Studies
Mutation studies were carried out following the procedure described by
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Thomson and Amyes (1993b). E. coli J62-2 transconjugants were inoculated into
100ml Isosensitest broths containing amoxycillin plus clavulanic acid in a 2:1
ratio at a range of concentrations. The concentrations included were one below
the plate MIC of the experimental transconjugant, one on the MIC, one above
the MIC and two above the MIC of the transconjugant. After 18 hours
incubation at 37°C those cultures which had grown, were subcultured into fresh
Isosensitest broth containing the same concentration of amoxycillin/clavulanate.
This was repeated five times. After the final subculture, bacteria were
harvested from 10ml of the culture by centrifugation at 4500g, for 15 minutes
(Heraeus Christ Bactifuge). The pellet was resuspended in 10ml DM media and
0.1ml spread onto Isosensitest agar plates containing amoxycillin/clavulanate at
the same concentration as the strain had been cultured in. Ten single colonies





3.1. Survey ofAntibiotic Resistance in
the Aerobic Faecal Flora of the
Healthy Population in Edinburgh.
There have been very few controlled studies conducted to determine the
carriage of antibiotic resistance genes amongst the commensal faecal flora of
healthy individuals selected from non-biased populations. Furthermore, there
has been little investigation into the biochemical and molecular basis for the
antibiotic resistance in such reservoirs.
3.1.1. Study Design
Between January and June 1991, a survey of antibiotic resistance in the aerobic
faecal flora of the healthy population in Edinburgh was undertaken. Four separate
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population groups in Edinburgh participated in the study (Table 10). A total of 100
specimens was collected. No volunteer was allowed to participate in the study if
they had received any antimicrobial treatment in the three weeks prior to
sampling. All participants were described as "healthy". In addition, to prevent bias,
those volunteers chosen from general practice had no gastrointestinal condition.
The study group consisted of 46 males, 45 females and 9 unknown and were
equally distributed throughout the population groups (Table 10).
Table 10. The study populations included in the survey
Group Number Male Female Unknown
Medical Students 24 11 11 2
Office Workers 9 7 0 2
Catholic Chaplaincy Members 33 14 19 0
General Practice Members 34 15 15 4
3.1.2. The Carriage of Antibiotic Resistance in the
Aerobic Faecal Flora
The carriage of antibiotic resistant determinants amongst the commensal
faecal flora of the healthy population examined in Edinburgh, along with
the antibiotic breakpoint sensitivity values used to determine resistance, is
shown in Table 11. The protocol employed for the isolation of resistant
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strains is as described in the Materials and Methods.
Table 11. Proportion of volunteers with antibiotic resistant bacteria





Number of volunteers with resistant bacteria
Students OW CCM GPM %
Ampicillin 10 8 4 8 22 42
Cefuroxime 4 10 2 10 17 39
Ceftazidime 2 0 0 0 0 0
Gentamicin 4 1 0 0 0 1
Tetracycline 10 10 2 9 6 27
Nalidixic acid 10 0 0 0 2 2
Ciprofloxacin 1 0 0 0 0 0
Trimethoprim 10 4 1 1 6 12
OW = Office Workers
CCM = Catholic Chaplaincy Members
GPM = General Practice Members
The highest incidence of resistance was identified against ampicillin as 42% of
the specimens contained lactose-fermenting, aerobic bacteria not susceptible to
the drug. Resistance to another P-lactam agent was also high; 39% of specimens
contained cefuroxime resistant bacteria. This result may, however, not be real (see
page 189). However, no resistance was found to the later generation cephalosporin,
ceftazidime. Similarly, no resistance was
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detected to ciprofloxacin while only a few specimens contained bacteria
resistant to nalidixic acid (2%) and gentamicin (1%). Tetracycline resistance was
present in 27% of specimens while trimethoprim resistance was found to be only
12%. There was no significant difference in the carriage of resistance found
between the different population groups.
3.1.3. Identification of the Ampicillin Resistant
Strains
The 42 ampicillin resistant strains that were obtained, were all identified
employing the API 20E system (Table 12). As shown in Table 12, E. coli
predominated amongst the isolates.
Table 12. Identification of the ampicillin resistant strains
Species Number Percentage
Escherichia coli 28 66.7
Klebsiella oxytoca 7 16.6
Klebsiella pneumoniae 2 4.8
Citrobacter freundii. 3 7.1
Citrobacter diuersus 1 2.4
Hafnia alvei. 1 2.4
The ampicillin resistant strains were analysed further:
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3.1.4. Sensitivity of Ampicillin Resistant Strains to a
Range of (3-Lactam Agents
The sensitivity of the ampicillin resistant strains to a range of (3-lactam agents
was tested. The minimum inhibitory concentration (MIC) of amoxycillin,
amoxycillin plus clavulanic acid, cefotaxime, ceftazidime and cefuroxime, was
determined. The results are shown in Table 13. Amongst the 42 isolates, 24
(57%) were highly resistant to amoxycillin (MIC > 512mg/L) and were
predominantly E. coli. Amongst the E. coli, 14% were cefuroxime resistant
(MIC > 4mg/L) whilst there was almost uniform sensitivity to cefotaxime and
ceftazidime (MIC < 2mg/L). The addition of clavulanic acid restored the
sensitivity of the E. coli to amoxycillin to an MIC below 32 mg/L in all but two
cases. Those isolates identified as Klebsiella spp. had lower MIC's of amoxycillin
and amoxycillin in combination with clavulanic acid than the E. coli and
universal sensitivity to cefuroxime, cefotaxime and ceftazidime. The small
number of Citrobacter spp. and Hafnia spp. identified showed variable
resistance to amoxycillin, amoxycillin plus clavulanic acid and cefuroxime but
no resistance to ceftazidime and cefotaxime.
3.1.5. Transfer ofAmpicillin Resistant Determinants
The ability of the ampicillin resistant strains to transfer their resistance
determinants by conjugation to the standard bacterial strain E. coli J62-2 and
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Table 13. Minimum Inhibitory Concentration (mg/L) of ampicillin





+ Clav CTZ CAZ CXM
•bp-lactamase Species
PS 19 >1024 16 2 2 2 TEM-1 E. coli
PS 43 >1024 16 2 2 4 TEM-1 E. coli
* PS 47 >1024 16 2 2 2 TEM-1 E. coli
* PS 279 >1024 16 2 2 4 TEM-1 E. coli
PS 302 >1024 16 2 2 4 TEM-1 E. coli
* PS 307 >1024 16 2 2 2 TEM-1 E. coli
PS 322 >1024 16 2 2 4 TEM-1 E. coli
* PS 516 >1024 16 2 2 2 TEM-1 E. coli
* PS 529 >1024 16 2 2 4 TEM-1 E. coli
PS 12 1024 8 2 2 2 TEM-1 E. coli
* PS 17 1024 16 2 2 4 TEM-1 E. coli
PS 27 1024 32 2 8 32 Chrom E. coli
* PS 31 1024 16 2 2 2 TEM-1 E. coli
* PS 275 1024 16 2 2 4 TEM-1 E. coli
* PS 277 1024 16 2 2 2 TEM-1 E. coli
* PS 283 1024 16 2 2 4 TEM-1 E. coli
PS 295 1024 8 2 2 8 TEM-1 E. coli
PS 305 1024 8 2 2 4 TEM-1 jE. coli
PS 319 1024 8 2 2 4 TEM-1 E. coli
* PS 320 1024 16 2 2 4 TEM-1 E. coli
PS 327 1024 8 2 2 8 TEM-1 E. coli
* PS 512 1024 16 2 2 4 TEM-1 E. coli
* PS 520 1024 16 2 2 2 TEM-1 E. coli
* PS 503 512 16 2 2 2 TEM-1 E. coli
PS 526 512 2 2 2 2 TEM-1 E. coli
PS 332 256 32 2 2 16 TEM-1 E. coli
PS 530 32 2 2 2 2 N.I E. coli
PS 336 16 2 2 2 4 Chrom E. coli
PS 35 64 2 2 2 2 SHV-1 K. oxy
PS 40 64 2 2 2 2 N.I K. oxy
PS 293 64 2 2 2 2 SHV-1 K.pneu
PS 318 64 2 2 2 2 K1 K. oxy
PS 508 64 4 2 2 2 SHV-1 K. oxy
PS 42 32 2 2 2 2 SHV-1 K. oxy
PS 308 32 2 2 2 2 SHV-1 K. oxy
PS 522 32 2 2 2 2 TEM-1 K. oxy
PS 312 32 2 2 2 2 N.D K.pneu
PS 285 1024 8 2 2 2 TEM-1 C. freu
PS 21 256 64 2 2 4 Chrom C. freu
PS 290 256 64 2 2 2 Chrom C. freu
PS 50 16 16 2 2 16 TEM-1 C. dive
PS 3 32 16 2 2 2 TEM-1 H. alvei
*
= Transferable strain - See section 3.1.5 N.D.= Not detected
d*(3-lactamase = see section 3.1.8. N.I. = Not identified
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therefore to an isogenic background was tested. Amongst the isolates, 14 (33%)
exhibited this ability. Each of the wild type transferable strains was noted as E. coli
from the previous identification procedure and have been labelled in Table 13.
Interestingly, each of the transferable strains mediated a high level of resistance to
amoxycillin.
3.1.6. Antibiogram Analysis of Ampicillin Resistant
Transconjugants
Each transconjugant was tested for its ability to confer resistance to a range of
antimicrobials including amoxycillin (lOmg/L), amoxycillin plus clavulanic acid
(10:5mg/L), trimethoprim (lOmg/L), gentamicin (4mg/L),
cefuroxime (4mg/L), ceftazidime (2mg/L), chloramphenicol (lOmg/L), tetracycline
(lOmg/L), streptomycin (lOmg/L) and spectinomycin (lOmg/L). As a result, an
antibiogram profile for each transconjugant was established (Table 14). One
profile, where resistance to ampicillin, cefuroxime, streptomycin and
spectinomycin was mediated, was found to predominate.
3.1.7. Plasmid Analysis ofAmpicillin Resistant
Transconjugants
Plasmid extraction, as outlined in the Materials and Methods, was carried out
in order to examine the plasmid content of each transconjugant. Although three
transconjugants contained more than one plasmid, the remainder of the
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ES 20 1 80.9 A Ap Cf Sm Sp
ES 59 3 80.9 A Ap Cf Sm Sp
ES 68 1 80.9 A Ap Cf Sm Sp
ES 75 1 84.1 A Ap Cf Sm Sp
ES 76 1 82.9 A Ap Cf Sm Sp
ES 60 1 87.9 B Ap Cf Sm Sp Cm Tc
ES 62 1 87.0 C Ap Cf Sm Sp Tc
ES 63 81.9 D Ap Cf Sm Sp
ES 73 1 81.9 D Ap Cf Sm Sp
ES 64 1 85.7 E Ap Cf Sm Sp
ES 65 121.5 F Ap CfSp
ES 67 1 46.5 G Ap Cf Sm Sp Tp
ES 69 1 54.8 H Ap Cf Sm Sp
ES 72 1 46.1 I Ap Cf Sm Sp
Ap = Ampicillin, Cf = Cefuroxime, Sm = Streptomycin
Sp = Spectinomycin, Cm = Chloramphenicol, Tc = Tetracycline
Tp = Trimethoprim
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transconjugants contained only a single plasmid (Figure 7, Table 14).
The relatedness of these plasmids was then investigated by endonuclease
restriction analysis with Eco Rl. As a result, the presence of common or closely
related plasmid types were observed. From the endonuclease digestion pattern
(Figure 8), the plasmids were assigned to a number of groups. Plasmids with
closely related restriction digest patterns were assigned to the same category,
that is, if they differed by no more than three bands. If the profiles differed,
however, by four bands or more, the plasmids were assigned to a separate group.
As shown in Figure 8, a number of different plasmid types (9) were identified. A
common plasmid type was, however, isolated on 5 occasions (Figure 8; Tracks A,
B, I, M and N). Each of these plasmids conferred resistance to amoxycillin,
, cefuroxime, streptomycin and spectinomycin suggesting the
plasmid was the same. Another plasmid was present on two occasions (Figure 8;
Tracks E and L) and appeared to be related to the common plasmid because the
bands present in the common plasmid also featured in the related plasmids.
Indeed, the profiles differed by only three bands. Furthermore, the antibiogram
profiles were identical. The remaining seven plasmids occurred on single
occasions and although the endonuclease restriction digest is quite different for
each, the antibiogram profile revealed that, in common with the other plasmids
isolated, resistance was mediated to amoxycillin, cefuroxime, streptomycin and
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Figure 7. Agarose gel electrophoresis of plasmid DNA extracted from
Edinburgh transconjugants
Tracks:-
A) ES 20; B) ES 59; C) ES 60; D) ES 62; E) ES 63; F) ES 64; G) ES 65; H) ES 67;
I) ES 68; J) ES 69; K) ES 72; L) ES 73; M) ES 75; N) ES 76; O) X pre-cut with
Hin dill




Figure 8. Agarose gel electrophoresis of restriction endonuclease
digestion of plasmid DNA, with Eco Rl, extracted from
Edinburgh transconjugants
Tracks:-
A) ES 20; B) ES 59; C) ES 60; D) ES 62; E) ES 63; F) ES 64; G) ES 65; H) ES 67;
I) ES 68; J) ES 69; K) ES 72; L) ES 73; M) ES 75; N) ES 76; O) X pre-cut with
Eco Rl; P) X pre-cut with Hin dill
A B C DEFGH I JKLMN O P
Kb
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spectinomycin and in some cases, resistance was also conferred to
chloramphenicol, tetracycline or trimethoprim. The analysis of the plasmids by
restriction endonuclease digestion and the subsequent plasmid classification is
shown in Table 14.
The distribution of the plasmid types throughout the study population groups is
shown in Table 15. Interestingly, the occurrence of the common plasmid type
(Group A) did not seem to be restricted to one population group suggesting that
this plasmid type might be spread throughout the community.
Table 15. Distribution of the ampicillin resistant plasmids amongst
the population groups
Source Plasmid Group
Medical Students A, C, G, H
Office Workers A
Catholic Chaplaincy Members B
General Practice Members A, D, E, F, I
3.1.8. Distribution of P-Lactamases in the Ampicillin
Resistant Strains
The different (5-lactamases responsible for mediating resistance to ampicillin
amongst the strains isolated, were determined by iso-electric focusing. All of the
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transconjugants encoded the TEM-1 P-lactamase (Table 13; Figure 9) regardless of
the plasmid type on which the gene was carried. In contrast, the non-transferable
strains which were also examined (Table 13; Figure 10, 11, 12 and 13) encoded a
variety of different P-lactamases. Amongst the non-transferable E. coli, only three
isolates did not produce TEM-1; in one isolate no p-lactamase was detected, whilst
in the other two isolates, chromosomal P-lactamases were identified. Amongst the
Klebsiella isolates there was a greater heterogeneity of P-lactamase production.
Whilst SHV-1 predominated amongst these isolates, TEM-1 and K1 were also
found to be present. In addition, one isolate produced no enzyme at all. The
Citrobacter spp. and Hafnia spp. produced only TEM-1 or chromosomal enzyme.
3.1.9. Specific Activity of the TEM-1 (3-Lactamase and
Resistance to Clavulanic Acid
It has been suggested that resistance to amoxycillin and amoxycillin plus
clavulanic acid may be associated with the specific activity of the P-lactamase.
Therefore, the specific activities of the P-lactamases in each of the
transconjugants were determined (Table 16). When compared with the
previously established MIC to amoxycillin and amoxycillin plus clavulanic acid,
no relationship could be established between the two (Table 13). Similarly, with
reference to Table 14, no significant correlation could be identified between the
plasmid type and the specific activity of the P-lactamase.
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Figure 9. Analytical iso-electric focusing of (3-lactamases in the
Edinburgh transconjugants
Tracks
A) ES 20; B) ES 59; C) ES 60; D) ES 62; E) ES 63; F) R1 (TEM-1 producer);
G) ES 64; H) ES 65; I) ES 67; J) ES 68; K) ES 69






Figure 10. Analytical iso-electric focusing of (3-lactamases isolated from
wild type, non-transferable ampicillin resistant strains in
Edinburgh
Tracks:-
A) PS 293; B) PS 308; C) PS 312; D) PS 19; E) PS 508; F) R1 (TEM-1 producer);
G) PS 27; H) PS 42; I) PS 43; J) PS 285; K) PS 290




Figure 11. Analytical iso-electric focusing of p-lactamases isolated from
wild type, non-transferable ampicillin resistant strains in
Edinburgh
Tracks
A) PS 295; B) R1010 (SHV-1 producer); C) PS 318; D) PS 319; E) R455 (OXA-1
producer); F) PS 336; G) PS 21; H) RP4 (TEM-2 producer); I) R1 (TEM-1
producer); J) PS 327







Figure 12. Analytical iso-electric focusing of (3-lactamases isolated from
wild type, non-transferable ampicillin resistant strains in
Edinburgh
Tracks:-
A) PS 3; B) PS 50; C) PS 332; D) R1 (TEM-1 producer); E) PS 522; F) PS 526; G)
PS 27; H) PS 35; I) R1010 (SHV-1 producer); J) PS 40
ABCDEFGHIJ
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Figure 13. Analytical iso-electric focusing of ^-lactamases isolated from
wild type, non-transferable ampicillin resistant strains in
Edinburgh
Tracks:-
A) PS 12; B) R1 (TEM-1 producer); C) PS 302; D) PS 305; E) PS 322;
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The MIC of amoxycillin and amoxycillin plus clavulanic acid was determined for
each ampicillin resistant transconjugant (Table 16). As a result, the level of
resistance to ampicillin owing purely to the transferable resistance determinants
was established. In comparison to the MIC values of wild type strains where 13
of the 14 transferable isolates were resistant to 1024mg/L amoxycillin (Table 13),
the level of resistance in the transconjugants was much lower. Only two
transconjugants were resistant to 512mg/L amoxycillin, while the remaining 12
transconjugants were resistant to 256mg/L amoxycillin. This suggests that the
resistance levels in the original strains do not simply derive from the (3-
lactamase activity but are interdependent with the rate of penetration of the
drug into the cell and the ability of the drug to bind to and inactivate its target,
the penicillin-binding proteins. All the transconjugants had an MIC of 8mg/L to
amoxycillin plus clavulanic acid. Yet again, no relationship could be established
between these MIC values and the specific activity of the (3-lactamases.
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Table 16. The different specific activities and the sensitivities to






Minimum inhibitory concentration mg/L
Amoxycillin Amoxycillin + Clavulanic acid
ES 62 (PS 283) 0.0127 512 8
ES 67 (PS 275) 0.0355 512 8
ES 20 (PS 47) 0.0022 256 8
ES 59 (PS 307) 0.0193 256 8
ES 60 (PS 320) 0.0068 256 8
ES 63 (PS 503) 0.0289 256 8
ES 64 (PS 512) 0.0177 256 8
ES 65 (PS 516) 0.0181 256 8
ES 68 (PS 277) 0.0052 256 8
ES 69 (PS 279) 0.0042 256 8
ES 72 (PS 17) 0.0031 256 8
ES 73 (PS 31) 0.0057 256 8
ES 75 (PS 520) 0.0034 256 8
ES 76 (PS 529) 0.0028 256 8
•I* = A pmoles nitrocephin hydrolysed / min/ mg protein
0 = Original isolate number
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3.2 Follow-up Survey of Ampicillin
Resistance in the Aerobic Faecal
Flora of the Healthy Population in
Edinburgh
The high carriage rate of ampicillin resistant determinants amongst the
commensal faecal flora of the healthy population in Edinburgh was surprising.
In addition, the presence of an epidemic plasmid amongst these strains was also
unexpected. To determine if ampicillin resistant bacteria are maintained in this
population group, a follow-up survey was conducted.
3.2.1. Study Design
Two years after the original survey of the carriage of antibiotic resistance in the
healthy population in Edinburgh, a follow-up survey was performed. Volunteers
were those from the original survey, whose faecal specimen contained bacteria
capable of transferring ampicillin resistance; five of the 14 candidates could be
contacted and hence participated in the survey. These participants were evenly
distributed between the various population groups, that is the general practice
members (2), office workers (2) and Catholic Chaplaincy Centre (1). As before,
there had been no antimicrobial therapy received by the participants in the
three weeks prior to sampling.
t
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3.2.2. The Carriage ofAmpicillin Resistance in the
Aerobic Faecal Flora
The carriage of ampicillin resistant determinants amongst the commensal
faecal flora of the selected healthy population re-examined in Edinburgh is
shown in Table 17. Amongst the five participants, three were found to contain
ampicillin resistant non-mucoid aerobic lactose-fermenting bacteria. The
protocol employed for the isolation of the ampicillin resistant strains is as
described in the Materials and Methods.
Table 17. Volunteers in Edinburgh re-examined for presence of
ampicillin (Ap) resistant bacteria (lOmg/L) in their
commensal faecal flora
Participants Population Group Sex Ap Resistant Bacteria
No.l OW Male ++
No.2 OW Male
-
No. 3 GPM Male ++
No.4 GPM Male ++
No.5 CCC Male
—
OW = Office Workers ++ = Growth
GPM = General Practice Members
_ = No growth
CCC = Catholic Chaplaincy Centre
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3.2.3. Transfer ofAmpicillin Resistant Determinants
The ability of the ampicillin resistant strains to transfer their resistance
determinants by conjugation to the isogenic background of the standard
bacterial strain E. coli J62-2 was tested. Amongst the three isolates, only one
(No.3) transferred ampicillin resistance. In the initial study, the transconjugant
obtained from bacteria isolated from this volunteer was ES 76.
3.2.4. Plasmid Analysis of the Ampicillin Resistant
Transconjugants
To examine the plasmid contents of the new transconjugant and to establish if
plasmid similarities with the original transconjugant (ES 76) existed, the
plasmids from both transconjugants were extracted and restricted by
endonuclease digestion as described previously. From the endonuclease digest
pattern, shown in Figure 14, the newly isolated plasmid (Track B) was identical
to the plasmid identified in ES 76 two years previously (Track A).
3.2.5. Distribution of ^-Lactamases in the Isolated
Ampicillin Resistant Strains
The different (3-lactamases responsible for mediating resistance to ampicillin
amongst all of the isolates, both transferable and non-transferable, were
determined by iso-electric focusing. From Figure 15, it may be seen that as in
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Figure 14. Agarose gel electrophoresis of endonuclease restriction
digest of plasmid DNA obtained from Edinburgh
transconjugants
Tracks
A) ES 76; B) PS 1528; C) X pre-cut with Hin dill
Figure 15. Analytical iso-electric focusing of P-lactamases in the
Edinburgh transconjugants
Tracks
D) PS 1527; E) PS 1528; F) PS 1529; G) R1 (TEM-1 producer)




the original survey, the transferable strain (Track E) produced TEM-1 P-
lactamase. While one of the non-transferable strains also produced TEM-1
(Track F), the other (Track D) produced a chromosomal P-lactamase (pi 9.5).
3.2.6. Identification and Antibiogram Analysis of the
Ampicillin Resistant Strains
The ampicillin resistant strains were all identified as E. coli employing the
standard biochemical tests outlined in the Materials and Methods. The single
transconjugant was tested for its ability to confer resistance to a range of
antimicrobials including amoxycillin (lOmg/L), trimethoprim (lOmg/L),
gentamicin (4mg/L), cephaloridine (lOmg/L), cefuroxime (4mg/L), ceftazidime
(2mg/L), chloramphenicol (lOmg/L), tetracycline (lOmg/L), streptomycin
(lOmg/L) and spectinomycin (lOmg/L). The transconjugant was found to
mediate resistance to ampicillin and streptomycin. In addition to ampicillin and
streptomycin, the plasmid identified in ES 76 two years previously was able to
confer resistance to spectinomycin and cefuroxime. It may be concluded
therefore, that the newly isolated plasmid has since lost these specific
resistance determinants. Alternatively, this variation might be explained if the
break-point concentrations, employed in the testing, were very close to the
actual MIC values of the strains. Under such circumstances, differences in the
sensitivity of the strains may be expected if slightly different concentrations of
antibiotic were used in each testing.
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3.3. A Comparison of Plasmids Isolated
from Normal Faecal E. coli with
Plasmids Isolated from Clinical
Urinary E. coli.
The genetic and biochemical basis for the development and spread of resistance
is well documented in clinical settings. Unfortunately, until now, few of the
studies on the normal E. coli from healthy populations have examined the
mechanisms of resistance in the strains isolated (see Section 3.1.8). The value of
such studies is obvious in establishing whether the resistance genes and
plasmids in the normal flora are indeed the progenitors of those encountered in
clinical isolates. A direct comparison was conducted in order to determine if the
plasmids, mediating resistance to ampicillin in the clinical environment, were
present in the healthy community.
3.3.1. Source ofPlasmids Employed in the Comparison
Study
In December 1990, a survey of antibiotic resistance in urinary bacteria responsible for
significant bacteriuria, isolated in central Scotland, was conducted (Thomson et al.,
1992a). Amongst the E. coli producing TEM-1 obtained from isolates in Edinburgh,
17 were able to transfer ampicillin resistance determinants to E. coli J62-2 (Thomson
and Amyes, 1993a). These transconjugants were employed as representatives of
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clinical plasmids and were compared with those plasmids (N = 14) obtained from the
healthy community in the survey described previously (Section 3.1).
3.3.2. Examination of Plasmids Employed in the
Comparison Study
A comparative investigation of plasmids encoding ampicillin resistance isolated from
clinical E. coli with ampicillin resistant plasmids isolated from normal E. coli was
carried out. All the plasmids examined had previously been transferred to E. coli
J62-2 from the original E. coli isolate. The results (Figure 16) show that there were
no common plasmids amongst those plasmids that had been isolated, on no more
than two occasions, from both sources.
In contrast, however, the results also show (Figure 17) that two representatives
of the epidemic plasmid isolated from the normal E. coli (Tracks B and D) were
very similar to two representatives of plasmids isolated from the clinical source
(Tracks A and C). Interestingly TRC-1, the novel TEM-derived plasmid-encoded
P-lactamase, resistant to inhibition by clavulanic acid, was identified on the
most common TEM-1 containing plasmid amongst the clinical urinary strains
(Thomson and Amyes, 1992a). From Figure 18, it is appparent that the TRC-1
encoded plasmid was identical to three of the epidemic clinical plasmids (Tracks
A, C and E) and to one of the normal E. coli plasmids (Track D) .
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Figure 16. Agarose gel electrophoresis of endonuclease restriction
digest of plasmid DNA extracted from normal faecal E. coli
(Tracks A-I) and from clinical urinary E. coli (Tracks K-S)
Tracks:-A) ES 60; B) ES 62; C) ES 63; D) ES 64; E) ES 65; F) ES 67; G) ES 69;
H) ES 72; I) ES 73; J) X pre-cut with Hin dill; K) CT 113; L) CT 114; M) CT 115;
N) CT 116; O) CT 117; P) CT 118; Q) CT 119; R) CT 160; S) CT 120; T) X pre-cut
with Hin dill







Figure 17. Agarose gel electrophoresis of endonuclease restriction
digest of plasmid DNA extracted from normal faecal E. coli
and from clinical urinary E. coli
Tracks
A) CT 111; B) ES 75; C) CT 112; D) ES 76; E) X pre-cut with Hin dill
A B C D E
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Figure 18. Agarose gel electrophoresis of endonuclease restriction
digest of plasmid DNA extracted from normal faecal E. coli,
from clinical urinary E. coli and from E. coli containing
TRC-1 plasmid
Tracks
A) CT 109; B) ES 59; C) CT 110; D) ES 68; E) CT 111; F) CT 82; G) ES 75; H) CT
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3.4. Survey of Antibiotic Resistance in
the Aerobic Flora ofDiagnostic
Faecal Specimens in Edinburgh.
A number of surveys have investigated the carriage of antibiotic resistance
amongst the commensal faecal flora of patients prior to their admission to
hospital (Datta, 1969; Shaw et al., 1973; Spgaard, 1975). Although clearly this
population group may not be considered "healthy", pre-admission patients do,
however, provide some indication of the carriage of antibiotic resistant bacteria in
the non-clinical community. As a comparison with the survey of antibiotic
resistance in the aerobic faecal flora of the healthy population in Edinburgh, a
study of the carriage of antibiotic resistance in negative faecal specimens sent to
the diagnostic laboratories of Edinburgh Royal Infirmary was performed. This
population group, like pre-admission patients, provides an estimation of the
carriage of antibiotic resistant bacteria in the non-clinical community.
3.4.1. Study Design
Between January and March 1991, 100 faecal specimens were obtained from the
diagnostic laboratory of Edinburgh Royal Infirmary. As outlined in the
Materials and Methods, these specimens had been submitted by general
practitioners from their patients in the Edinburgh region in order that they may
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be screened for the following bacterial pathogens: Salmonella spp., Shigella spp.,
Campylobacter spp. and E. coll 0157. All of the specimens employed in the
discussed survey tested negative for each of these pathogens. The sex distribution
of the donors of the specimens consisted of 26 males, 31 females and 43 unknown.
3.4.2. The Carriage of Antibiotic Resistance in the
Aerobic Faecal Flora
The carriage of antibiotic resistant determinants amongst the bacteria isolated
from the faecal specimens is shown in Table 18. The highest incidences of
resistance were observed against cefuroxime and ampicillin; 65% and 60% of the
faecal specimens contained bacteria resistant to these antibiotics respectively.
Resistance to the later generation cephalosporin, ceftazidime, was in contrast,
substantially lower at 6%. Bacterial resistance to another antimicrobial agent,
tetracycline, was also high with 43% of the specimens containing resistant
bacteria. A much lower proportion of specimens carried bacteria resistant to
trimethoprim (8%). Similarly, very little bacterial resistance was observed
against the quinolone agents tested; nalidixic acid resistant bacteria were
identified in only 3% of specimens while there were no ciprofloxacin resistant
bacteria. Gentamicin was the only other agent included in the study to which
there was also no bacterial resistance.
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Nalidixic acid 10 3
Ciprofloxacin 10 0
Trimethoprim 10 8
3.4.3. Identification of the Ampicillin Resistant
Strains
As in the previous survey, a single non-mucoid lactose-fermenting colony was
isolated and purified from each antibiotic incorporated plate supporting growth.
Each of the 60 isolated ampicillin resistant strains were identified employing either
API 20E test strips or the biochemical tests outlined in the Materials and Methods.
The identified strains were allocated to one of four groups as shown in Table 19.
E. coli represented the largest proportion of ampicillin resistant bacteria (65%).
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Table 19. Identification of the ampicillin resistant bacteria
Species Number Percentage
Escherichia coli 39 65
Klebsiella spp. 18 30
Citrobacter spp./ 3 5
Enterobacter spp.
Other 0 0
All 60 of the ampicillin resistant strains were analysed further.
3.4.4. Sensitivity ofAmpicillin Resistant Strains to a
Range of (3-Lactam Agents
As described previously, each ampicillin resistant strain was tested for its minimum
inhibitory concentration of amoxycillin, amoxycillin plus clavulanic acid (2 :1 ratio),
cefuroxime, ceftazidime and cefotaxime. The results are shown in Table 20.
A high level of resistance to amoxycillin (MIC >512 mg/L) was observed in 29/60
(48%) of the ampicillin resistant isolates. These isolates were predominantly E. coli
(65%). In contrast, the addition of clavulanic acid reduced the MIC of amoxycillin
for these E. coli to below 32mg/L in all but five cases. Similarly, as in strains
isolated from the healthy population, amongst the E. coli there was almost uniform
sensitivity to cefotaxime and ceftazidime (MIC < 2mg/L). Cefuroxime resistance
(MIC > 4mg/L) was, however, identified in 20.5% of the E. coli.
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Table 20. Minimum Inhibitory Concentration (mg/L) of ampicillin
resistant isolates to a range of antimicrobials
Strain No. Antimicrobial (mg/L) fi-lactama.se + Species
Amox
Amox
+ Clav CTZ CAZ CXM
* PS 78 >1024 8 2 2 8 TEM-1 E. coli
* PS 124 >1024 16 2 2 4 TEM-1 E. coli
* PS 145 >1024 16 2 2 2 TEM-1 E. coli
* PS 162 >1024 16 2 2 4 TEM-1 E. coli
* PS 165 >1024 16 2 2 2 TEM-1 E. coli
* PS 218 >1024 16 2 2 16 TEM-1 E. coli
PS 222 >1024 16 2 2 4 TEM-1 E. coli
PS 228 >1024 16 2 2 4 TEM-1 E. coli
* PS 249 >1024 8 2 2 4 TEM-1 E. coli
* PS 81 1024 4 2 2 4 TEM-1 E. coli
* PS 87 1024 8 2 2 4 TEM-1 E. coli
* PS 99 1024 8 2 2 2 TEM-1 E. coli
* PS 110 1024 8 2 2 2 TEM-1 E. coli
PS 62 1024 8 2 2 2 TEM-1 E. coli
* PS 133 1024 8 2 2 2 TEM-1 E. coli
* PS 149 1024 8 2 2 2 TEM-1 E. coli
* PS 151 1024 8 2 2 4 TEM-1 E. coli
* PS 155 1024 8 2 2 2 TEM-1 E. coli
* PS 158 1024 8 2 2 4 TEM-1 E. coli
* PS 170 1024 8 2 2 4 TEM-1 E. coli
* PS 174 1024 8 2 2 4 TEM-1 E. coli
* PS 191 1024 8 2 2 4 TEM-1 E. coli
* PS 194 1024 8 2 2 2 TEM-1 E. coli
* PS 231 1024 8 2 2 4 TEM-1 E. coli
* PS 239 1024 8 2 2 4 TEM-1 E. coli
PS 243 1024 8 2 2 4 TEM-1 E. coli
* PS 251 1024 8 2 2 2 TEM-1 E. coli
* PS 256 1024 8 2 2 2 TEM-1 E. coli
* PS 103 512 8 2 2 2 TEM-1 E. coli
PS 175 512 32 2 4 16 Chrom E. coli
PS 185 256 32 2 2 16 Chrom E. coli
PS 213 256 32 2 2 16 Chrom E. coli
PS 56 128 32 2 2 8 Chrom E. coli
PS 180 128 8 2 2 4 SHV E. coli
* PS 51 32 32 2 2 16 TEM-1 E. coli
* PS 111 16 16 2 2 2 TEM-1 E. coli
PS 225 16 8 2 2 8 Chrom E. coli
* PS 92 4 4 2 2 2 TEM-1 E. coli
* PS 138 4 4 2 2 2 TEM-1 E. coli
* PS 118 1024 32 2 2 64 TEM-1 Klebsiella
PS 254 128 2 2 2 2 SHV-1 Klebsiella
PS 246 128 2 2 2 4 SHV-1 Klebsiella
PS 253 64 2 2 2 2 SHV Klebsiella
PS 237 64 2 2 2 2 SHV-1 Klebsiella
PS 209 64 2 2 2 2 SHV-1 Klebsiella
* PS 136 64 2 2 2 2 TEM-1 Klebsiella
PS 259 32 2 2 2 2 SHV Klebsiella
PS 204 32 4 2 2 2 SHV Klebsiella
PS 198 32 2 2 2 2 SHV Klebsiella
* PS 142 32 2 2 2 2 TEM-1 Klebsiella
PS 140 32 2 2 2 2 SHV Klebsiella
PS 129 32 4 2 2 2 Kl Klebsiella
* PS 106 32 2 2 2 2 TEM-1 Klebsiella
PS 83 32 2 2 2 2 SHV-1 Klebsiella
* PS 72 32 2 2 2 2 TEM-1 Klebsiella
* PS 66 32 2 2 2 2 TEM-1 Klebsiella
* PS 114 16 2 2 2 2 TEM-1 Klebsiella
PS 206 16 4 2 2 2 Chrom Ent/Cit
PS 183 16 8 2 2 2 Chrom Eat 1 Cit.
* PS 74 16 8 2 2 8 TEM-1 Eat. /at
*
= Transferable strain - see section 3.4.5 13- lactamase *1* - see section 3.4.7. SHV = SHV derived enzyme
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3.4.5. Transfer ofAmpicillin Resistant Determinants
Following the procedure described in the Materials and Methods, each of the
ampicillin resistant strains was tested for the ability to transfer the resistance
determinants by conjugation to the standard bacterial strain E. coli J62-2.
Amongst the ampicillin resistant strains, 62% were capable of transferring
resistance; this is significantly higher than the transfer rate found amongst the
ampicillin resistant strains in the healthy population (33%). From Table 21, it
can be observed that the transferable strains were not all the same species. This
is also in contrast to the transferable strains from the healthy population which
were all identified as E. coli. E. coli did, however, exhibit the highest rate of
transfer amongst the species isolated (78%).
Table 21. Speciation of the transferable strains
Transferable Species Number Percentage
Escherichia coli 29 78
Klebsiella spp. 7 19
Citrobacter spp./ 1 3
Enterobacter spp.
115
3.4.6. Plasmid Analysis ofAmpicillin Resistant
Transconjugants
In order to characterise the plasmids in the transconjugants, the plasmids were
extracted following the procedure outlined in the Materials and Methods. The
similarity in profile and size of these plasmids was investigated by
endonuclease restriction analysis with Eco Rl. The plasmids were assigned to a
number of groups according to the endonuclease digest pattern (Figures 19 - 22).
As in section 3.1.7., plasmids with closely related endonuclease restriction
profiles were assigned to the same category if they differed from one another by
no more than three bands. Also, as before, if the profiles differed by three bands
or more, the plasmids were assigned to a separate group.
Amongst the plasmids originating in this population group, a widespread
heterogeneity was observed in the endonuclease restriction profiles; 21 different
plasmid profiles were identified (Table 22). One single type (Group C), however,
predominated and accounted for 19% of the plasmids in the isolates. When the
banding pattern from the digest profile of this common plasmid was analysed in
detail it was identical to the epidemic plasmid identified in the earlier studies.
To confirm this finding restriction endonuclease digestions, of both the epidemic
plasmid (ES 76) and this common plasmid, were separated side by side in an
agarose gel. There was no difference in the pattern and plasmids were obviously
of the same plasmid type. Although four other plasmid types (Groups A,B,0 &P)
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Figure 19. Agarose gel electrophoresis of restriction endonuclease
digestion, with Eco Rl, of plasmid DNA extracted from
Edinburgh diagnostic transconjugants
Tracks
A) ES 18; B) ES 19; C) ES 21; D) X pre-cut with Hin dill; E) ES 26; F) ES 27;
G) ES 28; H) A, pre-cut with Hin dill
ABCD EFGH
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Figure 20. Agarose gel electrophoresis of restriction endonuclease
digestion, with Eco Rl, of plasmid DNA extracted from
Edinburgh diagnostic transconjugants
Tracks:-
A) ES 39; B) ES 41; C) ES 42; D) ES 43; E) ES 44; F) ES 45; G) ES 46; H) ES 47;
I) ES 40; J) X pre-cut with Hin dill
A BCDEFGH I J




Figure 21. Agarose gel electrophoresis of restriction endonuclease
digestion, with Eco Rl, of plasmid DNA extracted from
Edinburgh diagnostic transconjugants
Tracks
A) ES 49; B) ES 50; C) ES 51; D) ES 52; E) ES 66; F) ES 70; G) ES 71; H) ES 48;
I) X pre-cut with Hin d III; J) ES 74; K) X pre-cut with Hin dill
ABCDEFGH I J K
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Figure 22. Agarose gel electrophoresis of restriction endonuclease
digestion with Eco R1 of plasmid DNA extracted from
Edinburgh diagnostic transconjugants
Tracks
A) ES 85; B) ES 87; C) ES 90; D) ES 94; E) ES 95; F) ES 96; G) ES 97; H) ES 99;
I) ES 100; J) ES 101; K) ES 114; L) X pre-cut with Hin clIII
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Table 22. Analysis of the diagnostic ampicillin resistant
transconjugants
Strain Plasmid R. Group Antibiogram
Number Size (Kb) Transconjugant Wild type
ES 21 (PS 62) 78.0 A Ap ApSmTc
ES 26 (PS 72) 78.0 A Ap Ap
ES 27 (PS 74) 78.0 A Ap ApSpCf
ES 28 (PS 78) 78.0 A Ap ApSm
ES 19 (PS 99) 49.0 B Ap Ap
ES 85 (PS 51) 49.0 B Ap ApCfCm
ES 87 (PS 66) 49.0 B Ap Ap
ES 90 (PS 92) 49.0 B Ap Ap
ES 41 (PS 149) 85.0 C ApSm ApSmTc
ES 48 (PS 170) 85.0 C ApSm ApSm
ES 51 (PS 194) 85.0 C ApSm ApSmSp
ES 70 (PS 249) 85.0 C ApSm ApSm
ES 71 (PS 251) 85.0 C ApSm ApSm
ES 100 (PS 138) 85.0 C ApSm ApSm
ES 101 (PS 142) 85.0 C ApSm ApSm
ES 39 (PS 133) 81.7 D ApSm ApSm
ES 42 (PS 151) 98.0 E ApSm ApSmSp
ES 43 (PS 155) 66.9 F Ap Ap
ES 44 (PS 231) 85.0 G Ap ApTc
ES 45 (PS 239) 75.1 H ApSmTc ApSmTc
ES 46 (PS 158) 117.4 I ApTc ApSpTc
ES 47 (PS 162) 84.3 J Ap Ap
ES 49 (PS 174) 139.4 K ApTpSmSpCmTc ApTpSmSpCmTc
ES 50 (PS 191) 56.5 L ApSp ApSmSp
ES 52 (PS 103) 139.5 M ApTpSmTc ApTpSmSpTc
ES 66 (PS 256) 137.9 N Ap ApSm
ES 94 (PS 106) 74.8 0 Ap Ap
ES 95 (PS 111) 59.9 P ApTc ApCf
ES 96 (PS 114) 59.9 P Ap Ap
ES 97 (PS 118) 74.8 0 Ap ApCerCf
ES 99 (PS 136) 60.6 Q Ap ApSp
ES 114 (PS 218) 92.7 R Ap ApSpCer
ES 18 (PS 87) 129.0 S ApSm ApTpSmCmTc
ES 74 (PS 249) 92.0 T ApSm ApSm
ES 40 (PS 145) 52.6 U Ap ApTc
ES 29 (PS 81) - - Ap ApSmSpTc
ES 38 (PS 124) _ — Ap ApTpSmSpCerTc
() = Original isolate number
R. Group = Restriction pattern group
* = No distinct profile obtained after three separate plasmid preparations and
endonuclease restriction digestions
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were each isolated on more than one occasion in different transconjugants
(Figures 19-22), no other plasmid type was found as frequently.
3.4.7. Distribution of (3-Lactamases in the Ampicillin
Resistant Strains
The different |3-lactamases responsible for mediating resistance to ampicillin
amongst the strains isolated, were determined by iso-electric focusing. All of the
transconjugants encoded the TEM-1 P-lactamase (Figure 23) regardless of the
plasmid type on which the gene was carried. As in the survey of antibiotic
resistance in the aerobic faecal flora of the healthy population in Edinburgh, the
non-transferable strains which were also examined (Figures 24 - 25) encoded a
variety of different (i-lactamases.
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Figure 23. Analytical iso-electric focusing of (3-lactamases in the
Edinburgh diagnostic transconjugants
Tracks:-
A) ES 18; B) ES 19; C) ES 21; D) ES 26; E) ES 27; F) R1 (TEM-1 producer);
G) ES 28; H) ES 29; I) ES 39; J) ES 40
These selected TEM-1 producing transconjugants are representative of all of the
transconjugants examined.




Figure 24. Analytical iso-electric focusing of (3-lactamases isolated from
wild type, non-transferable ampicillin resistant diagnostic
strains in Edinburgh
Tracks:-
A) PS 204; B) PS 206; C) PS 209; D) PS 213; E) PS 222; F) R1 (TEM-1 producer);
G) R1010 (SHV-1 producer); H) PS 225; I) PS 228; J) PS 237; K) PS 243; L) PS
246; M) PS 253; N) R1010; O) PS 254; P) PS 259; Q) R1





Figure 25. Analytical iso-electric focusing of (3-lactamases isolated from
wild type, non-transferable ampicillin resistant diagnostic
strains in Edinburgh
Tracks
A) ES 56; B) ES 83; C) ES 110; D) ES 129; E) ES 140; F) R1 (TEM-1 producer);







3.5. Survey of Antibiotic Resistance in
the Aerobic Faecal Flora of the
Healthy Black Communities in
South Africa.
From the limited studies conducted to determine the carriage of antibiotic
resistance genes amongst the commensal faecal flora of healthy individuals, it
appears that in this group, as in clinical isolates, there is a higher rate of
resistance associated with the use of antibiotics in developing countries rather
than developed countries.
3.5.1. Study Design
Between January and March 1992, a total of 361 faecal specimens were collected
from healthy volunteers resident in the Transvaal, South Africa, as outlined in
the Materials and Methods. Participants were included from both rural (183) and
urban (178) areas. As in the Edinburgh study, no volunteer was allowed to
participate in the survey if they had received any antimicrobial treatment in the
three weeks prior to sampling. Each participant completed a questionnaire, the
information from which has been collated and is represented in Table 23. On
average, the male / female distribution was 1:1.4 in both rural and urban groups.
Volunteers indicated a regular intake of meat (Table 23) although amongst the
urban population, meat was included in the diet more frequently.
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Table 23. Volunteers in the study
AGE
Location/ Total Number Number of Range Mean SD Mode
Study Group Individuals Females (yrs) (yrs) Meat/Week
Rural Studv
Infants 50 29 0-5 0.75 0.82 3
Children 47 26 6-11 9.1 1.42 3
Teenagers 36 19 12-19 14.0 1.24 3
Adults 50 35 >19 28.4 10.12 3
Total 183 109
Urban Studv
Infants 45 23 0-5 2.4 1.28 4
Children 42 18 6-11 9.1 1.69 4
Teenagers 47 22 12-19 13.1 0.93 7
Adults 44 42 >19 33.0 6.06 3
Total 178 105
Grand Total 361 214
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3.5.2. The Carriage of Antibiotic Resistance in the
Aerobic Faecal Flora
The carriage of antibiotic resistant determinants amongst the commensal faecal
flora of the healthy population examined in South Africa is shown in Table 24.
The protocol employed in the isolation of resistant bacteria is described in the
Materials and Methods. A high proportion of volunteers carried bacteria
resistant to antibiotics, in particular to ampicillin (88.6%) and trimethoprim
(74.2%). Five antibiotics were screened in the study and, for each, the
corresponding level of resistance identified was slightly higher amongst the
rural populations. There was no difference in the level of resistance to each
antimicrobial agent and age group except that gentamicin resistance in the
rural adults was much higher than it had been amongst their urban
counterparts (38.6% versus 4%).
3.5.3. Recognition of Environmental Conditions
In an attempt to establish if environmental conditions exerted any influence




























































































A representative water sample was taken in each study area except in Kagiso
(Table 25). Screening in the urban locations revealed the water, which is
municipally piped, to be free of any bacteria (< 1 organism / 50ml). In contrast, the
school in Hekpoort is provided with water from a bore hole; this was contaminated
with four different bacteria, Bacillus cereus, Acinetobacter anitratus, Enterobacter
cloacae and Pseudomonas aeruginosa (> 1000 organisms / ml). In the Shongwe
area, the rural adult population was not exposed to a contaminated water supply
as the water utilized at Shongwe hospital was filtered and chlorinated river
water. This water was completly bacteria-free (< 1 organism / 50ml). However,
the water tested from Middleplaas clinic, stored rain water, contained
Pseudom-onas aeruginosa, Serratia marcescens and a Gram-positive coccus
(>1000 organism/ml).
3.5.3.2. Living Conditions
The social conditions of the participants are reflected in Table 25. In both the
rural and urban study, approximately 50% of the participants were associated
with animals. Despite the possibility of animal to man transmission of bacteria,
this was probably not a major contributory factor in the spread of resistance as
resistant bacteria were as commonly observed in participants living in the
absence of animals.
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Hekpoort 7.0 6.2 61 79 +
Shongwe 7.4 7.7 1 88 +
Urban Studv
SOWETO 8.6 8.7 68 99 -
Kagiso 6.0 6.3 50 100 NT
NT = Not tested
3.5.3.3. Population Density
The most influential environmental factors observed were the number of people
per family and per house. Many of the rural homes were wattle and daub huts
with only one room for sleeping. Similarly, it was not uncommon for many urban
homes to have just one bedroom. As similar numbers of residents per house
(mean = 6.0 people/house) were recorded in both the rural and urban areas, it
would seem that this widespread over-crowding is a large contributor to the
high levels of resistance.
131
3.5.4. Identification of the Ampicillin Resistant
Strains
A total of 608 ampicillin resistant strains were collected from the survey.
Between one and four morphologically distinct colonies were isolated from each
ampicillin plate although all were lactose-fermenting strains. Each of the
strains was identified (Table 26) employing the biochemical tests described in
the Materials and Methods. E. coli. represented the largest proportion of
resistant bacteria when susceptibility to ampicillin was measured.
Table 26. The incidence of organisms isolated from the study
Species Number Percentage
E. coli 445 73
Klebsiella spp. 104 17
Enterobacter spp./
Citrobacter spp. 35 6
Other 24 4
The ampicillin resistant strains were analysed further.
3.5.5. Transfer ofAmpicillin Resistant Determinants
The ability of the ampicillin resistant strains to transfer their resistance
determinants to E. coli J62-2 was tested. Amongst the 608 strains, 158 (26%)
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were shown to contain self-transmissible plasmids. There was a significant
variation in the proportion of transferable strains in each population group. A
particularly high carriage rate of transferable strains was found amongst the rural
infants (74%) (Table 27). The transferable strains, however, were not restricted to
one species (Table 28) although E. coli was found to predominate (67.7%).
Table 27. Proportion of transferable strains in the different
population groups
Location/ Total No. of Total No. of Percentage
Study Group Transconjugants Isolates
Rural Studv
Infants 60 81 74
Children 17 54 31
Teenagers 9 82 11
Adults 12 112 10
Urban Studv
Infants 22 80 27
Children 16 66 24
Teenagers 11 53 20
Adults 11 80 14
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Table 28. Proportion of transferable ampicillin resistant species
Species Number Percentage
E. coli 107 67.7
Klebsiella spp. 20 12.7
Enterobacter spp./
Citrobacter spp. 3 1.9
Other 28 17.7
3.5.6. Plasmid Analysis of Ampicillin Resistant
Transconjugants
As outlined in the Materials and Methods, plasmids were extracted from the
transconjugants and restricted with Eco Rl. All of the restricted plasmid profiles
investigated from each transconjugant are shown in Figures 26 to 40. As before,
the plasmids were assigned to groups, categorised as described previously (see
section 3.1.7.). Amongst the 158 transconjugants which had been obtained, a total
of 92 different plasmid profiles were identified (Figures 26 - 40). The groups to
which the different plasmid types were delegated are shown in Tables 29 to 36. In
addition, the calculated size (Kb) for each plasmid identified, the donor number
from which the wild type strains were isolated and the antibiogram of both the
transferable wild type strains and the transconjugants are also shown in these
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tables. In determining the antibiogram profile, the ability of the strains to confer
resistance to a range of antimicrobials including amoxycillin (lOmg/L), amoxycillin
plus clavulanic acid (10:5mg/L), trimethoprim (lOmg/L), gentamicin (4mg/L),
cephaloridine (lOmg/L), cefuroxime (4mg/L), cefotaxime (lmg/L), nalidixic acid
(lOmg/L), ciprofloxacin (lmg/L), tetracycline (lOmg/L), chloramphenicol (lOmg/L),
spectinomycin (lOmg/L) and streptomycin (lOmg/L) were all tested. Whilst a wide
variety of antibiogram profiles were identified amongst the transferable wild type
strains, between the transconjugants the most frequently recognised resistant
determinants were those of trimethoprim and ampicillin.
From the tables, it is apparent that in the vast majority of cases, different
plasmids were identified from within each of the different donors. However, on
two occasions, the same plasmid was isolated from two separate strains from
the same donor. Amongst the rural infants, a plasmid of 65.1Kb was carried by
two separate strains in donor 11 (Table 29). As both of the donor strains share
the same antibiogram, it may be concluded that the same strain had been
isolated twice from the same donor. Similarly, this situation occurred amongst
the urban infants where a plasmid of 89.3Kb was carried by two separate
strains in donor 43 (Table 33). On a further seven occasions the same plasmid
was also isolated from two separate strains from the same donor. However, in
contrast to the preceding situation, the antibiogram of the wild type strains
differed from each other indicating the presence of the same plasmid in different
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strains in the same donor. This phenomenon was restricted to rural infants in
donor numbers 1, 9, 24, 28, and 29 (Table 29), and again in urban adults in
donor numbers 4 and 13 (Table 36).
The distribution of plasmids in each of the population groups will be considered
in turn.
3.5.6.1. Rural Infants
The characteristics of the plasmids extracted from each of the rural infant isolates
are summarised in Table 29 while the endonuclease restriction profdes of these
plasmids are shown in Figures 26 - 30. Amongst this particular group of
transconjugants, three distinct plasmid types were each identified on more than
three occasions. The most frequently isolated plasmid belonged to plasmid group
16 and was calculated to be 65.1Kb. It represented 14 of the 58 plasmids analysed
within this population. Amongst those antimicrobials tested, this plasmid
conferred resistance only to ampicillin and trimethoprim. The second such
plasmid, from group 26, was found in 9 transconjugants. This plasmid mediated
resistance to ampicillin and tetracycline and was 61.6Kb. The final plasmid to be
discovered on multiple occasions (7) was 49.8Kb and belonged to plasmid group 18.
As with the first, frequently isolated plasmid, this plasmid carried ampicillin and
trimethoprim resistant determinants. The remainder of the plasmids in this group
were identified in either one, two or at most, in three transconjugants.
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Table 29. Antibiogram and restriction profiles of transconjugants
obtained from rural infants
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1236 1 16 65.1 ApTp ApSmTcTp
PS 1237 1 16 65.1 ApTp ApTp
PS 1244 6 16 65.1 ApTp ApTp
PS 1245 7 16 65.1 ApTp ApSpSmAcTcTp
PS 1247 8 16 65.1 ApTp ApSmTpCm
PS 1249 9 16 65.1 ApTp ApSmAcCerTcTpCm
PS 1251 9 16 65.1 ApTp ApSmTp
PS 1252 10 16 65.1 ApTp ApSpSmAcTcTp
PS 1254 11 16 65.1 ApTp ApSpSmTp
PS 1255 11 16 65.1 ApTp ApSpSmTp
PS 1262 16 16 65.1 ApTp ApSmCtxTcTpCm
PS 1263 18 16 65.1 ApTp ApSpSmTp
PS 1265 19 16 65.1 ApTp ApSpAcTp
PS 1268 21 16 65.1 ApTp ApSmAcCerTcTpCm
PS 1239 2 17 65.9 ApTp ApSmTp
PS 1240 3 17 65.9 ApTp ApTp
PS 1283 37 17 65.9 Ap ApSmTp
PS 1238 1 18 49.8 ApTp ApSpSmTp
PS 1250 9 18 49.8 ApTp ApCerTp
PS 1253 10 18 49.8 ApTp ApTp
PS 1259 14 18 49.8 ApTp ApTp
PS 1260 15 18 49.8 ApTp ApSmTp
PS 1261 16 18 49.8 ApTp ApTp
PS 1264 18 18 49.8 ApTp ApSpSmTp
PS 1241 3 19 82.5 ApTp ApTcTp
PS 1242 4 19 82.5 ApTp ApSmTcTp
PS 1243 6 19 82.5 ApTp ApSmTp
PS 1246 8 20 116.7 ApTp ApSpSmTp
PS 1248 8 21 45.3 Ap ApSpTcTp
PS 1256 13 22 97.3 ApTp ApSmTp
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Table 29. Continued
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1257 13 23 58.8 Ap ApSmTcTp
PS 1258 14 24 89.4 ApSm ApSmTp
PS 1269 22 25 134.5 ApTc ApSmTcCm
PS 1270 23 25 134.5 ApTc ApSmTcTpCm
PS 1266 20 26 61.6 ApTc ApSmTcTpCm
PS 1271 23 26 61.6 ApTc ApSmAcTcTp
PS 1272 24 26 61.6 ApTc ApSmAcCerTcTp
PS 1273 24 26 61.6 ApTc ApSpSmAcTc
PS 1274 25 26 61.6 ApTc ApSmTpTc
PS 1276 28 26 61.6 ApTc ApSmTcCm
PS 1277 28 26 61.6 ApTc ApSmAcCerCtxTcTpCm
PS 1278 29 26 61.6 ApTc ApAcCerTc
PS 1279 29 26 61.6 ApTc ApSmAcCerCtxTcTpCm
PS 1267 20 27 63.3 ApTp ApSmTp
PS 1282 35 27 63.3 ApTp ApTp
PS 1275 27 28 42.1 ApTpSm ApSmTp
PS 1281 35 28 42.1 Ap ApSmTp
PS 1280 33 29 68.5 ApSpSmTc ApSpSmTcTp
PS 1284 37 30 60.0 ApSmTcTpCm ApSmTcTpCm
PS 1288 41 30 60.0 ApSmTcCm ApSmTcTpCm
PS 1285 39 31 78.7 Ap ApSmTp
PS 1286 40 32 30.5 Ap Ap
PS 1287 40 33 119.5 Ap Ap
PS 1289 42 34 64.4 ApTp ApSmTp
PS 1290 42 35 48.3 ApTp ApSmTp
PS 1291 42 36 51.9 ApTp ApSmTp
PS 1292 43 37 19.5 Ap ApSpSmAcTcTpCm
PS 1294 31 38 77.7 ApTp ApSmAcTcTp
PS 1293 31 88 50.1 ApTp ApSmAcTcTp
138
Figure 26. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural infant transconjugants
Tracks:-
A) PS 1236; B) PS 1237; C) PS 1238; D) PS 1239; E) PS 1240; F) PS 1241; G) PS







Figure 27. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural infant transconjugants
Tracks
A) PS 1246; B) PS 1247; C) PS 1248; D) PS 1249; E) PS 1250; F) PS 1252;
G) PS 1253; H) PS 1254; I) PS 1255; J) PS 1256; K) PS 1257; L) X DNA pre-
cut with Hin d 111; M) PS 1251; N) X DNA pre-cut with Hin dill









Figure 28. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural infant transconjugants
Tracks:
A) PS 1258; B) PS 1259; C) PS 1260; D) PS 1261; E) PS 1262; F) PS 1263; G) PS
1264; H) PS 1265; I) PS 1266; J) PS 1267; K) PS 1268; L) PS 1269; M) X DNA
pre-cut with Hin dill
ABCDEFGH I JKLM
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Figure 29. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural infant transconjugants
Tracks
A) PS 1270; B) PS 1271; C) PS 1272; D) PS 1273; E) PS 1274; F) PS 1275; G) PS
1276; H) PS 1277; I) PS 1278; J) PS 1279; K) X DNA pre-cut with Hin dill; L)
PS 1294; M) X DNA pre-cut with Hin dill
ABCDEFGH I JK LM
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Figure 30. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural infant transconjugants
Tracks
A) PS 1280; B) PS 1281; C) PS 1282; D) PS 1283; E) PS 1284; F) PS 1285; G) PS
1286; H) PS 1287; I) PS 1288; J) PS 1289; K) X DNA pre-cut with Hin dill; L)
PS 1290; M) PS 1291; N) PS 1292; O) PS 1293; P) X DNA pre-cut with Hin dill
ABCDEFGH I J K LMNOP
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3.5.6.2. Rural Children
The characteristics of the plasmids extracted from each of the rural children
isolates are summarised in Table 30 while their endonuclease restriction
profiles are shown in Figures 31 - 32. The maximum number of occasions on
which a single plasmid type was isolated in this group, was four. The plasmid,
named group 5, was 71.4Kb and conferred resistance to ampicillin alone.
Table 30. Antibiogram and restriction profiles of transconjugants
obtained from rural children
Strain Donor- Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1210 3 1 59.0 Ap Ap
PS 1220 28 1 59.0 Ap Ap Ac Cer
PS 1225 3 1 59.0 Ap Ap Ac
PS 1211 5 2 82.5 ApSpTcTp ApSpTcTp
PS 1213 8 3 59.1 ApTc ApSmTc
PS 1212 7 4 62.2 Ap Ap
PS 1214 12 4 62.2 Ap Ap
PS 1215 12 5 71.4 Ap Ap
PS 1217 15 5 71.4 Ap Ap
PS 1219 25 5 71.4 Ap Ap
PS 1226 10 5 71.4 Ap ApSpTc
PS 1216 14 6 69.2 ApTp ApAcTp
PS 1218 19 6 69.2 ApTp ApTp
PS 1221 29 7 54.6 ApSpSm ApSpSmTp
PS 1222 41 8 97.4 Ap ApTcTp
PS 1224 48 8 97.4 ApTp ApSmAcTp
PS 1223 42 91 23.5 ApSmTc ApSmTc
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Figure 31. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural children transconjugants
Tracks:-
A) PS 1210; B) PS 1214; C) PS 1215; D) X DNA pre-cut with Hin dill; E) PS










Figure 32. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural children transconjugants
Tracks
A) X DNA pre-cut with Hin dill; B) PS 1221; C) PS 1220; D) PS 1219; E) PS
1218; F) PS 1217; G) PS 1216; H) PS 1213; I) PS 1212; J) PS 1211
A BCDEFGH I J
'I I I I I I I I




The characteristics of the plasmids extracted from each of the rural teenagers
isolates are summarised in Table 31 while the endonuclease restriction profiles
of these plasmids are shown in Figure 33. Although the group of plasmids
isolated from rural teenagers was small, it possessed the greatest heterogeneity
of both carriage of resistance determinants and size of plasmids amongst all the
population groups. The largest plasmid to be identified amongst all the
transconjugants was present in this group. Belonging to group 12, this plasmid
was calculated as being 178.2Kb in size. Of interest, the wild type strain carried
the highest number of resistance determinants recognised.
Table 31. Antibiogram and restriction profiles of transconjugants
obtained from rural teenagers
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1228 19 7 54.6 ApSpTcTp ApSpTcTp
PS 1227 15 9 87.2 ApSpSmTc ApSpSmTcTp
PS 1229 25 10 78.3 ApSpTc ApSpAcCerTc
PS 1230 29 11 119.4 ApTc ApTc
PS 1231 36 12 178.2 ApTcTpGmCm ApSpSmAcTcTpGmCm
PS 1233 45 12 178.2 ApTcTpGmCm ApSmAcCerCxmCtxTc
GmCmTp
PS 1232 44 13 109.7 ApSmTc ApSmTc
PS 1234 48 14 62.0 ApTp ApTp
PS 1235 52 15 52.8 Ap ApSmAcTcTp
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Figure 33. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural teenager transconjugants
Tracks:-
A) PS 1227; B) PS 1228; C) PS 1229; D) PS 1230; E) PS 1231; F) PS 1233; G) X
DNA pre-cut with Hin dill; H) PS 1232; I) X DNA pre-cut with Hin d 111;
J) PS 1234; K) PS 1235; L) X DNA pre-cut with Hin dill
















The characteristics of the plasmids extracted from each of the rural adults
isolates are summarised in Table 32 while the endonuclease restriction profiles
of these plasmids are shown in Figure 34. Of the 12 transconjugants, all the
plasmids were shown to be distinct by endonuclease restriction digestion with
Eco Rl.
Table 32. Antibiogram and restriction profiles of transconjugants
obtained from rural adults
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconj ugant Wildtype
PS 1304 23 17 65.9 Ap ApSmTp
PS 1310 49 18 49.8 ApTp ApSpSmTp
PS 1301 1 39 95.0 ApSmTc ApSmTcTp
PS 1302 2 40 126.3 ApSpTc ApSpTc
PS 1305 24 41 94.8 ApSpSmTcTp ApSpSmTcTpCm
PS 1306 24 42 60.1 ApSmTp ApSmTp
PS 1307 36 43 55.3 Ap ApSmTcTp
PS 1308 38 44 26.4 ApSmTcTp ApSmTcTp
PS 1309 47 45 87.3 ApSpSmTcTp ApSpSmTcTpGm
PS 1311 50 46 102.5 ApSpSm ApSpSmAcTcTpCm
PS 1312 48 47 77.0 Ap Ap
PS 1303 14 89 23.9 ApSpTp ApSpTcTp
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Figure 34. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
rural adult transconjugants
Tracks
A) PS 1301; B) PS 1302; C) PS 1303; D) PS 1304; E) PS 1305; F) PS 1306; G) PS






The characteristics of the plasmids extracted from each of the urban infant
isolates are summarised in Table 33 while the endonuclease restriction profiles
of these plasmids are shown in Figures 35 - 36. Three of the plasmids isolated
from this group of transconjugants shared exactly the same restriction profile as
plasmid group number 18, identified in the rural infants. However, unlike
plasmid group number 18, resistance to streptomycin was also mediated by
these plasmids and they were therefore classified as plasmid group number 18a.
The antibiogram profile, streptomycin, ampicillin and trimethoprim was
recognised in 10 of the 22 transconjugants in this group.
3.5.6.6. Urban Children
The characteristics of the plasmids extracted from each of the urban children
isolates are summarised in Table 34 while the endonuclease restriction profiles
of these plasmids are shown in Figures 37-38. Plasmid number 18a which was
present in the urban infants was identified on a single occasion in
transconjugant number PS 1346. All the other plasmids identified were unique
to this group.
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Table 33. Antibiogram and restriction profiles of transconjugants
obtained from urban infants
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1329 40 4 57.3 Ap Ap
PS 1315 3 18 49.8 ApSmTp ApSpSmTpTc
PS 1322 21 18 49.8 ApSmTp ApSmTp
PS 1334 49 18 49.8 ApSmTp ApSmTp
PS 1313 1 48 71.8 ApSmTp ApSmTp
PS 1320 14 48 71.8 ApSmTp ApSmTp
PS 1324 25 48 71.8 ApSmTp ApSmTp
PS 1325 28 48 71.8 ApSmTp ApSmTp
PS 1326 29 48 71.8 ApSmTp ApSmTp
PS 1314 2 49 89.2 ApSmTp ApSmTp
PS 1316 5 50 11.5 ApSpTc ApSpTc
PS 1317 7 51 68.4 Ap ApSmTpCm
PS 1318 7 52 96.3 Ap ApSpSmTcTpCm
PS 1327 29 52 95.8 Ap ApSpSmTcTpCm
PS 1319 8 53 58.7 ApTp ApTp
PS 1321 20 54 108.0 ApSmTp ApSmTcTpCm
PS 1323 22 55 90.1 ApSm ApSmTp
PS 1328 36 56 47.2 ApTp ApSmTcTp
PS 1330 43 57 89.3 ApSmTc ApSmAcCerTc
PS 1331 43 57 89.3 ApSmTc ApSmAcCerTc
PS 1332 46 58 77.9 ApSm ApSmTp
PS 1333 46 59 75.3 ApSmTcTp ApSmTcTp
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Figure 35. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
urban infant transconjugants
Tracks
A) PS 1313; B) PS 1314; C) PS 1317; D) PS 1318; E) PS 1319; F) PS 1320; G) PS




Figure 36. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
urban infant transconjugants
Tracks
A) PS 1315; B) PS 1316; C) X DNA pre-cut with Hin dill; D) PS 1325; E) PS
1326; F) PS 1327; G) PS 1328; H) PS 1329; I) PS 1330; J) PS 1331; K) PS 1332;
L) PS 1333; M) PS 1334; N) A, DNA pre-cut with Hin dill
ABC DEFGHIJKLM N
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Table 34. Antibiogram and restriction profiles of transconjugants
obtained from urban children
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1346 31 18a 49.8 ApSmTp ApSmTp
PS 1337 7 28 42.1 ApSm ApSpSmAcTcTpCm
PS 1338 8 28 42.1 ApSm ApSm
PS 1339 9 28 42.1 Ap ApAcCerCtx
PS 1341 14 28 42.1 ApSm ApSmTpCm
PS 1335 3 60 78.0 ApTp ApTp
PS 1336 5 61 58.0 Ap ApSmTp
PS 1340 12 62 125.5 Ap ApTp
PS 1342 16 63 42.0 ApSmTp ApSmTp
PS 1347 39 63 42.0 ApTp ApTp
PS 1343 28 64 116.6 ApSpTcTp ApSpTcTp
PS 1344 30 65 89.5 ApSpSmTcCm ApSpSmTcTpCm
PS 1345 31 66 39.3 ApSpTc ApSpTc
PS 1349 45 67 94.8 ApSpSmTc ApSpSmCerTcTp
PS 1350 48 68 65.7 ApSmTp ApSmTp
PS 1351 53 69 55.4 Ap ApAcCerCtx
PS 1348 45 90 61.5 ApSpTcTp ApSpTcTp
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Figure 37. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
urban children transconjugants
Tracks
A) PS 1337; B) PS 1338; C) PS 1339; D) PS 1340; E) PS 1341; F) PS 1342; G) PS
1343; H) PS 1344; I) PS 1345; J) PS 1346; K) PS 1347; L) PS 1348; M) X DNA














Figure 38. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
urban children transconjugants
Tracks
A) PS 1335; B) PS 1336; C) X DNA pre-cut with Hin dill; D) PS 1349; E) PS
1350; F) PS 1351; G) X DNA pre-cut with Hin dill




The characteristics of the plasmids extracted from each of the urban teenagers
isolates are summarised in Table 35. Each of the plasmids in this group were
shown to be different from each other in restriction profile (Figure 39) even
though there was some similarity in antibiogram profile.
3.5.6.8. Urban Adults
The characteristics of the plasmids extracted from each of the urban adults
isolates are summarised in Table 36. This plasmid population group was
heterogeneous with a variety of endonuclease restriction profiles (Figure 40).
There was no correlation observed between the size of the plasmid and the
number of resistance determinants that it carried; 20 plasmids were larger than
100Kb, yet the number of resistance determinants carried by them ranged from
one to five. Table 37 provides an indication of the number of resistant
determinants found on the plasmids.
Table 37. Number of resistance determinants identified in the plasmids






Table 35. Antibiogram and restriction profiles of transconjugants
obtained from urban teenagers
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1353 8 70 110.4 ApSmTcTp ApSmTcTp
PS 1354 14 71 113.5 Ap ApTp
PS 1355 15 72 42.8 ApSm ApSpSmTp
PS 1356 17 73 43.6 Ap ApSpSmTc
PS 1357 21 74 70.4 ApSm ApSmTp
PS 1358 27 75 38.3 Ap ApSmTc
PS 1359 32 76 110.1 Ap Ap
PS 1361 45 77 60.7 Ap Ap
PS 1362 45 78 43.2 ApSm ApSmTp
PS 1352 2 86 22.0 ApSm ApSpSm
PS 1360 44 87 22.0 ApSpTp ApSpTp
Table 36. Antibiogram and restriction profiles of transconjugants
obtained from urban adults
Strain Donor Plasmid Plasmid Antibiogram
Number Number Group Size (Kb) Transconjugant Wildtype
PS 1365 13 78 43.2 ApSm ApSmAcCerTpCm
PS 1366 13 78 43.2 ApSm ApSmTp
PS 1367 15 79 82.0 ApTp ApTp
PS 1368 15 80 116.0 ApSmTc ApSmTc
PS 1369 24 81 129.2 ApSpTcTp ApSpSmTcTp
PS 1370 28 82 134.5 ApSpSmTcTp ApSpSmTcTpCm
PS 1371 29 83 85.0 ApTc ApTc
PS 1372 41 84 40.9 ApSmTp ApSmTp
PS 1373 47 85 39.5 ApSm ApSmTcTp
PS 1363 4 92 99.7 ApSm ApSmTp
PS 1364 4 92 99.7 ApSm ApSm
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Figure 39. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
urban teenager transconjugants
Tracks:-
A) PS 1353; B) PS 1354; C) PS 1355; D) PS 1356; E) PS 1357; F) PS 1358; G) PS
1359; H) PS 1360; I) X DNA pre-cut with Hin dill; J) PS 1352; K) PS 1361; L)
PS 1362; M) X DNA pre-cut with Hin dill
























Figure 40. Agarose gel electrophoresis of an endonuclease restriction
with Eco R1 of plasmid DNA extracted from South African
adult transconjugants
Tracks
A) PS 1363; B) PS 1364; C) PS 1365; D) PS 1366; E) PS 1367; F) PS 1368; G) PS
1369; H) PS 1370; I) PS 1371; J) X DNApre-cut with Hin dill; K) PS 1372; L)
PS 1373; M) X DNA pre-cut with Hin dill








3.5.7. Distribution of P-Lactamases in the Ampicillin
Resistant Transconjugants
The different P-lactamases responsible for mediating resistance to ampicillin
amongst the transconjugants were determined by iso-electric focusing. The TEM-1
P-lactamase was the most frequently isolated P-lactamase accounting for 91.8% of
the plasmid-encoded p-lactamases in the rural transconjugants and 98.4% of
P-lactamases in the urban transconjugants (Figure 41). TEM-2 p-lactamase was only
found in four (4.1%) of the rural transconjugants (Figure 42), while SHV-1 was
identified in four (4.1%) of rural transconjugants and, in addition, in one (1.6%) of the
urban transconjugants (Figure 43). Interestingly, all four transconjugants containing
plasmids encoding the TEM-2 p-lactamase, had the same antibiogram, that is, they
conferred resistance to ampicillin alone (Table 29 and 30). Furthermore two of these
plasmids, PS 1210 and PS 1225 were identical in endonulease restriction profile
whereas the other two (PS 1212 and PS 1248) were very different from these and
each other. In contrast, the five transconjugants containing plasmids encoding the
SHV-1 P-lactamase exhibited a diversity of antibiogram and restriction profiles.
3.5.8. Specific Activity of the TEM-1 P-Lactamase and
Resistance to Clavulanic Acid
As before, the specific activities of the TEM-1 P-lactamases, isolated from the
transconjugants, were determined. The MICs of amoxycillin and amoxycillin plus
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Figure 41. Analytical iso-electric focusing of [3-lactamases in the South
African transconjugants
Tracks
AO PS 1222; B) PS 1223; C) PS 1224; D) RP4 (TEM-2 producer); E) PS 1226; F)
R1 (TEM -1 producer); G) PS 1227; H) PS 1228; I) PS 1229; J) PS 1230; K) PS
1231; L) R1010 (SHV-1 producer)
These selected TEM-1 producing tranconjugants are representative of all the






Figure 42. Analytical iso-electric focusing of TEM-2 (3-lactamases in the
South African transconjugants
Tracks
A) PS 1210; B) PS 1212; C) R1 (TEM-1 producer); D) RP4 (TEM-2 producer); E)
PS 1225; F) PS 1248
A B C D E F
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Figure 43. Analytical iso-electric focusing of SHV-1 p-lactamases in the
South African transconjugants
Tracks
A) R1 (TEM-1 producer); B) PS 1219; C) PS 1232; D) R1010 (SHV-1 producer); E)
R455 (OXA-1 producer); F) PS 1233; G) PS 1312; H) PS 1316
A B C D E F G H
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clavulanic acid in the transconjugants were also ascertained (Tables 38 - 45). As
with the transconjugants obtained from the Edinburgh commensal faecal survey,
no significant difference could be identified between the MIC values and the
specific activity of the P-lactamase.
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Table 38. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from rural infants
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans *
PS 1236 (PS 712) 1024 512 8 8 0.188
PS 1237 (PS 713) 128 512 4 8 0.070
PS 1244 (PS 722) >1024 512 16 8 0.001
PS 1245 (PS 723) >1024 512 16 4 0.007
PS 1247 (PS 725) 1024 512 8 8 0.004
PS 1252 (PS 731) 1024 512 16 8 0.017
PS 1254 (PS 733) 1024 512 8 8 0.033
PS 1255 (PS 734) 1024 512 8 8 0.001
PS 1262 (PS 742) 1024 512 8 8 0.0004
PS 1265 (PS 746) >1024 512 16 8 0.0002
PS 1268 (PS 749) >1024 512 16 8 0.004
PS 1239 (PS 715) 1024 512 8 8 0.008
PS 1240 (PS 716) 64 512 2 8 0.006
PS 1283 (PS 778) 1024 512 8 8 0.0005
PS 1238 (PS 714) 256 512 4 8 0.039
PS 1250 (PS 729) 32 512 4 8 0.003
PS 1253 (PS 732) 64 512 2 8 0.009
PS 1259 (PS 739) 1024 512 8 8 0.055
PS 1260 (PS 740) 1024 512 8 8 0.0002
PS 1261 (PS 741) 128 512 2 8 0.002
PS 1264 (PS 745) 1024 512 8 8 0.004
PS 1241 (PS 717) >1024 512 16 8 0.011
PS 1242 (PS 719) >1024 512 16 8 0.047
PS 1243 (PS 721) 512 512 8 8 0.098
PS 1246 (PS 724) 128 512 8 8 0.001
PS 1256 (PS 736) >1024 518 2 8 0.011
PS 1257 (PS 737) >1024 512 16 4 0.017
PS 1258 (PS 738) >1024 256 8 4 0.268
PS 1269 (PS 753) 512 512 8 4 0.001
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Table 38. Continued
Transconjugant No. MIC amox* MIC amox/clav* Specific Activif
WT Trans WT Trans +
PS 1270 (PS 754) 1024 256 8 8 0.002
PS 1266 (PS 747) >1024 512 16 8 0.002
PS 1271 (PS 755) >1024 512 16 8 0.006
PS 1272 (PS 756) >1024 512 16 4 0.0004
PS 1273 (PS 757) >1024 512 16 4 0.002
PS 1274 (PS 758) 1024 256 16 4 0.001
PS 1276 (PS 762) 256 512 4 4 0.001
PS 1277 (PS 763) 128 512 16 8 0.0005
PS 1278 (PS 764) 32 256 16 4 0.0004
PS 1279 (PS 765) 256 256 16 4 0.0006
PS 1267 (PS 748) 1024 512 8 8 0.001
PS 1282 (PS 776) 512 512 8 8 0.004
PS 1275 (PS 761) 128 512 4 8 0.005
PS 1281 (PS 775) 1024 512 8 8 0.0005
PS 1280 (PS 771) 1024 512 8 8 0.001
PS 1284 (PS 779) 1024 512 8 8 0.003
PS 1288 (PS 786) 1024 512 8 8 0.0005
PS 1285 (PS 782) 1024 512 8 8 0.0001
PS 1286 (PS 784) 1024 512 8 8 0.009
PS 1287 (PS 785) 1024 512 8 8 0.009
PS 1289 (PS 787) 1024 512 8 8 0.03
PS 1290 (PS 788) 1024 512 8 4 0.001
PS 1291 (PS 789) 1024 512 8 8 0.001
PS 1292 (PS 790) 1024 512 16 8 0.0077
PS 1294 (PS 769) >1024 512 16 8 0.003
PS 1293 (PS 768) >1024 512 16 8 0.001
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Table 39. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from rural children
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans *
PS 1220 (PS 905) 64 512 16 8 0.065
PS 1211 (PS 879) 1024 512 8 8 0.027
PS 1213 (PS 884) 1024 512 8 8 0.003
PS 1214 (PS 890) 1024 512 8 8 0.177
PS 1215 (PS 891) 128 512 2 8 0.150
PS 1217 (PS 896) 256 512 4 8 0.002
PS 1226 (PS 886) 64 512 2 8 0.04
PS 1216 (PS 894) >1024 512 16 8 0.028
PS 1218 (PS 900) 128 512 2 8 0.029
PS 1221 (PS 908) 1024 512 8 8 0.007
PS 1222 (PS 919) >1024 >1024 16 8 0.300
PS 1224 (PS 926) >1024 >1024 16 8 0.041
PS 1223 (PS 920) >1024 1024 8 8 0.045
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Table 40. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from rural teenagers
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans *
PS 1228 (PS 816) 1024 512 8 8 0.3268
PS 1227 (PS 808) 1024 512 8 8 0.729
PS 1229(PS824) 1024 512 16 8 0.120
PS 1230 (PS 831) 1024 512 8 8 0.003
PS 1231 (PS 842) >1024 >1024 16 8 0.1106
PS 1233 (PS 860) >1024 >1024 16 8 0.098
PS 1234 (PS 863) >1024 512 16 8 0.393
PS 1235 (PS 867) >1024 512 16 8 0.156
Table 41. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from rural adults
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans *
PS 1304 (PS 645) 1024 512 8 8 0.009
PS 1310 (PS 708) 512 512 8 8 0.017
PS 1301 (PS 600) 1024 256 4 4 0.0004
PS 1302 (PS 603) 1024 512 8 8 0.001
PS 1305 (PS 646) 1024 512 8 8 0.0008
PS 1306 (PS 649) 512 512 8 8 0.004
PS 1307 (PS 679) >1024 512 8 8 0.002
PS 1308 (PS 682) 1024 1024 8 8 0.014
PS 1311 (PS 711) >1042 512 8 8 0.0004
PS 1312 (PS 706) 256 256 2 2 0.001
PS 1303 (PS 626) 1024 1024 8 8 0.001
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Table 42. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from urban infants
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans +
PS 1329.(PS 987) >1024 512 16 8 0.091
PS 1315.(PS 934) >1024 512 16 8 0.049
PS 1322 (PS 962) >1024 512 16 8 0.107
PS 1334 (PS 1006) 1024 512 8 8 0.001
PS 1313 (PS 929) 1024 512 8 8 0.12
PS 1320 (PS 953) 1024 512 16 8 0.128
PS 1324 (PS 966) 1024 512 16 8 0.033
PS 1325 (PS 972) 1024 512 16 8 0.131
PS 1326 (PS 973) 1024 512 16 8 0.137
PS 1314 (PS 931) 1024 512 16 8 0.003
PS 1316 (PS 936) >1024 1024 8 8 0.102
PS 1317 (PS 938) >1024 512 16 8 0.029
PS 1318 (PS 939) >1024 512 16 8 0.053
PS 1327 (PS 974) >1024 512 16 8 0.049
PS 1319 (PS 940) 1024 512 8 8 0.073
PS 1321 (PS 960) >1024 512 16 8 0.024
PS 1323 (PS 963) >1024 512 16 8 0.026
PS 1328 (PS 982) 512 512 8 8 0.112
PS 1330 (PS 992) 1024 512 16 8 0.188
PS 1331 (PS 994) 1024 1024 16 8 0.068
PS 1332 (PS 999) >1024 512 16 8 0.098
PS 1333 (PS 1000) 512 512 8 8 0.024
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Table 43. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from urban children
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans -i*
PS 1346 (PS 1045) 1024 512 8 8 0.087
PS 1337 (PS 1015) >1024 512 16 8 0.048
PS 1338 (PS1016) 64 512 2 8 0.116
PS 1339 (PS1018) 256 512 16 8 0.025
PS 1341 (PS 1024) 1024 512 16 8 0.146
PS 1335 (PS 1009) 1024 512 16 8 0.527
PS 1336 (PS 1012) >1024 1024 16 8 0.138
PS 1340 (PS 1022) 1024 512 16 8 0.100
PS 1342 (PS 1025) 1024 512 8 8 0.076
PS 1347 (PS 1054) 1024 512 8 8 0.117
PS 1343 (PS 1039) 1024 512 8 8 0.019
PS 1344 (PS 1043) 1024 1024 8 8 0.117
PS 1345 (PS 1044) 512 512 8 8 0.026
PS 1349 (PS 1062) >1024 512 16 8 0.054
PS 1350 (PS 1066) 1024 512 8 8 0.146
PS 1351 (PS 1074) 256 1024 16 8 0.081
PS 1348 (PS 1061) 1042 512 8 8 0.131
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Table 44. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from urban teenagers
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans *
PS 1353 (PS 1087) 1024 512 8 8 0.466
PS 1354 (PS 1095) 1024 512 8 8 0.039
PS 1355 (PS 1096) 1024 512 16 8 0.029
PS 1356 (PS 1099) 1024 512 8 8 0.051
PS 1357 (PS 1104) 1024 1024 8 8 0.017
PS 1358 (PS 1111) >1024 1024 16 8 0.0003
PS 1359 (PS 1117) >1024 1024 16 8 0.070
PS 1361 (PS 1122) 1024 512 16 8 0.064
PS 1362 (PS 1123) >1024 512 16 8 0.293
PS 1352 (PS 1080) 1024 1024 8 8 0.065
PS 1360 (PS 1121) >1024 1024 16 8 0.062
Table 45. The different specific activities and the sensitivities to
amoxycillin and amoxycillin plus clavulanic acid of the
ampicillin resistant transconjugants from urban adults
Transconjugant No. MIC amox* MIC amox/clav* Specific Activity
WT Trans WT Trans +
PS 1365 (PS 1142) >1024 512 16 8 0.024
PS 1366 (PS 1144) 1024 512 8 8 0.139
PS 1367 (PS 1145) 512 512 8 8 0.073
PS 1368 (PS 1146) >1024 512 16 8 0.046
PS 1369 (PS 1162) >1024 512 16 8 0.088
PS 1370 (PS 1171) 1024 256 8 8 0.078
PS 1371 (PS 1173) 1024 512 8 8 0.033
PS 1372 (PS 1190) 1024 512 8 8 0.058
PS 1373 (PS 1200) >1024 512 16 8 0.087
PS 1363 (PS 1130) >1024 512 16 8 0.031
PS 1364 (PS 1132) 128 512 2 8 0.044
*
= mg/L 4*= (i moles nitrcephin hydolysed / minute / mg protein
WT = wild type Trans = transconjugant
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3.6. Biochemical Investigation of TEM-1
p-Lactamase from Disparate Plasmids
Newer generation cephalosporins and P-lactam/p-lactamase inhibitor combinations
have the potential to select for mutations in the common plasmid-mediated
P-lactamases, TEM-1, TEM-2 and SHV-1 (Payne and Amyes, 1991). Such mutations
occur in a step-wise manner and consequently, resistance may be either conferred to
these agents directly or after a number of sequential mutations (Amyes and Gemmell,
1992). Some extended-spectram P-lactamases eg. TEM-9, have arisen as a result of a
silent mutation. While such a mutation is recognised in nucleotide sequencing, there
is no detectable alteration in the pi value of the new p-lactamase; analytical iso¬
electric focusing is established as the main P-lactamase definitive criterion. Similarly,
it has been demonstrated that a mutation at position 69 in the TEM-1 P-lactamase,
resulting in a leucine substitution for methionine, promotes resistance to P-lactam
/p-lactamase inhibitor combinations although this change is indistinguishable by
analytical iso-electric focusing. Furthermore, as with TRC-1 (Thomson and Amyes,
1992a), these new adapted P-lactamases may not be recognised by an altered MIC
value. Such alterations raise the question as to whether all P-lactamases described
as TEM-1 (pi 5.4) are indeed identical to one another.
Ten TEM-1 producing strains isolated from the surveys were investigated
biochemically in order to ascertain whether any biochemical variation existed
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between the TEM-1 P-lactamase in each of the strains.
3.6.1. Biochemical Analysis
Cell free extracts of each strain were prepared from 1 litre of bacterial culture
(Materials and Methods). The P-lactamase was partially purified and isolated in
a calibrated sephadex G75 column (Materials and Methods). As described
previously, spectrophotometry assays were conducted in order to determine the
relative rates of hydrolysis of benzylpenicillin, ampicillin, cephaloridine and
nitrocephin exhibited by each of the strains. The relative efficiency of hydrolysis
was also normalised with respect to benzylpenicillin. In addition, the
concentration of clavulanic acid required to inhibit, by 50%, the hydrolysis of
nitrocephin substrate by the P-lactamase (ID50) was determined by
spectrophotometry assay. The results are shown in Table 46.
From Table 46, it is clear that there is little variation in the biochemistry of the
enzymes extracted from the strains listed. Each isolate had a similar sensitivity
to amoxycillin when combined with clavulanic acid as is indicated by both the
MIC to the combination and the clavulanic acid ID50 value. Although the values
for ES 64 and ES 67 were slightly higher, the spectrophotometry assays
identified a general lack of variation in the rates of hydrolysis of ampicillin,
cephaloridine and nitrocephin.
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Table 46. Profile of each of the 10 strains included in the investigation
No.
MIC mg/L Rates ofHydrolysis Clav
ID50*Amox Amox/Clav Pen G Amp*!* Ceph*!* Nit*!*
ES 43 1024 8 100 3.5 2.4 16 0.08
ES 59 256 8 100 5.1 2 17 0.1
ES64 512 8 100 25 29 7.1 0.18
ES 67 512 8 100 21 30 12.4 0.05
ES 72 512 8 100 34 2.3 9 0.03
PS 1236 512 8 100 <1 <1 5.8 0.03
PS 1261 512 8 100 5.9 1.5 13.6 0.08
PS 1271 256 8 100 9.8 5.5 22.6 0.06
PS 1323 256 4 100 <1 4.7 15.8 0.077
PS 1337 512 8 100 32.9 2.8 17.0 0.062
Rates of hydrolysis expressed as a percentage of hydrolysis rate of
benzyl penicillin
pmole clavulanic acid
3.6.2. Selection for Mutants of the TEM-ip-Lactamase
TEM-l, TEM-2 and SHV-1 are encoded by a variety of plasmid types. As the
distribution of extended-spectrum [3-lactamases is limited, it has been
speculated that certain plasmid types may be either more successful in a
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nosocomial environment or may have properties that promote resistance gene
evolution (Jacoby and Sutton, 1991). Investigations were conducted to
determine whether some plasmids isolated from the commensal faecal flora of
healthy populations would adapt more successfully than others in a new
antibiotic environment.
The TEM derived [3-lactamase TRC-1 arose in an epidemic plasmid which has
been shown to be widespread in both hospital and community isolates that
contained TEM-1 (3-lactamase. The implication that TRC-1 arose as a result of
clinical therapy was demonstrated in an in vitro study which continuously
subcultured E. coli. J62-2 containing Rl, a TEM-1 producing plasmid, in the
presence of a range of sub-inhibitory concentrations of amoxycillin plus
clavulanic acid (Thomson and Amyes, 1993b). The result was the isolation of a
mutant enzyme with increased resistance to (3-lactamase inhibitors and
biochemical properties comparable with TRC-1. In order to ascertain whether
TRC-1 or a comparable laboratory mutant would be selected for in vitro from
the TEM-1 containing commensal plasmids, each of the 10 strains were
subjected to a similar challenge with amoxycillin plus clavulanic acid. The
treated strains resulting from this were investigated. Of interest, strain ES 59,
contains the epidemic plasmid identical to the epidemic plasmid on which TRC-1
was located.
As described in the Materials and Methods, each of the 10 strains were
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challenged for five days in 100ml Isosensitest broth containing different
concentrations (2 - 32mg/L) of amoxycillin in combination with clavulanic acid in
a 2:1 ratio. Table 47 shows the concentrations of amoxycillin plus clavulanic acid in
which growth of each strain persisted throughout the five day testing. All of the 10
parent strains were able to grow throughout the complete challenge in the presence
of both 2 and 4mg/L amoxycillin/clavulanate (Table 47). However, only two parent
strains tolerated increased concentrations of this combination. While ES 43 grew at
8mg/L, growth was suppressed at 16mg/L of the combination. PS 1261 was able to
grow in the presence of 16mg/L amoxycillin/clavulanate but no growth was observed
at 32mg/L amoxycillin/clavulanate.
As indicated in the Materials and Methods, bacteria from each flask were
isolated on Isosensitest agar plates containing the same concentration of
antibiotic in which the bacteria had been grown. Ten colonies were selected from
each agar plate. On MacConkey agar plates, these colonies were identified as
lactose non-fermenting strains. When the auxotrophic requirements were
checked on plates lacking histidine, the integrity of each colony was confirmed
as E. coli. J62-2.
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Table 47. Growth of isolates treated with amoxycillin plus clavulanic
acid at a range of concentrations
Amoxycillin / Clavulanic Acid Concentration (mg/L)
Ratio 2:1 - expressed as amoxycillin
Strain No. 2 4 8 16 32
ES 43 ++ ++ ++
ES 59 ++++---
ES 64 ++ ++ -
ES 67 ++ ++ -
ES 72 ++ ++
PS 1236 ++ ++
PS 1261 ++ ++ ++ ++
PS 1271 ++ ++
PS 1323 ++ ++




3.6.3. P-Lactamase Analysis of the Treated Strains
The type of (3-lactamase produced by each of the checked strains obtained from
each concentration was ascertained by iso-electric focusing, as already outlined,
but the polyacrylamide gel contained combined ampholines, ranges pH 3.5 -10
and pH 4 - 6, in a 1:1 mixture. A total of 230 isolates were examined. All of the
isolates still produced the TEM-1 (3-lactamase irrespective of the concentration
of amoxycillin plus clavulanic acid with which they had been challenged.
Figures 44 and 45 show a single representative for each of the 10 TEM-1
producing strains isolated from each challenge concentration of amoxycillin plus
clavulanic acid.
3.6.4. Sensitivity of the Treated Strains to
Amoxycillin and Amoxycillin plus Clavulanic
Acid
Following the procedure outlined previously, the MIC of amoxycillin and
amoxycillin plus clavulanic acid was measured for the representative from each
of the 23 groups of 10 treated strains. The results (Table 48) indicate that
challenge with different sub-inhibitory concentrations of amoxycillin/
clavulanate induces different responses in the strains. A variety of phenotypes
were observed in the challenged isolates. In general, after challenge with only
2mg/L of the combination, either no alteration or a slight reduction in the MIC
to amoxycillin alone and amoxycillin/clavulanate, was observed. However, when
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Figure 44. Analytical iso-electric focusing of single representatives of
TEM-1 producing strains after challenge with
amoxycillin/clavulanate
Tracks
A) ES 43 (2); B) ES 43 (4); C) ES 43 (8); D) ES 59 (2); E) ES 59 (4); F) ES 64 (2);
G) ES 64 (4); H) R1 (TEM-1 producer); I) ES 67 (2); J) ES 67 (4); K) ES 72 (2); L)
ES 72 (4); M) PS 136 (2); N) PS 1236 (4); O) R1
Figure in parenthesis equals challenge concentration (mg/L)
amoxycillin/clavulanate.
ABCD EFGH IJKL MNO
5.4
181
Figure 45. Analytical iso-electric focusing of single representatives of
TEM-1 producing strains after challenge with
amoxycillin/clavulanate
Tracks:-
A) PS 1261 (2); B) PS 1261 (4); C) PS 1261 (8); D) PS 1261 (16); E) PS 1271 (2);
F) PS 1271 (4); G) PS 1323 (2); H) PS 1323 (4); I) PS 1337 (2); J) PS 1337 (4); K)
R1 (TEM-1 producer)
Figure in parenthesis equals challenge (mg/L) amoxycillin/clavulanate.




the challenge concentration was increased, the MIC of both amoxycillin alone
and amoxycillin/clavulanate was seen either not to change or to increase
slightly in the strains. These phenotypic variations are in spite of no detectable
variation in the iso-electric focusing point as indicated in Section 3.6.3. In
addition, the specific activity of the [3-lactamase produced by this isolate is also
included in Table 48.
3.6.5 Plasmid Analysis of the Challenged and
Unchallenged Strains
Variation in the challenged strains from the parent strains was investigated.
The plasmids from both the unchallenged parent strains and the representative
challenged strains were extracted and restricted by endonuclease digestion as
described previously. Figures 46 and 47 both show the plasmid profiles of each
unchallenged parent strain together with the plasmid profiles of their
associated challenged strains at the various concentrations. As there is no
difference in the profiles originating from challenged strains and the profiles of
the unchallenged strains, it may be inferred that there has been no plasmid
rearrangement.
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Table 48. Comparison of isolates challenged with amoxycillin /
clavulanate
Strain Challenge MIC amox MIC amox/clav P-lactamase
Number Cone (mg/L) mg/L mg/L specific activity*!*
UC CH UC CH
ES 43 2 1024 1024 8 8 0.008
ES 43 4 1024 1024 8 8 0.036
ES 43 8 1024 >1024 8 16 0.014
ES 59 2 256 256 8 4 0.018
ES 59 4 256 512 8 8 0.017
ES 64 2 512 256 8 4 0.003
ES 64 4 512 512 8 8 0.004
ES 67 2 512 512 8 8 0.057
ES 67 4 512 1024 8 16 0.618
ES 72 2 512 512 8 8 0.010
ES 72 4 512 1024 8 16 0.009
PS 1236 2 512 256 8 4 0.035
PS 1236 4 512 1024 8 8 0.010
PS 1261 2 512 256 8 4 0.026
PS 1261 4 512 >1024 8 8 0.195
PS 1261 8 512 >1024 8 8 0.013
PS 1261 16 512 >1024 8 32 0.014
PS 1271 2 256 512 8 4 0.017
PS 1271 4 256 512 8 8 0.005
PS 1323 2 256 256 4 4 0.005
PS 1323 4 256 >1024 8 8 0.038
PS 1337 2 512 512 8 4 0.196
PS 1337 4 512 512 8 8 0.177
*!• = A (.imoles nitrocephin hydrolysed / minute / mg protein
UC = Unchallenged strain CH = Challenged strain
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Figure 46. Agarose gel electrophoresis of an endonuclease restriction
digest of plasmid DNA extracted from both amoxycillin /
clavulanate unchallenged and challenged strains
Tracks
A) ES 43 (0); B) ES 43 (2); C) ES 43 (4); D) ES 43 (8); E) ES 59 (0); F) ES 59 (2); G) ES
59 (4); H) ES 64 (0); I) ES 64 (2); J) ES 64 (4); K) ES 67 (0); L) ES 67 (4); M) ES 72; N)
ES 72 (4)
Figure in parenthesis equals challenge concentration (mg/L) amoxycillin /
clavulanate.








Figure 47. Agarose gel electrophoresis of an endonuclease restriction
digest of plasmid DNA extracted from both amoxycillin /
clavulanate unchallenged and challenged strains
Tracks
A) PS 1261 (0); B) PS 1261 (2); C) PS 1261 (4); D) PS 1261 (8); E)PS 1261 (16); F) PS
1236 (0); G) PS 1236 (2); H) PS 1236 (4); I) PS 1271 (0); J) PS 1271 (2); K) PS 1271
(4); L) PS 1323 (0); M) PS 1323 (2); N) PS 1323 (4); O) PS 1337(0); P) PS 1337 (4)




From the results, it is clear that there is no significant difference between the
strains in the rates of hydrolysis for each of the substrates tested. In addition,
the ID50 to clavulanic acid observed amongst the strains was very similar. It may
be concluded therefore, that there is little variation in the TEM-1 P-lactamase
which is produced in each strain.
Inspite of employing the published procedure to select variants of the TEM-1
P-lactamase (Thomson and Amyes, 1993b), no mutants were obtained from the
series of challenge experiments. The fact that no mutations were observed
could result from a number of reasons. First, as discussed previously, the
genetic background, that is plasmid type, may have a bearing on the ease of
selection of the various TEM P-lactamases (Jacoby and Sutton, 1991).
Interestingly, strain ES 59 contained the same plasmid on which TRC-1 had
arisen from TEM-1. As no mutations were obtained from this strain, it is clear
that the genetic background is not the only factor in the selection of TEM
variant enzymes. The fact that TRC-1 emerged on this plasmid in the clinical




Bacteria have responded to the development and clinical use of antibiotics with a
bewildering array of resistance mechanisms (Amyes and Gemmell, 1992). The
incidence of antibiotic resistance amongst clinical isolates is of worldwide concern
and has been extensively studied (Atkinson and Lorian, 1984; Shears et al., 1987;
McGowan et al., 1989; Mpller, 1989; Dornbusch et al., 1990; Senerwa et al., 1991;
Singh(b) et al., 1992; MacGowan et al., 1993). In particular, the development of
antibiotic resistance to the (3-lactam agents has been closely monitored (Sanders
and Sanders, 1992). Amongst this group of antimicrobials, there has been an
especial interest in antibiotic resistance mediated to ampicillin, as this is the most
widely used antimicrobial throughout the world (Amyes, 1989; Young et al., 1989;
Sanders and Sanders, 1992).
Much less attention has, however, been paid to the carriage of antibiotic
resistance genes in the normal non-pathogenic aerobic gut flora of healthy
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individuals. As indicated in a number of recent studies, this bacterial population
is of importance as the normal flora of healthy individuals could represent a
constant pool of resistance genes (Levy et al., 1988; Lester et al., 1990). Such
bacteria have the potential to complicate therapy, either by causing an
endogenous infection, or by transferring their resistance determinants to invading
pathogens (Datta, 1969; Moorhouse, 1969; Shaw et al., 1973; Shears et al., 1988a).
The purpose of the commensal faecal flora survey, conducted in Edinburgh, was
to ascertain the carriage rates of antibiotic resistance amongst the healthy
population. As a minimum requirement for participation, donors were requested
not to have received antibiotic treatment in the three weeks prior to sampling.
This time period was selected because previous studies have shown that changes
in faecal flora subjected to antimicrobials were usually reversed by 10 - 14 days
after stopping the drug (Levy, 1986).
In this study, the identified carriage rate of antibiotic resistance amongst 100
healthy volunteers was 42%, 39%, 27% and 12% for ampicillin, cefuroxime,
tetracycline and trimethoprim respectively. The high carriage rate of cefuroxime
resistant bacteria was unexpected. This is a result of the cefuroxime
concentration (4mg/L) incorporated into the MacConkey agar plates; this
breakpoint value, chosen for use with clinical therapy (BSAC guidelines, 1991),
does, however, not reflect changes in the development of bacterial resistance. In
addition, the low carriage rate of trimethoprim resistant bacteria was also
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unexpected given the fact that this antimicrobial has been available in general
practice for over 20 years (Huovinen, 1987; Elwell and Fling, 1989). No
resistance was detected to the third generation cephalosporin, ceftazidime and
only a low level of resistance was found to gentamicin, perhaps reflecting the
restricted use of these compounds to hospitals. Similarly, there was only a low
level of resistance to the quinolone antibacterials. This has been noted before in
surveys of resistance in commensal faecal flora (Amyes et al., 1992) and may
result from the lack of plasmid-mediated resistance to these agents (Lewin et al.,
1990; Courvalin, 1990; Amyes and Gemmell, 1992).
Amongst the other commensal faecal flora surveys of the healthy population which
have been conducted in the developed world, comparable carriage rates of antibiotic
resistance have been reported. In a survey conducted in Boston, of 289 volunteers,
34.9%, 30.1%) and 33.6% of the healthy population carried bacteria resistant to
ampicillin, tetracycline and sulphamethoxazole respectively (Levy et al., 1988).
Trimethoprim resistance was not studied. An examination of E. coli from faecal
samples of 310 healthy persons from different areas of the Netherlands revealed the
prevalence of antibiotic resistant E. coli to be 75.5% for ampicillin, 58.5% for
tetracycline, 60.5%> for sulphamethoxazole, 43.5% for trimethoprim and 38.0% for
nitrofurantoin (Bonten et al., 1992). These are higher rates of resistance than those
reported from an earlier study undertaken in the Netherlands, which revealed the
overall carriage rate of resistant E. coli as 26% for ampicillin, 42% for tetracycline
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and 46% for sulphamethoxazole (Degener et al., 1983). The most recent
investigation of this ldncl examined 85 healthy urban and rural dwellers in Jeddah
and reported the carriage rate of ampicillin, streptomycin, tetracycline, kanamycin,
and gentamicin resistant determinants to be 40.4%, 29.7%, 34.0%, 23.25% and
11.75% respectively (Ismaeel, 1993). The results from each of the various surveys of
the carriage of antibiotic resistance amongst the commensal faecal flora of the
healthy population are shown in Table 49.
In common with other surveys of the carriage of resistance in commensal faecal
flora, the highest carriage rate of resistance in the Edinburgh population was to
ampicillin. Ampicillin has been the most widely used antibiotic worldwide (Amyes,
1987; Young et al., 1989; Sanders and Sanders, 1992) and this may partly explain
the high levels of resistance encountered. In addition, ampicillin is poorly absorbed
from the gut facilitating the selection of resistant gut flora (Neu, 1979; Amyes, 1989).
The renewed interest in the carriage of resistance genes in the normal faecal flora
has been made with a view to predicting the importance of this bacterial
population as a threat to the use of antibiotics. However, determining the carriage
of antibiotic resistance in this bacterial population is, in common with clinical
isolates, associated with a number of complicating factors. In particular, amongst
clinical isolates, problems have arisen in relation to the choice of resistance
breakpoints, inoculum size and the correct medium (Hamilton-Miller, 1984).
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Table 49. The incidence of antibiotic resistance in commensal faecal
flora of the healthy population; a comparison of surveys
Antimicrobial
Survey Ap Tp NA Cm Tc Su Nit Sm Kn Gm
Developed Countries
1) Ireland 62 - 0 16 76 - - - 63 -
2) U.K. 25 - - 5 22 17 - 21 - -
3) The Netherlands 26 - - - 42 46 - - - -
4) The Netherlands 76 25 - - 47 86 29 - -
5) The Netherlands 76 44 - - 59 61 38 - - -
6) U.S.A. 35 - 1 4 31 - - 34 21 5
7) U.S.A 23 3 - 15 33 36 - 38 8 0
8) Scotland 42 12 2 - 27 - - - - 1
Developing Countries
9) Venezuela 85 61 - 56 93 93 - 95 56 0
10) China 47 64 - 42 92 87 - 79 26 32
11) India 98 98 23 97 - - - - - -
12) Saudia Arabia 41 - - - 34 - - 30 23 12
13) South Africa 87 74 10 53 - - - - - 8
I) Moorhouse, 1969; 2) Linton et al., 1972 (urban study only); 3) Degener et al., 1983;
4) Bonten et al., 1990; 5) Bonten et al., 1992; 6) Levy et al., 1988; 7) Lester et al.,
1990; 8) Ph.D Edinburgh survey, 1991; 9) Lester et al., 1990; 10) Lester et al., 1990;
II) Amyes et al., 1992; 12) Ismaeel, 1993; 13) Ph.D South Africa survey, 1992.
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Furthermore, the selection of specimens and patients may influence the findings.
Therefore, it has been concluded that the most significant assessment of changes
in resistance are made from long-term follow-up surveys in a single centre (Amyes
and Gemmell, 1992). These factors are all applicable to the faecal flora surveys of
the healthy population. In particular, it is difficult to draw comparative
conclusions between these different surveys as different protocols were employed
in each. The initial screening procedure varies not only in the amount of faecal
sample examined (Bonten et al., 1990; 1992) but also in the concentration of
antibiotic used to determine resistance (Levy et al., 1988; Lester et al., 1990).
Consequently, this variability may affect the overall figures for the carriage rates of
resistant organisms. This point is demonstrated firstly, in a study in the
Netherlands where 75.5% of the healthy population examined contained ampicillin
resistant faecal flora. The screening procedure was given as a partial explanation
for this high carnage rate (Bonten et al., 1992). Secondly, in a study of the carriage
ofE. coli. resistant to antimicrobial agents from healthy children in three cities, two
methods of colony selection were employed, namely, random colony selection and
disk diffusion colony selection. The latter procedure was described as having 1000-
fold greater sensitivity than the former (Lester et al., 1990).
The genetic and biochemical basis for the development and spread of P-lactam
resistance is well documented in clinical settings (Simpson et al., 1980;
Huovinen et al., 1988b; Mabilat and Courvalin, 1990; Cooksey et al., 1990;
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Burman et al., 1992; Thomson and Amyes, 1993a). Unfortunately, only a few of
the studies on normal E. coli have proceeded to examine the mechanisms of
resistance in the strains isolated (Simpson et al., 1986; Singh(a) et al., 1992;
Thomson et al., 1993b). The value of such studies is obvious to establish
whether the resistance genes and plasmids in the normal flora are indeed the
progenitors of those encountered in clinical isolates.
In this study, the (3-lactamases responsible for transferable and non-transferable
ampicillin resistance and the genetic carriers for the self-transmissable
resistance determinants have been identified. Restriction endonuclease
fingerprinting of the transconjugant plasmids identified nine different plasmid
types. The fact that one plasmid type not only occurred on five occasions but was
also isolated from three of the four different sample population groups and
another, very similar plasmid type occurred on two occasions, suggests the
presence of an epidemic plasmid in the community. Although the spread of
epidemic plasmids in hospitals is well reported (Amyes et al., 1987; Sirot et al.,
1988; Bauernfeind et al., 1993), this study represents the first indication that
this may also happen in bacteria carried by the healthy community.
The maintenance and stability of plasmids within bacterial populations is
uncertain (Hawkey, 1986). The Edinburgh commensal faecal flora follow-up
survey was, therefore, of considerable importance in that it provided some
indication of plasmid maintenance. This study examined five faecal specimens
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which had been obtained from those volunteers in the original survey whose
faecal specimen contained bacteria capable of transferring ampicillin resistance.
Interestingly, three specimens contained bacteria which were resistant to
ampicillin suggesting that, in these volunteers, the presence of ampicillin
resistant bacteria amongst the commensal faecal flora may either have been
continuous, or alternatively, intermittent throughout the two year period. Of
further interest, only in one strain was the ampicillin resistance determinant
located on a self-transmissable plasmid. When analysed by endonuclease
restriction fingerprinting, the plasmid was found to be identical in profile to the
plasmid which had been extracted from ampicillin resistant bacteria obtained
from the same volunteer two years previously. Although this newly isolated
plasmid differed in antibiogram profile from the same plasmid identified in the
first survey, the loss of the spectinomycin and cefuroxime resistance determinants
had clearly not affected the plasmid arrangement. It is likely that this difference
has occurred as a result of the problems associated with antibiogram sensitivity
testing; variations in sensitivity may be recorded in strains when the MIC of an
antibiotic is very close to the breakpoint concentration (BSAC guidelines, 1991).
The fact that a plasmid should persist in the commensal faecal flora in the
absence of any antibiotic selective pressure was of some surprise.
The identification and dissemination of epidemic plasmids within the clinical
community has been widely reported (Amyes et at., 1987; Sirot et al., 1988;
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Bauernfeind et al., 1993). However, to date, there have been no comparative
investigations between plasmids isolated from normal flora with those plasmids
isolated from clinical flora. The study conducted to compare plasmids isolated
from urinary isolates in Edinburgh with those plasmids isolated in the faecal
flora survey was, therefore, of great interest. This was particularly so as the
results from this research have shown that the epidemic plasmid identified
amongst the commensal faecal flora of the healthy population was identical to
an epidemic plasmid identified in urinary isolates in Edinburgh. It should be
remembered that the vast majority of urinary tract infections registered in
general practice are endogenous infections (Brumfitt et al., 1971; Degener et al.,
1983). Therefore, from these findings, it may be concluded that, in the absence
of antibiotic selection pressure, the resistance genes and plasmids in the normal
flora are evidently the progenitors of those encountered in clinical isolates.
It was of especial interest, that the epidemic plasmid present in the Edinburgh
community, common to both urinary isolates and isolates from faecal flora of
healthy individuals, was shown to be identical to the plasmid on which the TEM
derived (3-lactamase, TRC-1, was encoded when it was initially isolated
(Thomson and Amyes, 1992a). Although there was no increased resistance to
amoxycillin plus clavulanate detected amongst isolates from the healthy
community that contained the epidemic plasmid, the potential clearly exists for
TRC-1 type and TRI type (Vedel et al., 1992) enzymes to emerge in the community
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given firstly, the presence of the exact plasmid arrangement which encoded TRC-1
and secondly, the widespread use of P-lactamase inhibitor combinations amongst
general practitioners which encourages the selection of such enzymes (Thomson
and Amyes, 1992b). Unlike extended-spectrum P-lactamases, inhibitor-resistant
enzymes do, at present, seem to be rare (Vedel et al., 1992; Thomson and Amyes,
1993b). However, it is vital not to become complacent. It has been reported that
increased resistance to P-lactamase inhibitor combinations may be the result of a
silent mutation which is not detectable by isoelectric focusing; that is, there is no
alteration in the pi value (Delaire et al., 1992). Such initial subtle changes that
occur in the development of resistance may be masked through the inadequacies of
routine sensitivity testing (Thomson and Amyes, 1993b). In this research, ten
disparate plasmids, all carrying genes encoding the TEM-1 P-lactamase, were
challenged with various concentrations of amoxycillin plus clavulanic acid. No
mutants with increased resistance to this P-lactam/p-lactamase inhibitor
combination were obtained suggesting that amongst this plasmid population, there
has been no predisposition for the selection of these TEM derived P-lactamases.
Amongst clinical isolates, the TEM-1 P-lactamase is the most frequently isolated
P-lactamase (Matthew, 1979; Medeiros, 1984; Medeiros et al., 1988; Amyes,
1989; Young et al., 1989; Wiedemann et al., 1989; Sanders and Sanders, 1992).
Examination of the P-lactamases produced by the transconjugants of this study
revealed that plasmids encoding the TEM-1 P-lactamase were responsible for
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mediating resistance to ampicillin in every case. Although a variety of different
plasmid types were identified amongst the transconjugants, an epidemic
plasmid also prevailed. It may therefore be concluded that the high incidence of
resistance to ampicillin in Edinburgh is not only a result of the independent
spread of the TEM-1 P-lactamase gene alone but also the spread of an epidemic
plasmid encoding this P-lactamase.
The widespread presence of the TEM-1 p-lactamase amongst isolates from the
healthy population is of concern. The TEM-1 P-lactamase is recognised as the
progenitor to many extended-spectrum P-lactamases (Medeiros et al., 1988;
Philippon et al., 1989; Payne and Amyes, 1991), which from clinical experience
have been shown to be selected for in the presence of the newer cephalosporins
(Sirot et al., 1992; Bauernfeind et al., 1993). The potential exists, therefore, for
extended-spectrum P-lactamases to appear amongst the healthy community as
the introduction of the oral later generation cephalosporins into general practice
is imminent. Although, it has been argued that oral cephalosporins are no more
likely to select out extended-spectrum P-lactamases than their parenteral
counterparts (Cullman, 1992), it should be remembered that the threat of these
new compounds is in their increased usage.
Examination of the wild type ampicillin resistant isolates for their resistance
to other P-lactam agents revealed that amongst the E. coli there was complete
sensitivity to the newer cephalosporins, cefotaxime and ceftazidime. In
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addition, clavulanic acid was effective in restoring the sensitivity to
amoxycillin (MIC < 32mg/L) in 96% of cases. This resistance pattern results
from the predominance of the TEM-1 (3-lactamase as the mediator of ampicillin
resistance in these strains. Amongst those strains identified as Klebsiella spp.,
there was also a universal sensitivity to the newer cephalosporins and
clavulanic acid in combination with amoxycillin. Not surprisingly, SHV-1
predominated as the responsible P-lactamase mediating resistance in these
strains as others have noted elsewhere (Matthew, 1979; Shannon et al., 1990b).
Comparisons between commensal faecal flora surveys has been complicated by
variations in the selection criteria for volunteer participation. In order to make
an accurate assessment of the extent of the carriage of resistance genes in the
1 healthy population, the study groups should be as representative of the general
community as possible. Unfortunately, this may not always be possible as
encouraging participation in such studies is difficult. It is perhaps for this
reason that many of the earlier studies undertaken have looked at specific
populations and their relevance to the general community is therefore
questionable. Specific population groups examined for the carriage of antibiotic
resistance determinants in faecal flora include children (Moorhouse, 1969;
Lidin-Janson et al., 1977; Lester et al., 1990), particularly those attending day
care centres (Reves et al., 1987; 1990), and students (Bonten et al., 1990; 1992;
Lamikanra et al., 1989). In addition, the commensal faecal flora of patients prior
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to their admission to hospital has been well investigated (Datta, 1969; Shaw et al.,
1973; Spgaard, 1975). This population group may not be considered "healthy" but
none-the-less, it does provide some indication of the carriage of antibiotic resistant
bacteria in the nonclinical community.
For comparison with the commensal faecal flora survey of the healthy
population in Edinburgh, the survey of negative faecal specimens obtained from
the diagnostic laboratories in Edinburgh Royal Infirmary was conducted.
Although the donors of the specimens in this group, as with pre-admission
patients, may not be considered healthy, no obvious association exists with the
clinical community. It is not clear what is the impact of illness or debility on the
commensal faecal flora. In this study, amongst the 100 faecal specimens
obtained, a higher carriage of antibiotic resistant bacteria were identified than
in the commensal faecal flora of the healthy population in Edinburgh. This is
clearly represented in the histogram (Figure 48). The most noticeable differences
are for ampicillin, cefuroxime and tetracycline. In the diagnostic survey, the
identified carriage rates of resistance were found to be 60%, 65% and 43%
respectively, but in the healthy faecal flora survey were 42%, 39% and 27%
respectively. It may be speculated that although not clinically related, donors of
specimens from the diagnostic survey may have been receiving antimicrobials
for treatment of a gastrointestinal related condition. Under such circumstances,
increased levels of antibiotic resistant bacteria would be anticipated on account
200
of the selection pressure. Of interest, a lower carriage of trimethoprim resistant
bacteria was observed (8%). As before, the proportion of strains carrying
gentamicin or ceftazidime resistant determinants was low which again reflects
the restricted use of these antimicrobials to the hospital environment. Similarly
nalidixic acid and ciprofloxacin resistance was low amongst these bacterial
strains. Again this is probably a consequence of the non-transferable
mechanism of resistance associated with the quinolones (Lewin et al., 1990;
Courvalin, 1990; Amyes and Gemmell, 1992).
Figure 48. Comparison of the carriage of antibiotic resistant bacteria
















As in the analysis of the wild type ampicillin resistant strains obtained from the
commensal faecal flora of the healthy population in Edinburgh, the wild type
ampicillin resistant strains obtained from the diagnostic survey were tested for
their sensitivity to a range of (3-lactam agents. The results obtained closely
resembled the results of the first survey. Amongst the E. coli, there was a
universal sensitivity to the newer cephalosporins, cefotaxime and ceftazidime
and in addition clavulanic acid was effective in restoring the sensitivity to
amoxycillin (MIC < 32mg/L) in all but five cases. Significantly, in each of the five
cases, a chromosomal P-lactamase was identified as the mediator of resistance.
The Klebsiella spp. also displayed a similar sensitivity profile with universal
susceptibility to amoxycillin plus clavulanic acid, ceftazidime, cefotaxime and
cefuroxime. Notably, lower MIC values of amoxycillin (MIC < 128 mg/L) were
recorded amongst the Klebsiella spp. except in one isolate which had an MIC of
1024mg/L. This strain was identified as being a TEM-1 P-lactamase producer.
The genetic and biochemical basis for ampicillin resistance in these isolates were
also ascertained for comparison with the initial survey. The diagnostic strains
demonstrated a much higher frequency of transfer of resistant determinants
(65%) into E. coli J62-2 than the ampicillin resistant strains from the first
survey (33%). Given the higher carriage of ampicillin resistant strains identified
in this population, this finding is perhaps not surprising. When the
transconjugants were analysed, the antibiogram profiles were found to be very
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similar to those antibiogram profiles detected in the transconjugants of the
healthy population. This presumably results from the fact that both populations
are exposed to the same selecting agents.
It was anticipated that a wide variety of plasmid profiles, as determined by
restriction endonuclease digestion, would exist; 21 different profiles amongst 37
transferable strains was consequently not surprising. One plasmid type (Group
C) did, however, predominate as it was found in 19% of the isolates.
Interestingly, endonuclease restriction analysis showed that this plasmid was
identical to the epidemic plasmid encoding the TEM-1 gene that had been
identified in the commensal faecal flora survey of the healthy Edinburgh
population, the associated follow-up survey which was conducted two years later
and in addition, in the Edinburgh urinary isolates. It is of concern that the
same plasmid should persist in each of the different population groups
examined.
The incidence of antibacterial drug resistance amongst clinical isolates has been
shown to be higher in the developing world rather than the developed world
(Farrar, 1985). The limited number of conducted surveys indicate that this is
also the case with the carriage of antibiotic resistant strains within the normal
gut flora (Lester et al., 1990; Amyes et ai, 1992). For comparison, therefore, the
study which ascertained the carriage of antibiotic resistance amongst the
commensal faecal flora of the black populations in South Africa was conducted.
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South Africa is representative of a unique situation whereby both the developed
and developing world are represented. The black communities experience third
world living conditions with two important exceptions; there is generally no
unprescribed use of antibiotics and the water supply is often bacteria-free.
Such variations in living conditions are reflected in the vast differences of
bacterial carriage of antibiotic resistance. This was exemplified in a study of
urinary and non-urinary isolates, in which trimethoprim resistance varied
considerably between three hospitals; 59% of Hillbrow Hospital isolates, 50.6%
of Baragwanath Hospital isolates and 37.6% of Johannesburg Hospital isolates
were resistant (Wylie and Koornhof, 1989). While the high incidence of
trimethoprim resistance amongst clinical isolates was reportedly related to the
high dispension of this agent to both inpatients and outpatients (Wylie and
Koornhof, 1989), both Hillbrow and Baragwanath hospitals have a high
proportion of patients from poor community areas which may have influenced
the carriage rate.
In the commensal faecal flora survey in South Africa, the carriage rate of
antibiotic resistance was 88.6% for ampicillin and 74.2% for trimethoprim.
Chloramphenicol resistance was found to be lower at 52.6%, while the carriage
of gentamicin and nalidixic acid resistance were lower still at 7.5% and 10.2%
respectively. This lower carriage of resistance may reflect the lower usage of
these antimicrobials as opposed to ampicillin and trimethoprim, which are the
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most widely used antibacterials in the study areas (H.J. Koornhof, Personal
communication). The carriage rates of antibiotic resistance identified in South
Africa are substantially higher than in Edinburgh. This is a true comparison as
exactly the same methodology was employed in conducting each study.
These results strongly indicate that although South Africa is considered an
industrialised developed country, the black communities in the study are
representative of a developing country type under-culture. The findings of this
research may be applicable to certain other closed population groups in
developed countries. Such groups may include those on Indian reservations in
the United States, where hygienic conditions are poor and suitable for spread of
endemic disease (Blaser et al., 1983). It may be speculated, therefore, that the
carriage rates of antibiotic resistant bacteria amongst the faecal flora of similar
groups such as the poor Americans in Ghetto areas, Aborigines in Australia and
some population groups in Europe, may resemble those identified amongst the
black communities in South Africa.
The highest incidence to date for the carriage of resistant bacteria within
commensal populations was recently reported from South India (Amyes et al.,
1992); trimethoprim or ampicillin resistant bacteria were present in 98% of the
specimens screened. The factors contributing to the maintenance of this high
carriage of bacterial resistance included the contamination of the water supply
in combination with the inappropriate dispension and widespread use of
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antimicrobial agents (Young and Jesudason, 1990; Amyes et al., 1992). The
causal relationship between increased antibiotic resistance and increased
antibiotic usage has been explained before.
High carriage rates of antibiotic resistant determinants amongst the normal
flora of healthy children in the developing world have been demonstrated. In
Caracus and Qin Pu, 60.9% and 64.1% respectively of the children examined
contained trimethoprim resistant faecal flora. It has also been reported that the
carriage of antibiotic resistant strains is much higher amongst children than
adults (Linton et al., 1972; Hawkey, 1986). Possible reasons for this include high
antimicrobial prescribing amongst this group and lower standards of hygiene,
which facilitates the transmission of resistant organisms (Singh et al., 1990).
Examination of the resistance levels within our population sub-groups, however,
revealed a lack of correlation between age and antibiotic resistant faecal flora.
This compares with the commensal study of Dutch urban communities which
reported the same finding (Degener et al., 1983). However, this contrasts with
other findings; examination of child day care centres (DCC) (Reves et al., 1990),
revealed substantially higher levels of trimethoprim resistant faecal flora (30%)
amongst the children attending the centre than is prevalent in the general
population (6%). Similarly, ampicillin resistant faecal flora was reported as 70%
in this particular population, which again is substantially higher than
corresponding levels identified in the healthy community (34.9%) (Levy et al.,
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1988). In the current study, approximately half the urban infants attended a
childminder in SOWETO, the equivalent of a child day care centre, and yet the
levels of resistance observed in this particular group are not noticeably higher
than any other sub-group. This suggests the spread of antibiotic resistance
factors may occur at the same frequency in all strata of society if the general
levels of personal hygiene are low.
One of the distinctions between the developed and developing world is the lack
of a uncontaminated potable water supply in the latter. This has obvious
implications in facilitating the spread of infectious disease and had been
speculated to have a role in the transmission of antibiotic resistant organisms
(Amyes et al., 1992; Young, 1993). This study reports contamination of the water
and unsanitary conditions especially in rural areas which creates the
opportunity for cross infection between bacteria. Similar conclusions have been
drawn by other workers (Murray et al., 1985; Lamikanra and Ndep, 1989;
Amyes et al., 1992). However, in contrast to the Indian study, which indicated
contamination of the water supply coupled with high antimicrobial usage as
being responsible for the high resistance levels in that area, these factors may
only be contributors to the resistance levels witnessed in South Africa. This is
because in spite of very basic conditions in the urban areas of SOWETO, all our
participants came from houses with a tap supplying an uncontaminated supply
of water. Surprisingly, although the water was contaminated in rural areas, it
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did not seem to affect the carriage of antibiotic resistant E. coli; E. coli were not
isolated in the water samples. However, ablution facilities in the rural villages
were extremely limited increasing the opportunity for spread of resistant
determinants through the faecal/oral route.
In addition, unprescribed use of antimicrobial agents may be a contributing
factor to the high levels of resistance found in the developing world. Although the
ability to buy antibiotics over the counter may contribute to high level resistance
(Murray et al., 1985; Lamikanra and Ndep, 1989; Amyes et al., 1992), such
purchasing is not usually possible in South Africa (Wylie and Koornhof, 1989).
However, there might be a higher usage of antibiotics associated with this
population group in order to treat endemic diseases. It should, however, be borne
in mind that the justifiable prescription of an antibiotic does not guarantee that
it will be used correctly. This is true in the developed world as well but in
developing countries the temptation to save some of the course, divide the course
amongst the family or even sell the antibiotic will undoubtedly be greater.
It is probable that the main influence determining and maintaining the high
level of resistance in the black South African population is the severe
overcrowding in the homes (>6.0 people/house). Close contact facilitates the
transmission of resistant determinants (Singh et al., 1990). Intrafamilial contact
has been shown to be an important factor in the spread of resistant
determinants (Rydberg and Cederberg, 1986).
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Poor living conditions and poor sanitation, may be the major contributors in
maintaining the high levels of resistant bacteria in this reservoir. Indeed, these
factors may become more important than antibiotic usage itself.
As discussed previously, until now there has been little investigation into the
genetic and biochemical basis for the development and spread of resistance
amongst the non pathogenic commensal flora of healthy populations. In this study,
the (3-lactamases responsible for transferable ampicillin resistance and the genetic
carriers for such resistance have been determined. Amongst the 158
transconjugants, restriction endonuclease fingerprinting identified 92 different
plasmid types. Interestingly, the rural infant population group harboured three
distinct plasmids which were all isolated on multiple (>6) occasions. However, the
occurrence of such epidemic plasmids was restricted to this population group. The
lack of a common plasmid in the urban infants was, perhaps, particularly
surprising given the fact that 20 of the specimens were supplied from infants
attending one childminder. Previous surveys have indicated an association between
the presence of a common plasmid and children attending day care centres (Reves
et al., 1987). Furthermore, the widespread variation between plasmids was
surprising given the similarity between many of the antibiogram profiles.
In contrast to the findings from the Edinburgh surveys, where an epidemic
plasmid appeared to be dispersed across various population groups in the area,
in this study the different plasmid types appeared to be restricted to specific
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population groups. Only a single plasmid (Group 18) first recognised amongst
the rural infant population was subsequently identified in other population
groups; that is amongst rural infants and then again amongst rural children.
The identification of the same plasmid from the different strains isolated from
the same donor was of interest and presumably resulted from plasmid transfer
within the commensal flora rather than the acquisition of two strains carrying
the same plasmid from an external source.
This study demonstrated that as in the Edinburgh surveys, the TEM-1 p-lactamase
is the predominant mechanism of resistance involved in mediating resistance to
ampicillin amongst the commensal faecal flora of the healthy population. This
finding is indicative of this successful P-lactamase. However, unlike the results from
the Edinburgh survey, where TEM-1 P-lactamase was the only P-lactamase
recognised amongst the transconjugants, amongst the South African
transconjugants, SHV-1 and TEM-2 P-lactamases were both isolated, although their
occurrence was rare. It is not clear if the prevalence of these P-lactamases will
persist or increase amongst the community or alternatively whether TEM-1
P-lactamase will replace them. The potential for TEM-2 p-lactamase, in particular,
to spread throughout the community certainly exists. At present, TEM-2
P-lactamase is not frequently isolated. It may, therefore, be considered surprising
that many of the identified extended-spectrum P-lactamases have been derived from
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this particular P-lactamase (Amyes, 1989). It had been postulated that the high
level of gene expression associated with TEM-2 p-lactamase may be conducive to
the selection of variant (3-lactamases (P. Courvalin, Personal communication).
The predominance of the TEM-1 P-lactamase as the determinant of P-lactam
resistance amongst the commensal faecal flora of the healthy population has
been reported before (Simpson et at., 1986; Thomson et at., 1993). Amongst 24
isolates obtained from the commensal faecal flora survey conducted in India,
with the exception of one strain which produced OXA-1 P-lactamase, all the
isolates produced the TEM-1 P-lactamase (Thomson et at., 1993). The persistence
of the TEM-1 P-lactamase may be facilitated in the healthy community where
simple penicillins are probably the main selective pressure. The discovery of such
a wide variety of plasmids encoding the TEM-1 P-lactamase was, perhaps,
surprising as limited hygiene and sanitation are conditions in developing
countries which are conducive to the spread of epidemic strains (Thomson et at.,
1993). This finding suggests that ampicillin resistance is not simply the result of
spread of one particular strain or plasmid but rather from the spread and
subsequent independent acquisition of the p-lactamase gene.
The TEM-1 P-lactamase is purportedly so ubiquitous as a result of the
responsible genes residing on a series of transposons which facilitates the
transmission of the resistance determinants (Heffron et at., 1977; Chen and
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Clowes, 1987). The success of the TEM-1 (3-lactamase is also by virtue of its
biochemistry; TEM-1 [^-lactamase hydrolysis reaction of ampicillin and
amoxycillin are reportedly completed with maximum efficiency (Christensen
et al., 1990).
The commensal faecal flora of the healthy individual acting as a reservoir of
antibiotic resistant determinants (Levy et al., 1988; Lester et al., 1990), is a
hypothesis strengthened by this research. However, whilst a picture of the
mechanisms of resistance to (3-lactam agents has been established, the identity of
resistance plasmids in commensal flora begs the question as to their source. A
number of potential avenues exist through which the acquisition of resistant E. coli
may occur. It had been suggested that travel to developing countries, with or
without the use of prophylactic treatment, is indeed associated with the acquisition
of resistant E. coli. (Murray et al., 1990). In addition, it had long been speculated
that the ingestion of contaminated meat products is a source of resistant bacteria
(Shooter et al., 1970; Corpet, 1987). Furthermore, animal feedlots are recognised as
a reservoir of resistance determinants (Smith, 1968) and as both animal to man and
person to person transmission of resistance determinants has been shown (Levy et
al., 1976; Linton, 1977; Linton, 1986), this is another potential avenue to the
healthy population. Finally, the most recently elucidated avenue of resistant
determinants is that of day care centres. A high carriage rate of resistant organisms
has been demonstrated in this group (Reves et al., 1987; 1990; Singh et al., 1990).
212
This is to be expected because of the poor standard of hygiene between children
which allows direct spread of resistant organisms (Goodman et al., 1984; Singh
et al., 1990) and in addition this may be exacerbated by the higher antibiotic
prescribing associated with this age group (Hawkey, 1986). Although children are
not representative of the community at lar-ge, they may represent an avenue
through which resistant determinants may spread into the community.
Intrafamilial spread of resistant determinants had been demonstrated and may
occur once the child returns home (Rydberg and Cederberg, 1986).
4.1. Conclusions
The non-pathogenic commensal gut flora of the healthy population clearly
represents a reservoir of resistance determinants. FuiTher-more, it has been
speculated that these resistant determinants may be the progenitors of those
encountered in clinical isolates.
The recognition of the TEM-1 (^-lactamase prevailing throughout the healthy
community has confirmed the successful nature of this [3-lactamase. Speculation has
been made on the detrimental impact that TEM-1 [3-lactamase may have on the
healthy community. Not only will current therapy be complicated but, in addition,
TEM-1 (3-lactamase may act as a potential souixe of novel adapted (3-lactamases as
newer oral agents are introduced in to general practice.
213
The potential threat of this reservoir has been addressed but several questions
do, however, remain unanswered. Little is known about the maintenance and
transmission of these plasmids in the environment and, in particular, although
an association of antibiotic resistance genes with plasmid-mediated virulence
genes is purported to ensure greater survival of the strain, other factors affecting




ABRAHAM, E.R AND CHAIN, E. 1940. An enzyme from bacteria able to
destroy penicillin. Nature, 146: 837
ABRAHAM, E.P., CHAIN, E., FLETCHER, C.M., GARDNER, A.D., HEATLEY,
N.G. AND JENNINGS, M.A. 1941. Further observations on penicillin. Lancet,
II, 177-89
ACAR, J.F., GOLDSTEIN, F.W. AND KITZIS, M.D. 1993. Susceptibility survey
of piperacillin alone and in the presence of tazobactam. J. Antimicrob.
Chemother., 31 (Suppl. A): 23-28
AL-JEBOURI, M.M. AND AL-MESHHADANI, N.S. 1985. A note on antibiotic-
resistant Escherichia coli in adult man, raw sewage and sewage-polluted River
Tigris in Mosul, Nineva. J. Appl. Bacteriol., 59: 513-518
ALON, U., DAVIDAI, G., BERANT, M. AND MERZBACH, D. 1987. Five-year
survey of changing patterns of susceptibility of bacterial uropathogens to
trimethoprim-sulphamethoxazole and other antimicrobial agents. Antimicrob.
Agents Chemother., 31: 126-128
AMBLER, R.R AND SCOTT, G.K. 1978. Partial amino acid sequence of
penicillinase coded by Escherichia coli plasmid R6K. Proc. Nat. Acad. Sci. USA,
75: 3732-3736
AMBLER, R.P 1980. The structure of beta-lactamases. Phil. Trans. R. Soc.
London B 289: 321-331
AMBLER, R.P, COULSON, A.F.W., FRERE, J-M., GHUYSEN, J-M., JORIS, B.,
FORSMAN, M., LEVESQUE, R.C., TIRABY, G. AND WALEY, S.G. 1991. A
standard numbering scheme for the Class A P-lactamases. Biochem. J., 276:
269-272
215
AMYES, S.G.B. AND GOULD, I.M. 1984. Trimethoprim resistance plasmids in
faecal bacteria. Ann. Inst. Pasteur, 135B: 177-186
AMYES, S.G.B., DOHERTY, C.J. AND YOUNG, H-K. 1987. High-level
trimethoprim resistance in urinary bacteria. Eur. J. Clin. Microbiol., 5: 287-291
AMYES, S.G.B. 1987. Plasmid-mediated beta-lactamases: Relative clinical
importance. In Beta-lactamases: Current perspectives, p.31-48. Winchester:
Theracom
AMYES, S.G.B. 1989. The success of plasmid-encoded resistance genes in
clinical bacteria. J. Med. Microbiol., 28: 73-83
AMYES, S.G.B. AND GEMMELL, C.G. 1992. Antibiotic resistance in bacteria.
J. Med. Microbiol., 36: 4-29
AMYES, S.G.B., TAIT, S., THOMSON, C.J., PAYNE, D.J., NANDIVADA, L.S.,
JESUDASON, M.V., MUKUNDAN, U.D. AND YOUNG, H-K. 1992. The
incidence of antibiotic resistance in aerobic faecal flora in South India. J.
Antimicrob. Chemother., 9: 415-425
ANDERSON, E.S. AND DATTA, N. 1965. Resistance to penicillins and its
transfer in Enterobacteriaceae. Lancet, I: 407
ANDERSON, J.D., GILLESPIE, W.A. AND RICHMOND, M.H. 1973a.
Chemotherapy and antibiotic-resistance transfer between enterobacteria in the
human gastro-intestinal tract. J. Med. Microbiol., 6: 461-473
ANDERSON, J.D., INGRAM, L.C., RICHMOND, M.H. AND WIEDEMANN, B.
1973b. Studies on the nature of plasmids arising from conjugation in the human
gastro-intestinal tract. J. Med. Microbiol., 6: 475-486
ANDERSON, J.D. 1974. The effect of R-factor carriage on the survival of
Escherichia coli. in the human intestine. J. Med. Microbiol., 7: 85-90
ANDERSON, E.S., HUMPHREYS, G.O. AND WILLSHAW, G.A. 1975. The
molecular relatedness of R factors in Enterobacteria of human and animal
origin. J. Gen. Microbiol., 91: 376-382
ANDREWS, P. 1964 Estimation of the molecular weights of proteins by
Sephadex gel-filtration. Biochem. J., 91:222-233
APPELBAUM, PC., SPANLER, S.K., SHIMAN, R. AND JACOBS, M.R. 1992.
Susceptibilities of 540 anaerobic Gram-negative bacilli to amoxicillin,
amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin and clindamycin.
Antimicrob. Agents Chemother., 36: 1140-1143.
216
APPELBAUM, P.C. 1993. Comparative susceptibility profile of
piperacillin/tazobactam against anaerobic bacteria. J. Antimicrob. Chemother.,
31 (Suppl. A): 29-38
ARONOFF, S.C., JACOBS, M.R., JOHENNING, S. AND YAMABE, S. 1984.
Comparative activities of the p-lactamase inhibitors YTR 830, sodium
clavulanate and sulbactam combined with amoxicillin or ampicillin. Antimicrob.
Agents Chemother., 26: 580-582
ATKINSON, B.A. AND LORIAN, V. 1984. Antimicrobial agent susceptibility
patterns of bacteria in hospitals from 1971 to 1982. J. Clin. Microbiol., 20: 791-
796
AYLIFFE, G.A.J. 1963. Ampicillin inactivation and sensitivity of coliform
bacilli. J. Gen. Microbiol., 30: 339-348
BACHMANN, B. 1972. Pedigrees of some mutant strains of Escherichia coli K-
12. Bac.teri.ol Rev. 36: 525-555
BARRY, A.L., PFALLER, M.A. AND FUCHS, P.C. 1993. The antibacterial
activity of co-amoxiclav. J. Antimicrob. Chemother., 31: 612-615
BARTHELEMY, M., PEDUZZI, J. AND LABIA, R. 1988a. Complete amino acid
sequence of p453-plasmid-mediated PIT-2 p-lactamase (SHV-1). Biochem. J.,
251: 73-79
BARTHELEMY, M., PEDUZZI, J., YAGHLANE, H.B. AND LABIA, R. 1988b.
Single amino acid substitution between SHV-1 P-lactamase and cefotaxime-
hydrolzing SHV-2 enzyme. FEBS Lett., 231: 217-220
BATCHELOR, F.R., DOYLE, F.P., NAYLER, J.H.C. AND ROLINSON, G.N.
1959. Synthesis of penicillin: 6-aminopenicillanic acid in penicillin
fermentations. Nature, 183: 257-258
BAUERNFEIND, A. 1986. Classification of (3-lactamases. Rev. Infect. Dis., 8
(Supp. 5): S470-S481
BAUERNFEIND, A. AND HORL, G. 1987. Novel R-factor borne p-lactamase of
Escherichia, coli confering resistance to cephalosporins. Infection, 15: 257-259
BAUERNFEIND, A. 1990. Perspectives of beta-lactamases inhibitors in therapy
of infections caused by Escherichia coli or Klebsiella with plasmidic resistance
to third generation cephalosporins. Infection, 18: 48-52
BAUERNFEIND, A., ROSENTHAL, E., EBERLEIN, E., HOLLEY, M. AND
SCHWEIGHART, S. 1993. Spread of Klebsiella pneumoniae producing SHV-5
beta-lactamase among hospitalized patients. Infection, 21: 18-22
217
BELAAOUAJ, A., LAPOUMEROULIE, C., VEDEL, G., NEVOT, P.,
KRISHNAMOORTHY, R. AND PAUL, G. 1991. Amino acid 241 of TEM-1 is
highly critical in conferring resistance to ampicillin-clavulanic acid combination;
Molecular characterization of a natural mutant. Abstracts of the 31st I.C.A.A.C.
No. 944: 256
BETTELHEIM, K.A., DULAKE, C. AND TAYLOR, J. 1971. Postoperative
urinary infections caused by Escherichia coli. J. Clin. Pathol., 24: 442-443
BICKNELL, R., EMANUEL, E.L., GAGNON, J. AND WALEY, S.G. 1985. The
production and molecular properties of the zinc beta-lactamase of Pseudomonas
maltophilia IID 1275. Biochem. J., 229: 791-797
BLASER, M.J., POLLARD, R.A. AND FELDMAN, R.A. 1983. Shigella infection
in the United States, 1974-1980. J. Infect. Dis., 147: 771-775
BONOMO, R.A., CURRIE-McCUMBER, C. AND SHLAES, D.M. 1992. OHIO-1
(3-lactamase resistant to mechanism-based inactivators. FEMS Microbiol. Lett.,
92: 79-82
BONTEN, M., STOBBERINGH, E., PHILIPS, J. AND HOUBEN, A. 1990. High
prevalence of antibiotic resistant Escherichia coli in faecal samples of students
in the south-east of The Netherlands. J. Antimicrob. Chemother., 26: 585-592
BONTEN, M., STOBBERINGH, E., PHILIPS, J. AND HOUBEN, A. 1992.
Antibiotic resistance ofEscherichia coli in fecal samples of healthy people in two
different areas in an industralized country. Infection, 20: 258-262
BROGDEN, R.N., HELL, R.C., SPEIGHT, T.M. AND AVERY, G.S. 1979.
Cefuroxime. A review of its antibacterial activity, pharmacological properties
and therapeutic use. Drugs, 17: 233-266
BROGDEN, R.N., CARMINE, A., HEEL, R.C., MORLEY, P.A., SPEIGHT, T.M.
AND AVERY, G.S. 1981. Amoxycillin/clavulanic acid: A review of its
antibacterial activity, pharmacokinetics and therapeutic use. Drugs, 22: 337-362
BROWN, A.G., BUTTERWORTH, D., COLE, M., HANSCOMB, G., HOOD, J.D.
AND READING, C. 1976. Naturally-occurring (3-lactamase inhibitors with
antibacterial activity. J. Antibiotics, 29: 668-669
BROWN, A.G. 1981. New naturally occurring (3-lactam antibiotics and related
compounds. J. Antimicrob. Chem.other., 7: 15-48
BRUMFITT, W., FAIERS, M.C., REEVES, D.S. AND DATTA, N. 1971.
Antibiotic-resistant Escherichia coli causing urinary-tract infection in general
practice: relation to faecal flora. Lancet, I: 315-317
218
BSAC WORKING PARY. 1991. A guide to sensitivity testing. J. Antimicrob.
Chemother., 27 (Suppl. D): 1-50
BUIRMA, R.J.A., HORREVORTS, A.M. AND WAGENVOORT, J.H.T. 1991.
Incidence of multi-resistant Gram-negative isolates in eight Dutch hospitals.
Scand. J. Infect. Dis., (Suppl. 78): 35-44
BURMAN, L.G., HAEGGMAN, S., KUISTILA, M., TULLUS, K. AND
HUOVINEN, P. 1992. Epidemiology of plasmid-mediated (3-lactamases in
Enterobacteria in Swedish neonatal wards and relation to antimicrobial
therapy. Antimicrob. Agents Chemother., 36: 989-992
BURT, S.J. AND WOODS, D.R. 1976. Evolution of transferable antibiotic
resistance in coliform bacteria from remote environments. Antimicrob. Agents
Chemother., 10: 567-568
BURTON, H.S. AND ABRAHAM, E.P 1951. Isolation of antibiotics from a
species of Cephalosporium. Cephalosporins PI, P2, P3, P4 and P5. Biochem. J.,
50: 168-174
BUSH, K. AND SYKES, R.B. 1983. P-lactamase inhibitors in perspective. J.
Antimicrob. Chemother., 11: 97-107
BUSH, K. AND SYKES, R.B. 1986. Methodology for the study of (3-lactamases.
Antimicrob. Agents Chemother., 30: 6-10
BUSH, K. 1988a. Recent developments in P-lactamase research and their
implications for the future. Rev. Infect. Dis., 10: 681-690
BUSH, K. 1988b. P-lactamase inhibitors from laboratory to clinic. Clin.
Microbiol. Rev., 1: 109-123
BUSH, K. 1989a. Minireviews: Characterization of P-lactamases. Antimicrob.
Agents Chem.oth.er., 33: 259-263
BUSH, K. 1989b. Classification of P-lactamases: Groups 1, 2a, 2b and 2b'.
Antimicrob. Agents Chemother., 33: 264-270
BUSH, K. 1989c. Classification of P-lactamases: Groups 2c, 2d, 2e, 3 and 4.
Antimicrob. Agents Chemother., 33: 271-276
BUSH, K. AND SINGER, S.B. 1989. Biochemical characteristics of extended
broad spectrum p-lactamases. Infection, 17: 429-433
BUSH, K, FLAMM, R.K., OHRINGER, S., SINGER, S.B., SUMMERILL, R.
AND BONNER, D.P. 1991. Effect of clavulanic acid on activity of P-lactam
antibiotics in Serratia marcescens isolates producing both a TEM P-lactamase
and a chromosomal cephalosporinase. Antimicrob. Agents Chemother., 35: 2203-
2208
219
CHAIN, E., FLOREY, H.W., GARDNER, A.D., JENNINGS, M.A.,ORR-EWING,
J. AND SANDERS, A.G. 1940. Penicillin as a chemotherapeutic agent. Lancet,
II: 226-228
CHAUVETTE, R.R., FLYNN, E.H., JACKSON, B.G., LAVAGNINO, E.R.,
MORIN, R.B., MUELLER, R.A., PIOCH, R.P., ROESKE, R.W., RYAN, C.W.,
SPENCER, J.L. AND VAN HEYNINGEN, E. 1962. Chemistry of cephalosporin
antibiotics. II. Preparation of a new class of antibiotics and the relation of
structure to activity. J. Am. Chem. Soc., 84: 3401-3402
CHEN, S-T. AND CLOWES, R.C. 1987. Variations between the nucleotide
sequences of Tnl, Tn2 and Tn3 and expression of P-lactamase in Pseudomonas
aeruginosa and Escherichia coli. J. Bacteriol., 169: 913-916
CHERUBIN, C.E., ENG, R.H.K., SMITH, S.M. AND TAN, E.N. 1991. An in-
vitro and in-vivo comparison of the activity of (3-lactamase inhibitor
combinations with imipenem and cephalosporins against Escherichia coli
producing TEM-1 or TEM-2 p-lactamase. J. Antimicrob. Chemother., 28: 61-70
CHERUBIN, C.E. 1992. Activity of amoxycillin/clavulanic acid against
Escherichia coli in vivo. J. Antimicrob. Chemother., 30: 229
CHRISTENSEN, H., MARTIN, M.T. AND WALEY, S.G. 1990. P-lactamases as
fully efficient enzymes. Biochem. J., 266: 853-861
COLEMAN, K., GRIFFIN, D.R.J., PAGE, J.W.J. AND UPSHON, PA. 1989. In
vitro evaluation of BRL 42715, a novel P-lactamase inhibitor. Antimicrob.
Agents Chemother., 33: 1580-1587
COLLATZ, E., LABIA, R. AND GUTMANN, L. 1990. Molecular evolution of
ubiquitous P-lactamases towards extended-spectrum enzymes active against
newer P-lactam antibiotics. Mol. Microbiol., 4: 1615-1620
COOKSEY, R-, SWENSON, J., CLARK, N., GAY, E. AND THORNSBERRY, C.
1990. Patterns and mechanisms of P-lactam resistance among isolates of
Escherichia coli from hospitals in the United States. Antimicrob. Agents
Chemother., 34: 739-745
CORPET, D.E. 1987. Antibiotic residues and drug resistance in human
intestinal flora. Antimicrob. Agents Chemother., 31: 587-593
COURVALIN, P. 1990. Plasmid-mediated 4-quinolone resistance: a real or
apparent absence? Antimicrob Agents Chemother., 34: 681-684
CROSA, J.H., OLARTE, J., MATA, L.J., LUTTROPP, L.K. AND PENARANDA,
M.E. 1977. Characterization of an R-plasmid associated with ampicillin
resistance in Shigella dysenteriae type 1 isolated from epidemics. Antimicrob.
Agents Chemother., 11: 553-558
220
CULLMANN, W. 1992. The threat of resistance to the new oral cephalosporins.
Chemotherapy, 38 (Suppl. 2): 10-17
CURTIS, N.A.C., EISENSTADT, R.L., RUDD, C. AND WHITE, A.J. 1986.
Inducible type 1 (5-lactamase of Gram-negative bacteria and resistance to (I-
lactam antibiotics. J. Antimicrob. Chemother., 17: 51-61
DALE, J.W. AND SMITH, J.T. 1974. R-factor-mediated (3-lactamases that
hydrolyse oxacillin: Evidence for two district groups. J. Bacteriol., 119: 351-356
DATTA, N. AND KONTOMICHALOU, P. 1965. Penicillinase synthesis
controlled by infections R factors in Enterobacteriaceae. Nature, 208: 239-241
DATTA, N. 1969. Drug resistance and R factors in the bowel bacteria of London
patients before and after admission to hospital. Br. Med. J., 2: 407-411
DAVIS, B.D. AND MINGIOLI, E.S. 1950. Mutants ofEscherichia Coli requiring
methionine or vitamin B12. J. Bacteriol., 60: 17-28
DAVIS, C.E. AND ANANDAN, J. 1970. The evolution of R factor. A study of a
"preantibiotic " community in Borneo. N. Engl. J. Med., 282: 117-122
DEGENER, J.E., SMIT, A.C.W., MICHEL, M.F., VALKENBURG, H.A. AND
MULLER, L. 1983. Faecal carriage of aerobic Gram-negative bacilli and drug
resistance of Escherichia coli in different age-groups in Dutch urban
communities. J. Med. Microbiol., 16: 139-145
DELAIRE, M., LABIA, R., SAMAMA, J-P. AND MASSON, J-M. 1992. Site-
directed mutagenesis at the active site of Escherichia coli TEM-1 P-lactamase.
J. Biol. Chem., 267: 20600-20606
DOMAGK, G. 1935. Ein beitrag zur chemotherapie der bakteriellen Infektionen.
Dtsch. Med. Wsch., 61: 250-253
DONOWITZ, G.R. AND MANDELL, G.L. 1988. Beta-lactam antibiotics. N.
Engl. J. Med., 318: 419-426
DORNBUSCH, K. and the European Study Group on Antibiotic Resistance.
1990. Resistance to P-lactam antibiotics and ciprofloxacin in Gram-nagative
bacilli and staphylococci isolated from blood: a European collaborative study. J.
Antimicrob. Chemother., 26: 269-278
DOWSE, L.J. AND PRIGENT, B.M. 1991. Epidemiology of beta-lactamases in
Africa: Correlation with resistance to beta-lactam antibiotics. Clin.
Therapeutics, 13: 243-253
DOYLE, F.B., LONG, A.A.W., NAYLER, J.H.C. 1961. The new penicillins stable
towards both acid and penicillinase. Nature, 192: 1183-1184
221
EHRLICH, P. 1913. Address in pathology in chemotherapeutics: scientific
principles, methods and results. Lancet, II: 445-451
ELWELL, L.P., ROBERTS, M., MAYER, L.W. AND FALKOW, S. 1977. Plasmid-
mediated (1-lactamase production in Neisseria gonorrhoeae. Antimicrob. Agents
Chemother., II: 528-533
ELWELL, L.P. AND FLING, M.E. 1989. Resistance to trimethoprim, p.249-290.
In: L.E. Bryan (ed.), Handbook in Experimetnal Pharmacology, 91. Microbial
resistance to drugs. Springer-Verlag
ENGLISH, A.R., RETSEMA, J.A., GIRARD, A.E., LYNCH J.E. AND BARTH,
W.E. 1978. CP-45,899, a beta-lactamase inhibitor that extends the antibacterial
spectrum of beta-lactams: Initial bacteriological characterization. Antimicrob.
Agents Chemother., 14: 414-419
FARRAR, W.E. 1985. Antibiotic resistance in developing countries. J. Infect.
Dis., 152: 1103-1106
FLEMING, A. 1929. On antibacterial action of cultures of a penicillium with
special reference to their use in isolation of B. influenzae. Br. J. Exp. Pathol., 10:
226-236
FLETCHER, C. 1984. First clinical use of penicillin. Br. Med. J., 289: 1721-1723
FORNASINI, M., REVES, R.R., MURRAY, B.E., MORROW, A.L. AND
PICKERING, L.K. 1992. TVimethoprim-resistant Escherichia coli in households
of children attending day care centres. J. Infect. Dis., 166: 326-330
FRACASTORO, G. 1546. Contagion, contagious diseases and their treatment,
69-75. In T.D. Brock (ed.), Milestones in Microbiology. Prentice-Hall
International
FRENCH, G. AND LING, T. 1988. Amoxycillin/clavulanate resistant
Escherichia coli. Lancet, I: 704
GILLESPIE, S.H., FOX, R., PATEL, S., NGOWL, F.I. AND TILLOTSON, G.S.
1992. Antibiotic susceptibility of Enterobacteriaceae isolated from patients in
Northern Tanzania. J. Antimicrob. Chemother., 29: 227-228
GISBY, J. AND BEALE, A.S. 1988. Comparative efficacies of amoxicillin-
clavulanic acid and ampicillin-sulbactam against experimental Bacteroides
fragilis-Escherichia coli mixed infections. Antimicrob. Agents Chemother., 32:
1830-1833
GOODMAN, R.A., OSTERHOLM, M.T., GRANOFF, D.M. AND PICKERING,
L.K. 1984. Infectious diseases and child day care. Pediatrics, 74: 134-139
222
GORDILLO, M.E., REEVE, G.R., PAPPAS, J., MATHEWSON, J.J., DuPONT,
H.L. AND MURRAY, B.E. 1992. Molecular characterization of strains of
enteroinvasive Escherichia coli 0143, including isolates from a large outbreak in
Houston, Texas. J. Clin. Microbiol., 30: 889-893
GROSS, R.J., WARD, L.R., THRELFALL, E.J., KING, H. AND ROWE, B. 1982.
Drug resistance among infantile enteropathogenic Escherichia coli strains
isolated in the United Kingdom. Br. Med. J., 285: 472-473.
GREENWOOD, D. 1983. Antimicrobial Chemotherapy. Bailliere's concise
Medical Textbooks p24. Bailliere Tindall, London.
GRUNEBERG, R.N. 1984. Antibiotic sensitivities of urinary pathogens, 1971-
1982. J. Antimicrob. Chemother., 14: 17-23
GRUNEBERG, R.N. 1990. Changes in the antibiotic sensitivities of urinary
pathogens, 1971-1989. J. Antimicrob. Chemother., 26 (Suppl. F): 3-11
GUTMANN, L., KITZIS, M-D., YAMABE, S. AND ACAR, J.F. 1986.
Comparative evaluation of a new (3-lactamase inhibitor, YTR 830, combined
with different (1-lactam antibiotics against bacteria harbouring known (3-
lactamases. Antimicrob. Agents Chemother., 29: 955-957
GWYNN, M.N. AND ROLINSON, G.N. 1983. Selection of variants of Gram-
negative bacteria with elevated production of type 1 (3-lactamase. J. Antimicrob.
Chemother., 11: 577-581
HAMILTON-MILLER, J.M.T. 1982. P-lactamases and their clinical significance.
J. Antimicrob. Chemother., 9 (Suppl. B): 11-19
HAMILTON-MILLER, J.M.T. 1984. Resistance to antibacterial agents acting on
antifolate metabolism, p.173-190. In: L. E. Bryan (ed.), Antimicrobial Drug
Resistance. Orlando, Academic Press.
HAMILTON-MILLER, J.M.T. 1990. The emergence of antibiotic resistance:
myths and facts in clinical practice. Intensive Care Med., 16 (Suppl. 3): S206-
S211
HANCOCK, R.E.W. 1988a. Antibiotic uptake into Gram-negative bacteria. Eur.
J. Clin. Microbiol. Infect. Dis., 7: 713-720
HANCOCK, R.E.W. 1988b. Intrinsic antibiotic resistance of Pseudomonas
aeruginosa. J. Antimicrob. Chemother., 18: 653-656.
HARTLEY, C.L. AND RICHMOND, M.H. 1975. Antibiotic resistance and
survival ofE. coli in the alimentary tract. Br. Med. J., 4: 71-74
HARTMAN, B.J. AND TOMASZ, A. 1984. Low affinity penicillin-binding
protein associated with beta-lactam resistance in Staphylococcus aureus. J.
Bacteriol., 158: 513-516
223
HAWKEY, P.M. 1986. Resistant bacteria in the normal human flora. J.
An.timi.crob. Chem.other., 18 (Suppl. C): 133-139
HEDGES, R.W., DATTA, N., KONTOMICHALOU, P. AND SMITH, J.T. 1974.
Molecular specificities of R factor-determined beta-lactamases: Correlation with
plasmid compatibility. J. Bacteriol., 117: 56-62
HEDGES, R.W. AND JACOB, A.E. 1974. Transposition of ampicillin resistance
from RP4 to other replicons. Mol. Gen. Genet., 132: 31-40
HEDGES, R.W., VIALARD, J.L., PEARSON, N.J. AND O'GRADY, F. 1977. R-
plasmids from Asian strains of Vibrio cholerae. Antimicrob. Agents Chemother.,
11: 585-588
HEDGE, P.J. AND SPRATT, B.G. 1985. Resistance to p-lactam antibiotics by
re-modelling the active site of an E. coli. penicillin-binding protein. Nature, 318:
478-480
HEFFRON, F., RUBENS, C. AND FALKOW, S. 1977. Transposition of a plasmid
deoxyribonucleic acid sequence that mediates ampicillin resistance: identity of
laboratory-constructed plasmids and clinical isolates. J. Bacteriol., 129: 530-533
HENLE. J. 1840. Concerning miasmatic, contagious and miasmatic-contagious
diseases, p.76-79. In T.D. Brock (ed.), Milestones in Microbiology. Prentice-Hall
International
HOLMBERG, S.D., SOLOMAN, S.L. AND BLAKE, PA. 1987. Health and
economic impacts of antimicrobial resistance. Rev. Infect. Dis., 9: 1065-1078
HOLTJE, J-V. AND TOMASZ, A. 1975. Lipoteichoic acid: A specific inhibitor of
autolysin activity in Pneumococcus. Proc. Nat. Acad. Sci. USA, 72: 1690-1694
HOOD, J. 1991. Ph.D. Thesis, EDINBURGH
HOOVER, J.R.E. 1983. Beta-lactam antibiotics structure-activity relationships,
p. 119-246. In: Antibiotics containing the beta-lactam structure II (Demain, A.L.
and Solomon, N.A. Eds.). Spinger-Verlag
HUOVINEN, P. 1987. Trimethoprim resistance. Antimicrob. Agents Chemother.,
31: 1451-1456
HUOVINEN, P., HUOVINEN, S. AND JACOBY, G.A. 1988a. Sequence of PSE-2
beta-lactamase. Antimicrob. Agents Chemother., 32: 134-136
HUOVINEN, S., HUOVINEN, P. AND JACOBY, G. 1988b. Detection of
plasmid- mediated P-lactamases with DNA probes. Antimicrob. Agents
Chemother., 32: 175-179
224
ISMAEEL, N.A. 1993. Resistance of bacteria from human faecal flora to
antimicrobial agents. J. Trop. Med. Hyg., 96: 51-55
JACK, G.W. AND RICHMOND, M.H. 1970. A comparative study of eight
distinct [3-lactamases synthesized by Gram-negative bacteria. J. Gen.
Microbiol., 61: 43-61
JACOBS, M.R., ARONOFF, S.C., JOHENNING, S., SHLAES, D.M. AND
YAMABE, S. 1986. Comparative activities of the (3-lactamase inhibitors YTR
830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum
penicillins against defined [3-lactamase-producing aerobic Gram-negative
bacilli. Antimicrob. Agents Chemother., 29: 980-985
JACOBS, M.R., ARONOFF, S.C., APPELBAUM, PC. AND YAMABE, S. 1989.
In vitro activity ofYTR 830. J. Chemother., 1: 151-154
JACOBY, G.A. AND SUTTON, L. 1985. [3-lactamases and (3-lactam resistance
in Escherichia coli. Antimicrob. Agents Chemother., 28: 703-705
JACOBY, G.A. AND SUTTON, L. 1991. Properties of plasmids responsible for
production of extended-spectrum (3-lactamases. Antimicrob. Agents Chemother.,
35: 164-168
JACOBY, G.A. AND MEDEIROS, A.A. 1991. Minireview. More extended-
spectrum (3-lactamases. Antimicrob. Agents Chemother., 35: 1697-1704
JACOBY, G.A. AND ARCHER, G.L. 1991. New mechanisms of bacterial
resistance to antimicrobial agents. N. Engl. J. Med., 324: 601-612
JAFFE, A., CHABBERT, Y.A. AND SEMONIN, O. 1982. Role of porin proteins
OmpF and OmpC in the permeation of (3-lactams. Antimicrob. Agents
Chemother., 22: 942-948
JARLIER, V., NICOLAS, M-H., FOURNIER, G. AND PHILIPPON, A. 1988.
Extended broad-spectrum (3-lactamases conferring transferable resistance to
newer (3-lactam agents in Enterobacteriaceae: Hospital prevalence and
susceptibility patterns. Rev. Infect. Di.s., 10: 867-878
JELSCH, C., LENFANT, F., MASSON, J.M. AND SAMAMA, J.P. 1992. (3-
lactamase TEM-1 of E. coli. Crystal structure determination at 2.5 A resolution.
FEBS, 299: 135-142
JONES, J.G. 1986. Antibiotic resistance in aquatic bacteria. J. Antimicrob.
Chemother., 18 (Suppl. C): 149-154
JOUVENOT, M., DESCHASEAUX, M.L., ROYEZ, M., MOUGIN, C., COOKSEY,
R.C., MICHEL-BRIAND, Y. AND ADESSI, G.L. 1987. Molecular hybridization
versus isoelectric focusing to determine TEM-type beta-lactamases in Gram-
negative bacteria. Antimicrob. Agents Chemother., 31: 300-305
225
KASPAR, C.W. AND BURGESS, J.L. 1990. Antibiotic resistance indexing of
Escherichia coli. to identify sources of fecal contamination in water. Can. J.
Microbiol., 36: 891-894
KELCH, W.J. AND LEE, J.S. 1978. Antibiotic resistance patterns of Gram-
negative bacteria isolated from environmental sources. Appl. Environ.
Mi.crobi.ol., 36: 450-456
KELLY, J.A., DIDEBERG, O., CHARLIER, P., WERY, J.P., LIBERT, M.,
MOEWS, PC., KNOX, J.R., DUEZ, C., FRAIPONT, CL., JORIS, B., DUSART,
J., FRERE J.M. AND GHUYSEN, J.M. 1986. On the origin of bacterial
resistance to penicillin: Comparison of a (3-lactamase and a penicillin target.
Science, 231: 1429-1431
KIRBY, W.M.M. 1944. Extraction of a highly potent penicillin inactivator from
penicillin resistant staphylococci. Science, 99: 452-453
KLIEBE, C., NIES, B.A., MEYER, J.F., TOLXDORFF-NEUTZLING, R.M. AND
WIEDEMANN, B. 1985. Evolution of plasmid-coded resistance to broad-
spectrum cephalosporins. Antimicrob. Agents Chemother., 28: 302-307
KLINGERN, B. 1981. An in-vitro comparison of new cephalosporins with special
reference to Pseudomonas aeruginosa. J. Antimicrob. Chemother., 8 (Suppl. B):
97-105
KOCH, R. 1884. The etiology of tuberculosis, pll6-118. In T.D. Brock (ed.),
Milestones in Microbiology. Prentice-Hall International
KORFMANN, G., KLIEBE, C. AND WIEDEMANN, B. 1986. (3-lactam
antibiotics and selection of resistance: speculation on the evolution of R-
plasmids. J. Antimicrob. Chemother., 18 (Suppl. C): 113-121
KORFMANN, G. AND WIEDEMANN, B. 1988. Genetic control of (3-lactamase
production in Enterobacter cloacae. Rev. Infect. Dis., 10: 793-799
KNOTHE, H., SHAH, P., KREMERY, V., ANTAL, M. AND MITSUHASHI, S.
1983. Transferable resistance to cefotaxime, cefoxitin, cefamandole and
cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia
marcescens. Infection, 11: 315-317
KNUDSEN, E.T., BROWN, D.M. AND ROLINSON, G.N. 1962. A new orally
effective penicillinase - stable penicillin - BRL .1621. Lancet, II: 632-634
KRESKEN, M. AND WIEDEMANN, B. 1986. Development of resistance in the
past decade in central Europe. J. Antimicrob. Chemother., 18 (Suppl. C): 235-
242
KUCK, N.A., JACOBUS, N.V., PETERSEN, P.J., WEISS, W.J. AND TESTA,
R.T. 1989. Comparative in vitro and in vivo activities of piperacillin combined
with the beta-lactamase inhibitors tazobactam, clavulanic acid and sulbactam.
Antimicrob. Agents Chemother., 33: 1964-1969
226
KUEMMERLE, H.P., GRASSI, C., LORIAN, V. AND WILLIAMS, J.D. 1983. In
Clinical Chemotherapy, Volume 1: Fundamentals. Thieme-Stratton Inc. New
York
KUNIN, C.M., LIPTON, H.L., TUPASI, T., SACKS, T., SCHECKLER, W.E.,
JIVANI, A., GOIC, A., MARTIN, R., GUERRANT, R.L. AND THAMLIKITKUL,
V. 1987. Social, behavioural, and practical factors affecting antibiotic use
worldwide: Report of Task Force 4. Rev. Infect. Dis., 9: S270-S285
KUYE, 0., TEAL, J., DeVRIES, V.G., MORROW, C.A. AND TALLY, F.P. 1993.
Safety profile of piperacillin/tazobactam in phase I and III clinical studies. J.
Antimicrob. Chemother., 31 (Suppl. A): 113-124
LABIA, R., BEGUIN-BILLECOQ, R. AND GUIONIE, M. 1981. Behaviour of
ceftazidime towards (I-lactamases. J. Antimicrob. Chemother., 8 (Suppl. B): 141-
146
LABIA, R., MORAND, A. AND PEDUZZI, J. 1986. Timentin and (3-lactamases.
J. Antimicrob. Chemother., 17 (Suppl C): 17-26
LAMIKANRA, A. AND NDEP, R.B. 1989. Trimethoprim resistance in urinary
tract pathofgens intwo Nigerian hospitals. J. Antimicrob, Chemother., 3: 151-
154
LAMIKANRA, A., FAYINKA, S.T. AND OLUSANYA, O.O. 1989. Transfer of low
level trimethoprim resistance in faecal isolates obtained from apparently
healthy Nigerian students. FEMS Microbiol. Lett., 59: 275-278
LARSON, E.L., McGINLEY, K.J., FOGLIA, A.R., TALBOT, G.H. AND
LEYDEN, J.J. 1986. Composition and antimicrobic resistance of skin flora in
hospitalized and healthy adults. J. Clin. Microbiol, 23: 604-608
LEIGH, D.A., BRADNOCK, K. AND MARRINER, J.M. 1981. Augmentin
(amoxycillin and clavulanic acid) therapy in complicated infections due to (5-
lactamase producing bacteria. J. Antimicrob. Chemother., 7: 229-236
LESTER, S.C., DEL PILAR PLA, M., WANG, F., PEREZ SCHAEL, I., JIANG,
H. AND O'BRIEN, T.F. 1990. The carriage of Escherichia coli resistant to
antimicrobial agents by healthy children in Boston, in Caracus, Venezuela and
in Qin Pu, China. N. Engl. J. Med.., 323: 285-289
LEVY, S.B., FITZGERALD, G.B. AND MACONE, A.B. 1976. Spread of
antibiotic-resistant plasmids from chicken to chicken and from chicken to man.
Nature, 260: 40-42
LEVY, S.B. 1982. Microbial resistance to antibiotics. An evolving and persistent
problem. Lancet,-. 83-87
227
LEVY, S.B., HEDGES, R.W, SULLIVAN, F., MEDEIROS, A.A. AND
SOSROSEPUTRO, H. 1985. Multiple antibiotic resitance plasmids in
Enterobacteriaceae isolated from diarrhoeal specimens of hospitalized children
in Indonesia. J. Antimicrob. Chemother., 16: 7-16
LEVY, S.B. 1986. Ecology of antibiotic resistance determinants, p. 17-29. In: S.B.
Levy and R.P. Novick (ed.), Antibiotic resistance genes: ecology, transfer and
expression. Cold Spring Harbour Laboratory, Cold Spring Harbour, N.Y.
LEVY, S.B., BURKE, J.P. AND WALLACE, C.K. 1987. Antibiotic use and
antibiotic resistance worldwide. Rev. Infect. Dis., 9 (Suppl.): 231-316
LEVY, S.B., MARSHALL, B., SCHLUEDERBERG, S., ROWSE, D. AND DAVIS,
J. 1988. High frequency of antimicrobial resistance in human fecal flora.
Antimicrob. Agents Chemother., 32: 1801-1806
LEWIN, C.S., ALLEN, R.A. AND AMYES, S.G.B. 1990. Potential mechanisms
of resistance to the modern fluorinated 4-quinolones. J. Med. Microbiol., 31:
153-161
LIDIN-JANSON, G., FALSEN, E., JODAL, U., KAIJSER, B. AND LINCOLN,
K. 1977. Characteristics of antibiotic-resistant Escherichia coli in the rectum of
healthy school-children. J. Med.. Microbiol., 10: 299-308
LINDBERG, F. AND NORMARK, S. 1986. Contribution of chromosomal
P-lactamases to P-lactam resistance in Enterobacteria. Rev. Infect. Dis., 8
(Suppl. 3): S292-S304
LINTON, K.B., LEE, PA., RICHMOND, M.H., GILLESPIE, W.A., ROWLAND,
A.J. AND BAKER, V.N. 1972. Antibiotic resistance and transmissible R-factors
in the intestinal coliform flora of healthy adults and children in an urban and a
rural community. J. Hyg., 70: 99-104
LINTON, A.H. 1977. Animal to man transmisssion of Enterobacteriaceae.
R.S.H., 3: 115-118
LINTON, A.H. 1986. Flow of resistance genes in the environment and from
animals to man. J. Antimicrob. Chemother., 18 (Suppl. C): 189-197
LISTER, J. 1867. On the antiseptic principle in the practice of surgery. Br. Med.
J., 2:246-248
LIU, P.Y.F., GUR, D., HALL, L.M.C. AND LIVERMORE, D.M. 1992. Survey of
the prevalence of P-lactamases amongst 1000 Gram-negative bacilli isolated
consecutively at the Royal London Hospital. J. Antimicrob. Chemother., 30: 429-
447
LIVERMORE, D.M. 1985. Do P-lactamases 'trap' cephalosporins? J.
Antimicrob. Chemother., 15: 511-521
228
LIVERMORE, D.M. 1987. Chromosomal beta-lactamase induction and stable
derepression in relation to antibiotic resistance in Gram-negative bacteria. In
Beta-lactamases: Current perspectives, p. 13-26. Winchester: Theracom
LIVERMORE, D.M., AKOVA, M., WU, P. AND YANG, Y. 1989. Clavulanate and
P-lactamase induction. J. Antimicrob. Chemother., 24 (Suppl. B): 23-33
LIVERMORE, D.M. AND SEETULSINGH, P. 1991. Susceptibility of
Escherichia coli isolates with TEM-1 P-lactamase to combinations of BRL
42715, tazobactam or clavulanate with piperacillin or amoxycillin. J.
Antimicrob. Chemother., 27: 761-767
LIVERMORE, D.M. 1991. Mechanisms of resistance to P-lactam antibiotics.
Scand. J. Infect. Dis., (Suppl. 78): 7-16
LIVERMORE, D.M. AND CORKILL, J.E. 1992. Effects of C02 and pH on
inhibition of TEM-1 and other P-lactamases by penicillanic acid sulfones.
Antimicrob. Agents Chemother., 36: 1870-1876
LIVERMORE, D.M. 1993. Determinants of the activity of P-lactamase inhibitor
combinations. J. Antimicrob. Chemother., 31 (Suppl. A): 9-21
LORIAN, V. AND SABATH, L.D. 1972. Penicillins and cephalosporins:
Differences in morphologic effects on Proteus mirabilis. J. Infect. Dis., 125: 560-
564
MA, M.Y., GOLDSTEIN, E.J.C., FRIEDMAN, M.H., ANDERSON, M.S. AND
MULLIGAN, M.E. 1983. Resistance of Gram-negative bacilli as related to
hospital use of antimicrobial agents. Antimicrob. Agents Chemother., 24: 347-
352
MABILAT, C., GOUSSARD, S., SOUGAKOFF, W., SPENCER, R.C. AND
COURVALIN, P. 1990. Direct sequencing of the amplified structural gene and
promoter for the extended-broad-spectrum p-lactamase TEM-9 (RHH-1) of
Klebsiella pneumoniae. Plasmid, 23: 27-34
MABILAT, C. AND COURVALIN, P. 1990. Development of "oligotyping" for
characterization and molecular epidemiology of TEM p-lactamases in members
of the family Enterobacteriaceae. Antimicrob. Agents Chemother., 34: 2210-2216
MacGOWAN, A.P., BROWN, N.M., HOLT, H.A., LOVERING, A.M.,
McCULLOCH, S.Y. AND REEVES, D.S. 1993. An eight-year survey of the
antimicrobial susceptibility patterns of 85,971 bacteria isolated from patients in
a district general hospital and the local community. J. Antimicrob. Chemother.,
31: 543-557
MANAVATHU, E.K., LERNER, S.A., FEKETE, T., PERLIN, M.H., ZIAJA, E.
AND PRICE, S. 1990. Characterization of a mutant TEM P-lactamase that
confers resistance to ampicillin (amp) plus clavulanic acid (CA). Abstracts of the
30th I.C.A.A.C. No. 281: 133
229
MARTINELLI, R., ALBERTO DA SILVA LOPES, A., DE OLIVEIRA, M.M.M.G.
AND ROCHA, H. 1981. Amoxicillin-clavulanic acid in treatment of urinary tract
infection due to Gram-negative bacteria resistant to penicillin. Antimicrob.
Agents Chemother., 20: 800-802
MARTINEZ, J.L., CERCENADO, E., RODRIGUEZ-CREIXEMS, M.,
VINCENTE-PEREZ, M.F., DELGADO-IRIBARREN, A. AND BAQUERO, F.
1987. Resistance to beta-lactam/clavulanate. Lancet, II: 1473.
MARTINEZ, J.L., VICENTE, M.F., DELGADO-IRIBARREN, A., PEREZ DIAZ,
J.C. AND BAQUERO, F. 1989. Small plasmids are involved in amoxicillin-
clavulanate resistance in Escherichia coli. Antimicrob. Agents Chemother., 33:
595
MATTHEW, M., HARRIS, A., MARSHALL, M.J. AND ROSS, G.W. 1975. The
use of analytical isoelectric focusing for detection and identification of (5-
lactamases. J. Gen. Microbiol., 88: 169-178
MATTHEW, M. 1979. Plasmid-mediated P-lactamases of Gram-negative
bacteria: properties and distribution. J. Antimicrob. Chemother., 5: 349-358
MAYER, K.H. 1986. The epidemiology of antibiotic resistance in hospitals. J.
Antimicrob. Chemother., 18 (Suppl. C): 223-233
McGOWAN, J.E., HALL, E.C. AND PARROTT, P.L. 1989. Antimicrobial
susceptibility in Gram-negative bacteremia: Are nosocomial isolates really more
resistant? Antimicrob. Agents Chemother., 33: 1855-1859
MEDEIROS, A.A., KENT, R.L. AND O'BRIEN, T.F. 1974. Characterization and
prevalence of the different mechanisms of resistance to beta-lactam antibiotics
in clinical isolates of Escherichia coli. Antimicrob. Agents Chemother., 6: 791-
801
MEDEIROS, A.A. 1984. p-lactamases. Br. Med. Bull., 40: 18-27
MEDEIROS, A.A., MAYER, K.H. AND OPAL, S.M. 1988. Plasmid-mediated
beta-lactamases. Antimicrob. Newslett., 5: 61-65
MEYERS, J.A., SANCHEZ, D., ELWELL, L.P. AND FALKOW, S. 1976. Simple
agarose gel electrophoretic method for the identification and characterisation of
plasmid deoxyribonucleic acid. J. Bacteriol., 127: 1529-1537
MOELLERING, R.C. 1990. Interaction between antimicrobial consumption and
selection of resistant bacterial strains. Scand. J. Infect. Dis., (Suppl. 70): 18-24
MOELLERING, R.C. 1991. P-lactamase inhibition: Therapeutic implications in
infectious diseases- an overview. Rev. Infect. Dis., 13 (Suppl. 9): S723-S726
230
MOELLERING, R.C. 1993. Meeting the challenges of P-lactamases. J.
Antimicrob. Chemother., 31 (Suppl. A): 1-8
M0LLER, J.K. 1989. Antimicrobial usage and microbial resistance in a
university hospital during a seven-year period. J. Antimicrob. Chemother., 24:
983-992
MOORHOUSE, E.C. 1969. Transferable drug resistance in Enterobacteria
isolated from urban infants. Br. Med. J., 2: 405-407
MOOSDEEN, F., KEEBLE, J. AND WILLIAMS, J.D. 1986. Induction/inhibition
of chromosomal P-lactamases by P-lactamase inhibitors. Rev. Infect. Dis., 8
(Suppl. 5): S562-S568
MUGGLETON, P.W., O'CALLAGHAN, C.H. AND STEVENS, W.K. 1964.
Laboratory evaluation of a new antibiotic - cephaloridine (Ceporin). Br. Med. J.,
2: 1234-1237
MUGGLETON, P.W. 1981. Why ceftazidime? J. Antimicrob. Chemother., 8
(Suppl. B): 1-3
MURRAY, B.E. AND MOELLERING, R.C. 1978. Patterns and mechanisms of
antibiotic resistance. Medical Clinics of North America, 62: 899-923
MURRAY, B.E., RENSIMER, E.R. AND DuPONT, H.L. 1982. Emergence of
high-level trimethoprim resistance in fecal Escherichia coli during oral
administration of trimethoprim or trimethoprim-sulfamethoxazole. N. Engl. J.
Med., 306: 130-135
MURRAY, B.E. AND RENSIMER, E.R. 1983. Transfer of trimethoprim
resistance from fecal Escherichia coli isolated during a prophylaxis study in
Mexico. J. Infect. Dis., 147: 724-728
MURRAY, B.E., ALVARADO, T., KIM., K.-H., VORACHIT, M., JAYANETRA, P.,
LEVINE, M.M., PRENZEL. I., FLING, M., ELWELL, L., McCRACKEN, G.H.,
MADRIGAL. G., ODIO, C. AND TRABULSI, L.R. 1985. Increasing resistance to
trimethoprim-sulfamethoxazole among isolates ofEscherichia coli in developing
countries. J. Infect. Dis., 152: 1107-1113.
MURRAY, B.E., MATHEWSON, J.J., DuPONT, H.L., ERICSSON, C.D. AND
REVES, R.R. 1990. Emergence of resistant fecal Escherichia coli in travelers
not taking prophylactic antimicrobial agents. Antimicrob. Agents Chemother.,
34: 515-518
MURRAY, B.E. 1991. New aspects of antimicrobial resistance and the resulting
therapeutic dilemmas. J. Infect. Dis., 163: 1185-1194
231
MATTHEW, M. 1979. Plasmid-mediated (3-lactamases of Gram-negative
bacteria: properties and distribution. J. Antimicrob. Chemother., 5: 349-358
NANDIVADA, L.S., LEWIN, C.S. AND AMYES, S.G.B. 1990. Bacterial
resistance to the combination of ampicillin and clavulanic acid. In abstracts of
the 90th Annual Meeting of the American Society for Microbiology, Anaheim,
California. No. A87
NANDIVADA, L.S. AND AMYES, S.G.B. 1990. Plasmid-mediated p-lactam
resistance in pathogenic Gram-negative bacteria isolated in South India. J.
Antimicrob. Chemother., 26: 279-290
NEU, H.C. 1974. Summary of the symposium on amoxicillin. J. Infect. Dis., 129:
S272-S274
NEU, H.C. 1979. Amoxicillin. Ann Intern Med., 90: 356-360
NEU, H.C. 1986. P-lactam antibiotics: structural relationships affecting in vitro
activity and pharmacologic properties. Rev. Infect. Dis., 8 (Suppl. 3): S237-S259
NEWTON, G.G.F. AND ABRAHAM, E.P. 1954. Degradation, structure and
some derivatives of cephalosporin N. Biochem. J., 58: 103-111
NEWTON, G.G.F. AND ABRAHAM, E.P. 1955. Cephalosporin C, a new
antibiotic containing sulphur and D-a- aminoadipic acid. Nature, 175: 548
NIKAIDO, H., ROSENBERG, E.Y. AND FOULDS, J. 1983. Porin channels in
Escherichia coll:: Studies with P-lactams in intact cells. J. Bacteriol., 153: 232-
240
NIKAIDO, H. 1989. Role of the outer membrane of Gram-negative bacteria in
antimicrobial resistance, p.1-34. In: L.E. Bryan (ed.), Handbook in
Experimental Pharmacology, 91. Microbial Resistance to Drugs. Springer-Verlag
NORD, C.E. AND HEIMDAHL, A. 1986. Impact of orally administered
antimicrobial agents on human oropharyngeal and colonic microflora. J.
Antimicrob. Chemother., 18 (Suppl. C): 159-164
NORD, C.E. 1990. Studies on the ecological impact of antibiotics. Eur. J. Clin.
Microbiol. Infect. Dis., 9: 517-518
NORD, C.E., BRISMAR, B., KASHOLM-TENGVE, B. AND TUNEVALL, G.
1993. Effect of piperacillin/tazobactam treatment on human bowel microflora. J.
Antimicrob. Chemother., 31 (Suppl. A): 61-65
O'BRIEN, T.F. and the International Survey of Antibiotic Resistance Group.
1986. Resistance to antibiotics at medical centres in different parts of the world.
J. Antimicrob. Chemother., 18 (Suppl. C): 243-253
232
O'CALLAGHAN, C.H., MUGGLETON, P.W. AND ROSS, G.W. 1969. Effects of P-
lactamase from Gram-negative organisms on cephalosporins and penicillins.
Antimicrob Agents Chemother. G. Hobby (ed.). Am. Soc. Microbiol., Betheseda: 57
O'CALLAGHAN, C.H.O'CALLAGHAN, C.H., SYKES, R.B., GRIFFITHS, A.
AND THORNTON, J.E. 1976. Cefuroxime, a new cephalosporin antibiotic:
activity in vitro. Antimicrob. Agents Chemother., 9: 511-519
OLIPHANT, A.R. AND STRUHL, K. 1989. An efficient method for generating
proteins with altered enzymatic properties: Application to (3-lactamase. Proc.
Nat. Acad. Sci. USA, 86: 9094-9098
PAGE, J.W.J., FARMER, T.H. AND ELSON, S.W. 1989. Hyperproduction of
TEM-1 P-lactamase by Escherichia coli strains. J. Antimicrob. Chemother., 23:
160-161
PALZKILL, T. AND BOTSTEIN, D. 1992a. Identification of amino acid
substitutions that alter the substrate specificity of TEM-1 p-lactamase. J.
Bacteriol., 174: 5237-5243
PALZKILL, T. AND BOTSTEIN, D. 1992b. Probing P-lactamase structure and
function using random replacement mutagenesis. Proteins, 14: 29-44
PAPANICOLAOU, G.A., MEDEIROS, A.A. AND JACOBY, G.A. 1990. Novel
plasmid-mediated P-lactamase (MIR-1) conferring resitance to oxyimino- and -
mthoxy P-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob.
Agents Chemother., 34: 2200-2209
PAYNE, D.J., MARRIOTT, M.S. AND AMYES, S.G.B. 1990. Characterization of
a unique ceftazidime-hydrolysing P-lactamase, TEM-E2. J. Med. Microbiol., 32:
131-134
PAYNE, D.J. AND AMYES, S.G.B. 1991. Transferable resistance to extended-
spectrum p-lactams: a major threat or a minor inconvenience? J. Antimicrob.
Chemother., 27: 255-261
PAYNE, D.J., WOODFORD, N. AND AMYES, S.G.B. 1992. Characterization of
the plasmid-mediated P-lactamase BIL-1. J. Antimicrob. Chemother., 30: 119-
127
PETROCHEILOU, V., SYKES, R.B. AND RICHMOND, M.H. 1977. Novel R-
plasmid mediated beta-lactamase from Klebsiella aerogenes. Antimicrob Agents
Chemother., 12: 126-128
PHILIPPON, A., LABIA, R. AND JACOBY, G. 1989. Minireview: Extended-
spectrum p-lactamases. Antimicrob. Agents Chemother., 33: 1131-1136
PICKERING, L.K. AND MURRAY, B.E. 1984a. Occasional Review: Current
concepts of antimicrobial therapy-2. J. Trop. Pediatr., 30: 172-176
233
PICKERING, L.K. AND MURRAY, B.E. 1984b. Occasional Review: Current
concepts of antimicrobial therapy-3. J. Trop. Pediatr., 30: 197-203
PIDDOCK, L.J.V. AND WISE, R. 1985. Newer mechanisms of resistance to (3-
lactam antibiotics in Gram-negative bacteria. J. Antimicrob. Chemother., 16:
279-284
PIDDOCK, L.J.V., FANG JIN, Y. AND TURNER, H.L. 1993. Activity of 13 p-
lactam agents combined with BRL 42715 against P-lactamase producing Gram-
negative bacteria compared to combinations with clavulanic acid, tazobactam
and sulbactam. J. Antimicrob. Chemother., 31: 89-103
PRATT, R.F. 1989. p-lactamase inhibitors, p.178-205. In Design of Enzyme
Inhibitors as Drugs, (Sandler, M. and Smith, H.J., Eds), Oxford University
Press, Oxford
RAZ, R., ROTTENSTERICH, E., BOGER, S. AND POTASMAN, I. 1991.
Comparison of single-dose administration and three-day course of amoxicillin
with those of clavulanic acid for treatment of uncomplicated urinary tract
infection in women. Antimicrob. Agents Chemother., 35: 1688-1690
READING, C. AND COLE, M. 1977. Clavulanic acid: a beta-lactamase-
inhibiting beta-lactam from Streptomyces clavuligerus. Antimicrob. Agents
Chemother., 11: 852-857
REDJEB, S.B., YAGHLANE, H.B., BOUJNAH, A., PHILIPPON, A. AND
LABIA, R. 1988. Synergy between clavulanic acid and newer P-lactams on nine
clinical isolates of Klebsiella pneumoniae, Escherichia coli and Salmonella
typhimurium resistant to third-generation cephalosporins. J. Antimicrob.
Chemother., 21: 263-266
RE ID, A.J. 1986. Ph.D. Thesis. EDINBURGH
REGUERA, J.A., BAQUERO, F., PEREZ-DIAZ, J.C. AND MARTINEZ, J.L.
1991. Factors determining resistance to P-lactam combined with P-lactamase
inhibitors in Escherichia coli. J. Antimicrob. Chemother., 27: 569-575
REID, A.J., SIMPSON, I.N., HARPER, P.B. AND AMYES, S.G.B. 1987.
Ampicillin resistance in Haemophilus influenzae: identification of resistance
mechanisms. J. Antimicrob. Chemother., 20: 645-656
REID, A.J., SIMPSON, I.N., HARPER, P.B. AND AMYES, S.G.B. 1988.
Cephaloridine resistance in Gram-negative bacteria isolated in Scotland. J.
Pharm. Pharmacol., 40: 571-573
REIG, R., ROY, C., HERMIDA, M., TERUEL, D. AND COIRA, A. 1993. A
survey of P-lactamases from 618 isolates of Klebsiella spp. J. Antimicrob.
Chemother., 31: 29-35
234
REVES, R.R., MURRAY, B.E., PICKERING, L.K., PRADO, D., MADDOCK, M.
AND BARTLETT III, A.V. 1987. Children with trimethoprim- and ampicillin-
resistant fecal Escherichia coli in day care centres. J. Infect. Dis., 156: 758-762
REVES, R.R., FONG, M., PICKERING, L.K., BARTLETT III, A., ALVAREZ, M.
AND MURRAY, B.E. 1990. Risk factors for fecal colonization with trimethoprim-
resistant and multiresistant Escherichia coli among children in day-care centres
in Houston, Texas. Antimicrob. Agents Chemother., 34: 1429-1434
RICHMOND, M.H. AND SYKES, R.B. 1973. The beta-lactamases of Gram-
negative bacteria and their possible physiological role. Adv. Microb. Physiol., 9:
31-88
RICHMOND, M.H. AND LINTON, K.B. 1980. The use of tetracycline in the
community and its possible relation to the excretion of tetracycline-resistant
bacteria. J. Antimicrob. Chem,other., 6: 33-41
ROLINSON, G.N., STEVENS, S., BATCHELOR, F.R., WOOD, J.C. AND
CHAIN, E.B. 1960. Bacteriological studies on a new penicillin-BRL.1241.
Lancet, II: 564-567
ROLINSON, G.N. AND STEVENS, S. 1961. Microbiological studies on a new
broad-spectrum penicillin, "Penbritin". Br. Med. J., 2: 191-196
ROLINSON, G.N. 1988. The influence of 6-aminopenicillanic acid on antibiotic
development. J. Antimicrob. Chemother., 22: 5-14
ROLINSON, G.N. 1991. Evolution of (3-lactamase inhibitors. Rev. Infect. Dis., 13
(Suppl. 9): S727-S732
ROWE, B. AND THRELFALL, E.J. 1984. Drug resistance in Gram-negative
aerobic bacilli. Br. Med. Bull., 40: 68-76
ROY, C., FOZ, A., SEGURA, C., TIRADO, M., FUSTER, C. AND REIG, R. 1983.
Plasmid-determined [i-lactamases identified in a group of 204 ampicillin-
resistant Enterobacteriaceae. J. Antimicrob. Chemother., 12: 507-510
ROY, C., SEGURA, C., TIRADO, M., REIG, R., HERMIDA, M., TERUEL, D.
AND FOZ, A. 1985. Frequency of plasmid-deterimed P~lactamases in 680
consecutively isolated strains of Enterobacteriaceae. Eur. J. Clin. Microbiol., 4:
146-147
ROY, C., SEGURA, C., TORRELLAS, A., REIG, R., TERUEL, D. AND
HERMIDA, M. 1989. Activity of amoxycillin/clavulanate against P-lactamase-
producing Escherichia coli and Klebsiella spp. J. Antimicrob. Chemother., 24
(Suppl. B): 41-47
235
ROY, C., TERUEL, D., REIG, R., HERMIDA, M. AND TEIXELL, M. 1992.
P-lactamases and susceptibility phenotypes to P-lactam antibiotics in
Escherichia coli strains. J. Antimicrob. Chemother., 29: 593-594
RUBENS, C., HEFFRON, F. AND FALKOW, S. 1976. Transposition of a plasmid
deoxyribonucleic acid sequence that mediates ampicillin resistance:
Independence from host rec funtions and orientation of insertion. J. Bacteriol.,
128: 425-434
RUB10, M.C., GIL, J., CASTILLO, J., OTAL, I., GOMEZ-LUS, M.L., RUBIO,
E., SARRASECA, C., TORRELLAS, A. AND GOMEZ-LUS, R. 1989. The
susceptibility to amoxycillin/clavulanate of Enterobacteriaceae with plasmid-
mediated ampicillin resistance: a twelve year study of strains in one Spanish
hospital. J. Antimicrob. Chemother., 24 (Suppl. B): 35-40
RUDY, R.R AND MURRAY, B.E. 1984. Evidence for an epidemic trimethoprim-
resistance plasmid in fecal isolates of Escherichia coli from citizens of the
United States studying in Mexico. J. Infect. Dis., 150: 25-29
RYDBERG, J. AND CEDERBERG, A. 1986. Intrafamilial spreading of
Escherichia coli resistant to trimethoprim. Scand. J. Infect. Dis., 18: 457-460
SANDERS, C.C. 1983. Novel resistance selected by the new expanded-spectrum
cephaloporins: A concern. J. Infect. Dis., 147: 585-589
SANDERS, C.C. 1984. Inducible P-lactamases and non-hydrolytic resistance
mechanisms. J. Antimicrob. Chemother., 13: 1-3
SANDERS, C.C. AND SANDERS, W.E. 1985. Microbial resistance to newer
generation P-lactam antibiotics: Clinical and laboratory implications. J. Infect.
Dis., 151: 309-406
SANDERS, C.C. AND SANDERS, W.E. 1986. Type 1 P-lactamases of Gram-
negative bacteria: Interactions with p-lactam antibiotics. J. Infect. Dis., 154:
792-800
SANDERS, C.C., IACONIS, J.P., BODEY, G.P. AND SAMONIS, G. 1988.
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the
family Enterobacteriaceae-. Role of PSE-1 p-lactamase and high levels of TEM-1
and SHV-1 and problems with false susceptibility in disk diffusion tests.
Antimicrob. Agents Chemother., 32: 1365-1369
SANDERS, C.C. AND WIEDEMANN, B. 1988. Conference Summary. J. Infect.
Dis., 10: 679-680
SANDERS, C.C. AND SANDERS, W.E. 1992. P-lactam resistance in Gram-
negative bacteria: Global trends and clinical impact. Clin. Infect. Dis., 15: 824-
839
236
SAWAI, T., MITSUHASHI, S. AND YAMAGISHI, S. 1968. Drug resistance of
enteric bacteria. XIV. Comparison of {3-lactamases in Gram-negative rod
bacteria resistant to a-aminobenzylpenicillin. Jpn. J. Microbiol., 12: 423-434
SEETULSINGH, P.S., HALL, L.M.C. AND LIVERMORE, D.M. 1991. Activity of
clavulanate combinations against TEM-1 (3-lactamase-producing Escherichia
coli isolates obtained in 1982 and 1989. J. Antimicrob. Chemother., 27: 749-759
SELWYN, S. 1980. The discovery and evolution of penicillins and
cephalosporins in Beta-lactam antibiotics: Penicillins and cephalosporins in
perspective. Hodder and Stoughton. London, Sydney, Auckland, Toronto.
SELWYN, S. 1982. The evolution of broad-spectrum penicillins. J. Antimicrob.
Chemother., 9 (Suppl. B): 1-10
SEMMELWEIS,I. 1850. Lecture on the genesis of puerperal fever (childhood
fever), p.80-82. In T.D. Brock (ed.), Milestones in Microbiology. Prentice-Hall
International
SENERWA, D., MUTANDA, L.N., GATHUMA, J.M. AND OLSVIK, O. 1991.
Antimicrobial resistance of enteropathogenic Escherichia coli strains from a
nosocomial outbreak in Kenya. A.P.M.I.S., 99: 728-734
SHANNON, K., WILLIAMS, H., KING, A. AND PHILLIPS, I. 1990a.
Hyperproduction of TEM-1 beta-lactamase in clinical isolates of Escherichia coli
serotype 015. FEMS Microbiol. Lett., 67: 319-324
SHANNON, K.P, KING, A., PHILLIPS, I., NICOLAS, M.H. AND PHILIPPON,
A. 1990b. Importation of organisms producing broad-spectrum SHV-group (3-
lactamases into the United Kingdom. J. Antimicrob. Chemother., 25: 343-351
SHANNON, K, KING, A. AND PHILLIPS, I. 1992. Prevalence of resistance to
(3-lactam antibiotics in Escherichia coli isolated from blood from 1969-1991. J.
Antimicrob. Chemother., 30: 661-672
SHAW, E.J., DATTA, N., JONES, G., MARR, F.M. AND FROUD, W.J.B. 1973.
Effect of stay in hospital and oral chemotherapy on the antibiotic sensitivity of
bowel coliforms. J. Hyg., 71: 529-534
SHEARS, P., HART, C.A., BROADHEAD, R.L. AND COULTER, J.B.S. 1987. A
note on antibiotic resistance in Escherichia coli isolated from children with
diarrhoea in the Sudan. Aran.. Trop. Paediatr., 7: 38-41
SHEARS, P., HART, C.A. AND SULIMAN, G. 1988a. A preliminary
investigation of antibiotic resistance in Enterobacteriaceae isolated from
children with diarrhoea from four developing countries. Ann. Trop. Med.
Parasitol., 82: 185-188
237
SHEARS, P., SULIMAN, G. AND HART, C.A. 1988b. Occurrence of multiple
antibiotic resistance and R plasmids in Enterobacteriaceae isolated from
children in the Sudan. Epidem. Inf., 100: 73-81
SHEARS, P., SULIMAN, G. AND HART, C.A. 1989. Restriction endonuclease
characterization of resistant plasmids in Enterobacteriaceae isolated from
children in the Sudan. Epidem. Inf., 103: 487-496
SHOOTER, R.A., COOKE, E.M., ROUSSEAU, S.A. AND BREADEN, A.L. 1970.
Animal sources of common serotypes of Escherichia coli in the food of hospital
patients. Lancet,: 226-228
SIMPSON, I.N., HARPER, PB. AND O'CALLAGHAN, C.H. 1980. Principal p-
lactamases responsible for resistance to P-lactam antibiotics in urinary tract
infections. Antimicrob. Agents Chemother., 17: 929-936
SIMPSON, I.N., PLESTED, S.J. AND HARPER, PB. 1982. Investigation of the
p-lactamase stability of ceftazidime and eight other new cephalosporin
antibiotics. J. Antimicrob. Chemother., 9: 357-368
SIMPSON, I.N., KNOTHE, H., PLESTED, S.J. AND HARPER, PB. 1986.
Qualitative and quantitative aspects of P-lactamase production as mechanisms
of P-lactam resistance in a survey of clinical isolates from faecal samples. J.
Antimicrob. Chemother., 17: 725-737
SINGH, K.V., REVES, R.R., PICKERING, L.K. AND MURRAY, B.E. 1990.
Comparative in vitro activities of amoxicillin-clavulanic acid, cefuroxime,
cephalexin, and cephalothin against trimethoprim-resistant Escherichia coli
isolated from stools of children attending day care centres. Antimicrob. Agents
Chemother., 34: 2047-2049
SINGH(a), K.V., REVES, R.R., PICKERING, L.K. AND MURRAY, B.E. 1992.
Identification by DNA sequence analysis of a new plasmid-encoded
trimethoprim resistance gene in fecal Escherichia coli isolates from children in
day-care centres. Antimicrob. Agents Chemother., 36: 1720-1726
SINGH(b), M., CHAUDHRY, M.A., YADAVA, J.N.S. AND SANYAL, S.C. 1992.
The spectrum of antibiotic resistance in human and veterinary isolates of
Escherichia coli collected from 1984-1986 in Northern India. J. Antimicrob.
Chemother., 29: 159-168
SIROT, D., SIROT, J., LABIA, R., MORAND, A., COURVALIN, P.,
DARFEUILLE-MICHAUD, A., PERROUX, R. AND CLUZEL, R. 1987.
Transferable resistance to third-generation cephalosporins in clinical isolates of
Klebsiella pneumoniae', identification of CTX-1, a novel P-lactamase. J.
Antimicrob. Chemother., 20: 323-334
SIROT, J., CHANAL, C., PETIT, A., SIROT, D., LABIA, R. AND GERBAUD, G.
1988. Klebsiella pneumoniae and other Enterobacteriaceae producing novel
238
plasmicl-mediated p-lactamases markedly active against third-generation
cephalosporins: Epidemiological studies. Rev. Infect. Dis., 10: 850-859
SIROT, D.L., GOLDSTEIN, F.W., SOUSSY, C.J., COURTIEU, A.L., HUSSON,
M.O., LEMOZY, J., MEYRAN, M., MOREL, C., PEREZ, R., QUENTIN-NOURY,
C., REVERDY, M.E., SCHEFTEL, J.M., ROSEMBAUM, M. AND REZVANI, Y.
1992. Resistance to cefotaxime and seven other [3-lactams in members of the
family Enterobacteriaceae: a 3-year survey in France. Antimicrob. Agents
Chemother., 36: 1677-1681
SMITH, D.H. 1967. R factor infection of Escherichia coli lyophilized in 1946. J.
Bacteriol., 94: 2071-2072
SMITH, H.W. 1968. Anti-microbial drugs in animal feeds. Nature, 218: 728-731
SMITH, H.W. AND HALLS, S. 1966. Observations on infective drug resistance
in Britain. Br. Med. J., 1: 266-269
S0GAARD, H. 1975. Incidence of antibiotic resistance and transmissible R
factors in the Gram-negative bowel flora of hospital patients on admission.
Scand. J. Infect. Di.s., 7: 253-258
SOUGAKOFF, W., GOUSSARD, S. AND COURVALIN, P. 1988a. The TEM-3 p-
lactamase, which hydrolzes broad-spectrum cephalosporins, is derived from the
TEM-2 penicillinase by two amino acid substitutions. FEMS Microbiol. Lett., 56:
343-348
SOUGAKOFF, W., GOUSSARD, S., GERBAUD, G. AND COURVALIN, P.
1988b. Plasmid-mediated resistance to third-generation cephalosporins caused
by point mutations in TEM-type penicillinase genes. Rev. Infect. Dis., 10: 879-
884
SOUSA, J.C., CARNEIRO, G., PEIXE, M.L., QUEIROS, M.L. AND REBELO. I.
1991. Characterization of p-lactamases encoded by pathogenic strains of
Escherichia coli from Portugal. J. Antimicrob. Chemother., 27: 437-440
SPRATT, B.G. 1975. Distinct penicillin binding proteins involved in the division,
elongation, and shape of Echerichia coli K12. Proc. Nat. Acad. Sci. USA, 72:
2999-3003
SPRATT, B.G. 1980. Biochemical and genetical approaches to the mechanism of
action of penicillin. Philosophical Transactions of the Royal Society ofLondon B,
289:273-283
STENDERUP, J., 0RSKOV, I. AND 0RSKOV, F. 1983. Changes in serotype and
resistance pattern of the intestinal Escherichia coli flora during travel. Scand.
J. Infect. Dis., 15: 367-373
239
SUTCLIFFE, J.G. 1978. Nucleotide sequence of the ampicillin resistance gene
ofEscherichia coli plasmid pBR322. Proc. Nat. Acad. Sci. USA, 75: 3737-3741
SUTHERLAND, R., CROYDON, E.A.P. AND ROLINSON, G.N. 1972.
Amoxycillin: A new semi-synthetic penicillin. Br. Med. J., 3: 13-16
SUTHERLAND, R. 1990. Development of beta-lactamase inhibitors. J. Reprod.
Med., 35 (Suppl. 3): 307-312
SYKES, R.B. 1982. The classification and terminology of enzymes that
hydrolyse P-lactam antibiotics. J. Infect. Dis., 145: 762-765
SYKES, R.B. AND MATTHEW, M. 1976. The P-lactamases of Gram-negative
bacteria and their role in resistance to P-lactam antibiotics. J. Antimicrob.
Chemother., 2: 115-157
TAKAHASHI, S. AND NAGANO, Y. 1984. Rapid procedure for isolation of
plasmid DNA and application to epidemiological analysis. J. Clin. Microbiol.,
20: 608-613
THOMSON, C.J. AND AMYES, S.G.B. 1992a. TRC-1: Emergence of a clavulanic
acid-resistant TEM P-lactamase in a clinical strain. FEMS Microbiol. Lett.,
91:113-118
THOMSON, C.J. AND AMYES, S.G.B. 1992b. Prospects for expanding the use
of P-lactamase inhibitors. J. Med. Microbiol., 37: 297-298
THOMSON, C.J., PATON, R.H., HOOD, J., MILES, R.S. AND AMYES, S.G.B.
1992a. Antibiotic resistance in urinary bacteria isolated in central Scotland. Int.
J. Antimicrob. Chemother., 1: 223-228
THOMSON, C.J., HOOD, J., MILES, R.S. AND AMYES, S.G.B. 1992b.
Prevalence of the TEM-1 P-lactamase in urinary E. coli: continued efficacy of
amoxycillin plus clavulanic acid. Abstracts of the first International Congress
on the Management of Infection No. 21: 73
THOMSON, C.J. AND AMYES, S.G.B. 1993a. Molecular epidemiology of the
plasmid-encoded TEM-1 P-lactamse in Scotland. Epidem. Inf., 110: 117-125
THOMSON, C.J. AND AMYES, S.G.B. 1993b. Selection of variants of the TEM-
1 P-lactamase, encoded by a plasmid of clinical origin, with increased resistance
to P-lactamase inhibitors. J. Antimicrob. Chemother., 31: 655-664
THOMSON, C.J., TAIT, S., JESUDASON, M.V. AND AMYES, S.G.B. 1993.
Dissemination of the TEM-1 beta-lactamase gene into disparate plasmids in
faecal Escherichia coli isolated in Vellore, South India. Journal of Infection (In
Press)
240
THOMSON, K.S., WEBER, D.A., SANDERS, C.C. AND SANDERS, W.E. 1990.
Beta-lactamase production in members of the family Enterobacteriaceae and
resistance to beta-lactam-enzyme inhibitor combinations. Antimicrob. Agents
Chemother., 34: 622-627
TIPPER, D.J. AND STROMINGER, J.T. 1965. Mechanism of action of
penicillins: A proposal based on their structural similarity to acyl-D-alanyl-D-
alanine. Proc. Nat. Acad.. Sci. USA, 54: 1133-1141
TREFOUEL, J., TREFOUEL, J., NITTI, F. AND BOVET, D. 1935. Activite du p-
aminophenylsulfamide sur les infections streptococciques experimentales de la
souris et du lapin. C. R. Soc. Biol. Paris, 120: 756-758
TOMASZ, A. 1986. Penicillin-binding proteins and the antibacterial
effectiveness of (3-lactam antibiotics. Rev. Infect. Dis., 8 (Suppl. 3): S260-S278
TULLUS, K., BERGLUND, B., FRYKLUND, B., KUHN, I. BURMAN, L.G.
1988. Influence of antibiotic therapy on faecal carriage of P-fimbriated
Escherichia coli and other Gram-negative bacteria in neonates. J. Antimicrob.
Chemother., 22: 563-568
TURCK, M., RONALD, A.R., CLARK, H., WINTERBAUER, R.H., ATLAS, E.,
SILVERBLATT, F. AND PETERSDORF, R.G. 1969. Studies on the epidemiology
ofEscherichia, coli, 1960-1968. J. Infect. Dis., 120: 13-16
UBUKATA, K, YAMASHITA, N. AND KONNO, M. 1985. Occurrence of a beta-
lactam inducible penicillin-binding protein in methicillin-resistant
staphylococci. Antimicrob. Agents Chemother., 27: 851-887
VEDEL, G., BELAAOUAJ, A., GILLY, L., LABIA, R., PHILIPPON, A., NEVOT,
P. AND PAUL, G. 1992. Clinical isolates of Escherichia coli producing TRI (3-
lactamases: novel TEM-enzymes conferring resistance to P-lactamase inhibitors.
J. Antimicrob. Chemother., 30: 449-462
WADDELL, W.J. 1956. A simple ultraviolet spectrophotometric method for the
determination of protein. J. Lab. Clin. Med.., 48: 311-314
WAKSMAN, S.A. AND LECHEVALIER, H.A. 1949. Neomycin, a new antibiotic
active against streptomycin-resistant bacteria, including tuberculosis
organisms. Science, 109: 305-307
WANGER, A.R., MURRAY, B.E., ECHEVERRIA, P., MATHEWSON, J.J. AND
DuPONT, H.L. 1988. Enteroinvasive Escherichia coli in travelers with
diarrhoea. J. Infect. Dis., 158: 640-642
WATANABE, T. 1963. Infective heredity ofmultiple drug resistance in bacteria.
Bacteriol. Rev., 27: 87-115
241
WIEDEMANN, B. 1986. Genetic and biochemical basis of resistance of
Enterobacteriaceae to p-lactam antibiotics. J. Antimicrob. Chemother., 18
(Suppl. B): 31-38
WIEDEMANN, B., KLIEBE, C. AND KRESKEN, M. 1989. The epidemiology of
P-lactamases. J. Antimicrob. Chemother., 24 (Suppl. B): 1-22
WILLIAMS, H., KING, A., SHANNON, K. AND PHILLIPS, I. 1988.
Amoxycillin/Clavulanate resistant Escherichia coli. Lancet, I: 304-305
WISE, R., ANDREWS, J.M. AND BEDFORD, K.A. 1980. Clavulanic acid and
CP-45,899: a comparison of their in vitro activity in combination with
penicillins. J. Antimicrob. Chemother., 6: 197-206
WISE, R. 1982. P-lactamase inhibitors. J. Antimicrob. Chemother., 9 (Suppl. B):
31-40
WISE, R. 1992. Oral cephalosporins. J. Antimicrob. Chemother., 29: 91-96
WOODFORD, N., PAYNE, D.J., JOHNSON, A.P., WEINBREN, M.J.,
PERINPANAYAGAM, R.M., GEORGE, R.C., COOKSON, B.D. AND AMYES,
S.G.B. 1990. Transferable cephalosporin resistance not inhibited by clavulanate
in Escherichia coli. Lancet, 336: 253
WU, P.J., SHANNON, K. AND PHILLIPS, I. 1992. p-lactamases and
susceptibility to P-lactam antibiotics in Escherichia coli. J. Antimicrob.
Chemother., 30: 868-871
WYLIE, B.A. AND KOORNHOF, H.J. 1989. Trimethoprim resistance in Gram-
negative bacteria isolated in South Africa. J. Antimicrob. Chemother., 24: 973-
982
YOUNG, H-K., NANDIVADA, L.S. AND AMYES, S.G.B. 1989. Antibiotic
resistance in the tropics. 1. The genetics of bacterial ampicillin resistance in
tropical areas. Trans. R. Soc. Trop. Med. Hyg., 83: 38-41
YOUNG, H.K. AND JESUDASON, M.V. 1990. Antibiotic resistant bacteria in
drinking water in South India. J. Pharm. Pharmacol., 42: 66P
YOUNG, H-K. 1993. Antimicrobial resistance spread in aquatic environments.
J. Antimicrob. Chemother., 31: 627-635
ZHOU, X.Y., KITZIS, M.D., ACAR, J.F. AND GUTMANN, L. 1993. Activity of
the P-lactamase inhibitor BRL 42715 against cephalosporinases produced by
Enterobacteriaceae. J. Antimicrob. Chemother., 31: 473-480
242
^ 3 hi
The Prevalence of Antimicrobial Resistance in Human Faecal
Flora in South Africa.
12 2 2
P.M.A. Shanahan , B.A. Wylie , P.V. Adrian , H.J. Koornhof ,
1 1*
C.J. Thomson and S.G.B. Amyes .
^Department of Medical Microbiology, The Medical School, University of
2
Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland and Emergent
Pathogen Research Unit of the Medical Research Council, University of the
Witwatersrand and the South African Institute for Medical Research,
Johannesburg 2000, South Africa.
* All correspondence and reprint request should be sent to Professor
S.G.B. Amyes, Department of Medical Microbiology, The Medical School,
University of Edinburgh, Teviot Place, Edinburgh EH8 9AG, Scotland
Antibiotic resistance in faecal flora Page 2
Shanahan et al
SUMMARY
Between January and March 1992, 361 faecal specimens were collected from
the healthy black population in the Transvaal Province of South Africa.
Each specimen was examined for the prevalence of antimicrobial resistance
in commensal bacteria. Volunteers, from both rural and urban dwellings,
were divided into four age groups. The overall carriage rate of resistance
varied from 88.6% for ampicillin, 74.2% for trimethoprim, 52.6% for
chloramphenicol, 10.2% for nalidixic acid to 7.5% for gentamicin. The
carriage of resistance found to each individual antimicrobial agent was
slightly higher in the rural population rather than the urban population
but there was no correlation between the prevalence of antimicrobial
resistance and the age group.
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INTRODUCTION
The increasing prevalence of bacterial resistance to most antibiotics is
of concern as the choice of agents available for treatment becomes limited
and inevitably more complicated. Furthermore, the potential exists where
no available therapeutic agent would be effective against many
pathogens
The incidence of antibiotic resistance amongst clinical isolates is well
documented. Antibacterial drug resistance has been shown to be higher in
2
the developing world rather than the developed world. Trimethoprim
resistance amongst pathogenic Gram negative bacteria was found to be 64Z
3 4 5
in South India, 49.1Z in South Africa and 63.3Z in Nigeria. In
contrast, the levels of such resistance were found to be only 14-19Z in
Finland^ and 23Z in Scotland.^ Reasons for the high levels of
resistance in the developing countries may include the availability of
antibiotics without prescription and the contamination of the water
T 8supply.
In contrast, the incidence of such resistance amongst the normal non
pathogenic flora such as E. coli of healthy individuals, in the absence of
concurrent or recent antibiotic consumption, has been less extensively
89 10 11
recorded. ' ' ' The carriage of resistance determinants in these
organisms may complicate treatment as the potential exists firstly, for
their transfer to any invading pathogens and secondly, the resistant
12
bacteria may cause an endogenous infection.
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It is recognised that transfer of resistance factors is encouraged
I 13whenfantibiotics are administered. The acquisition of resistant
bacteria may be achieved through ingestion of contaminated food, person to
person or animal to man transmission.^'^ A number of sources have been
associated with the emergence of resistant bacteria including developing
2 16
countries, clinical practice, animal feedlots and, more recently,
day care centres (DCC).^
The normal commensal flora is increasingly recognised as a reservoir of
antibiotic resistance. As in clinical isolates, levels of resistance in
this group appear to be higher in the developing rather than developed
countries. This study examines resistance in the commensal faecal flora in
the black population of South Africa. This study area represents a unique
situation in having third world living conditions with two important
exceptions; there isjno unprescribed use of antibiotics and the water
supply is often bacteria-free.
METHODS
Population Description
The survey participants consisted of healthy volunteers resident in the
Transvaal, South Africa. Candidates were excluded from the study if they
had received any medical treatment in the three weeks prior to sampling.
This time period allowed any changes in faecal flora, resulting from
9 18
antimicrobial usage, to be reversed. ' A completed questionnaire
accompanied each specimen; it supplied information regarding the donor's
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age, sex, address, medical history and data on social conditions. The
study examined eight separate population groups from both urban and rural
areas. In the urban area the four groups comprised infants attending
either a childminder or a creche in SOWETO (0-5 years), urban children
(6-11 years) and urban teenagers (12-19 years) attending a school in
Kagiso, a town on the West Rand and urban adults (>19 years) who resided
in SOWETO. The rural population was composed of infants attending a "well
baby" clinic at Middleplaas in the KaNgwane district, rural children and
rural teenagers attending a school at Hekpoort in the Magaliesburg
district and lastly adults resident in KaNgwane district. Notably, the
rural adults were all associated with the hospital at Shongwe Mission and
consequently were in contact with patients. This specific population
consisted of healthy mothers feeding sick children, mothers attending a
nutrition centre for children and finally escorts to patients visiting the
out patients department. Parental consent was obtained for all persons
involved of <18 years.
Sample Collection and Processing
The survey collection was performed between January - March 1992; a total
d
of 361 specimens were obtained. Rectal swabs or freshly passed faecal
specimens were deposited in small plastic containers for immediate
transport to the laboratory. Following the protocol established for such
g
studies, each faecal specimen was plated onto Oxoid MacConkey Agar
plates containing either ampicillin (lOmg/L), nalidixic acid (lOmg/L),
chloramphenicol (lOmg/L), gentamicin (4mg/L) or no antibiotic. Each
specimen was also plated onto Modified Difco Mueller Hinton Agar plates
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containing trimethoprim (lOmg/L). The plates were incubated overnight
at 37°C. Each plate was scored for the presence or absence of bacterial
colonies which were subsequently classified as either lactose fermenters
or lactose non- fermenters.
Water Sample Collection and Processing
From each study centre, except for Kagiso, a 100ml sample of the normal
drinking water was collected in a sterile bottle. After immediate
transportation to the laboratory, the water was filtered and the filter
pad placed on an Oxoid MacConkey agar plate containing no antibiotic. The
plate was incubated overnight at 37°C. Each plate was examined for the
presence of bacterial colonies which were subsequently identified.
Bacterial Identification
Bacterial colonies were identified by standard biochemical analysis. Each
strain was allocated to one of four groups; E. coll, Klebsiella species,
Enterobacter species, or other enterobacteria.
Conjugation Studies
All the isolates resistant to ampicillin and trimethoprim were tested for
the ability to transfer their resistance determinants by the method of
19
Amyes and Gould (1984). j The conjugation experiments employed the
20




A total of 361 participants were included from both the rural (183) and
urban (178) studies. The male/female distribution was 1:1.4 in both the
groups. The adult population was predominantly female (Table 1).
Frequency of Antibiotic Resistance
The results of the survey are shown in Table 2. A high proportion of
volunteers carried bacteria resistant to antibiotics; in particular to
ampicillin (88.6%) and trimethoprim (74.2%). Five antibiotics were
screened in the study and, for each, the corresponding level of resistance
identified was slightly higher amongst the rural populations. There was no
difference in the level of resistance to each antimicrobial agent and age
group except that gentamicin resistance in the rural adults was much
higher than it had been amongst their urban counterparts (38.6% versus
4%).
Identification of Ampicillin and Trimethoprim Resistant Strains
All the ampicillin and trimethoprim resistant strains were identified
(Table 3). E.coli represented the largest proportion of resistant bacteria
when either susceptibility to ampicillin or trimethoprim was measured.
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Frequency of Transfer
A total of 608 ampiclllin resistant strains and 357 trimethoprim resistant
strains were collected from the survey. The results of the transfer
experiments show that only 29Z of the ampicillin resistant isolates
contained self-transmissable plasmids. In contrast, 51.2Z of trimethoprim
resistant isolates contained self-transmissable plasmids while a further
3.AX contained trimethoprim resistant plasmids which could be mobilised
with X+ factor.
Environmental Conditions
In an attempt to establish if environmental conditions exerted any
influence over the carriage of antibiotic resistance in bacteria, various
factors were examined.
(i) Water supply. A representative water sample was taken in each study
area except in Kagiso (table 4). Screening in the urban locations revealed
the water, which is municipally piped, to be free of any bacteria. In
contrast, the water tested from Middleplaas clinic, stored rain water,
contained Pseudomonas aeruginosa, Serratia marcescens and a gram-positive
coccus. The school in Hekpoort is provided with water from a bore hole.
This was contaminated with four different bacteria, Bacillus cereus,
Acinetobacter anitratus, Enterobacter cloacae and Pseudomonas aeruginosa.
The rural adult population was not exposed to a contaminated water supply
as the water utilized at Shongwe hospital was filtered and chlorinated
river water. This water was completely bacteria-free.
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(ii) Living conditions. The social conditions of the participants are
reflected in Table 4. In both the rural and urban study, approximately 50%
of the participants were associated with animals. Despite the possibility
of animal to man transmission of bacteria, this was probably not a major
contributory factor in the spread of resistance as resistant bacteria were
as commonly observed in participants living in the absence of animals.
(iii) Population density. The most influential environmental factors
observed were the number of people per family and per house. Many of the
rural homes were wattle and daub huts with only one room for sleeping.
Similarly, it was not uncommon for many urban homes to have just one
bedroom. As similar numbers of residents per house (mean= 6.0
people/house) were recorded in both the rural and urban areas, it would
seem that this widespread over-crowding is a large contributor to the high
levels of resistance.
DISCUSSION
Commensal flora represent an increasingly well recognised reservoir of
resistance genes. In this study the carriage rate of antimicrobial
resistance amongst the commensal flora of selected black South African
populations was examined. The incidence of antibiotic resistance carriage
was 88.6% for ampicillin and 74.2% for trimethoprim. Chloramphenicol
resistance was found to be lower at 52.6% while the carriage of gentamicin
and nalidixic acid resistance were lower still at 7.5% and 10.2%
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respectively. This lower carriage of resistance may reflect the lower
usage of these antimicrobials as opposed to ampicillin and trimethoprim
which are the most widely used antibacterials in the study areas.
The highest incidence to date for the carriage of resistant bacteria
g
within commensal populations was recently reported from South India;
trimethoprim or ampicillin resistant bacteria were present in 98% of the
specimens screened. The factors contributing to the maintainance of this
high carriage of bacterial resistance included the contamination of the
water supply and the inappropriate dispension and widespread use of
g
antimicrobial agents. The causal relationship between increased
antibiotic resistance and increased antibiotic usage has been explained
before.
It has been reported that the carriage of a antibiotic resistant strains
13
is much higher amongst children than adults. Possible reasons for this
include high antimicrobial prescribing amongst this group and lower
standards of hygiene which facilitate the transmission of resistant
organisms. Examination of the resistance levels within our population
sub-groups, however, revealed a lack of correlation between age and
antibiotic resistant faecal flora. This compares with the commensal study
21
of Dutch urban communities which reported the same finding. However,
this contrasts with other findings: examination of child day care centres
(DCC)^, revealed substantially higher levels of trimethoprim resistant
faecal flora (30%) amongst the children attending the centre than is
prevalent in the general population (6%). Similarly, ampicillin resistant
faecal flora was reported as 70% in this particular population which again
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is substantially higher than corresponding levels identified in the
9
healthy community (34.9Z). In the current study, approximately half the
urban infants attended a child-minder in SOWETO, the equivalent of a child
day care centre, and yet the levels of resistance observed in this
particular group are not noticeably higher than any other sub-group. This
suggests the spread of antibiotic resistance factors may occur at the same
frequency in all strata of society.
One of the distinctions between the developed and developing world is the
lack, of a uncontaminated potable water supply in the latter. This has
obvious implications in facilitating the spread of infectious disease and
had been speculated to have a role in the transmission of antibiotic
g
resistant organisms. This study reports contamination of the water and
unsanitary conditions especially in rural areas which creates the
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opportunity for cross infection between bacteria. ' ' However, in
contrast to the Indian study which indicated contamination of the water
supply coupled with high antimicrobial usage as being responsible for the
high resistance levels in that area, these factors may only be
contributors to the resistance levels witnessed in South Africa. This is
because in spite of very basic conditions in the urban areas of SOWETO,
all our participants came from houses with a tap supplying an
uncontaminated supply of water. Surprisingly, although the water was
contaminated in rural areas, it did not seem to affect the carriage of
antibiotic resistant _E. coli; E^. coli were not isolated in the water
samples. However, ablusion facilities in the rural villages were extremely
limited increasing the opportunity for spread of resistant determinants
through the faecal/oral route.
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In addition, unprescribed use of antimicrobial agents may be a
contributing factor to the high levels of resistance found in the
developing world. Although the ability to buy antibiotics over the counter
5 8 22
may contribute to high level resistance, ' ' such purchasing is not
4
usually possible in South Africa. However, there might be a higher
usage of antibiotics associated with this population group in order to
treat endemic diseases.
It is probable that the main influence determining and maintaining the
high level of resistance in the black South African population is the
severe overcrowding in the homes (>6.0 people/house). Close contact
23
facilitates the transmission of resistant determinants. Intrafamilial
contact has been shown to be an important factor in the spread of
resistant determinants.^
Once established, poor living conditions and poor sanitation, may be the
major contributors in maintaining the high levels of resistant bacteria in
this reservoir. Indeed, these factors may become more important than
antibiotic usage itself.
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TABLE 1. Volunteers in the Study.
AGE
Location/ Total No. of No. Females Range Mean SD Mode
Study Group Individuals (yrs) (yrs) Meat/Week
Rural Study
Infants 50 29 0-5 0.75 0.82 3
Children 47 26 6-11 9.1 1.42 3
Teenagers 36 19 13-18 14.0 1.24 3
Adults 50 35 >19 28.4 10.12 3
Urban Study
Infants 45 23 0-5 2.4 1.28 4
Children 42 18 6-11 9.1 1.69 4
Teenagers 47 22 13-18 13.1 0.93 7
Adults 44 42 >19 33.0 6.06 3
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TABLE 3. The Incidence of Organisms Isolated from the Study.
Number Isolated (Z)
Organism Ap resistant strains Tp resistant strains
E. coll 445 (73) 297 (83)
Klebsiella species 104 (17) 46 (13)
Citrobacter/Enterobacter 35 (6) 8 (2)
Other 24 (4) 6 (2)
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TABLE 4. Social Conditions of Volunteers in the Survey.
Location Mean Mean
No./Family No./House
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Faecal specimens from 100 healthy volunteers living in Edinburgh were examined for
the presence of antibiotic resistant bacteria A high incidence of ampicillin resistance
was found as 42% of specimens containing normally sensitive bacteria were resistant to
the drug, however only 12% of the specimens contained trimethoprim resistant
bacteria There was no detectable resistance to the third generation cephalosporin,
ceftazidime or the 4-quinolone, ciprofloxacin Identification of the ^-lactamases
produced by the ampicillin resistant isolates demonstrated that the TEM-1 (3-lactamase
predominated particularly in E. coli where it was identified in 86% of isolates. Thirty
three percent of the ampicillin resistant isolates were able to transfer their resistance to
E. coli K12 strain J62-2 and analysis of these transconjugants by iso-electric focusing
revealed that the TEM-1 ^-lactamase was present in 100% of the transconjugants.
Restriction endonuclease fingerprinting of the TEM-1 containing plasmids revealed an
epidemic plasmid in the community.
(3-lactam Resistance in Commensal Faecal Flora Page 3
Shanahan, Thomson & Amyes
Introduction
There is increasing evidence to suggest that the healthy members of a community may
contain the largest reservoir of bacterial antibiotic resistance genes [1,2] Such
resistance determinants may complicate treatment as the potential exists, firstly, for
their transfer to any invading pathogens and, secondly, the resistant bacteria may cause
an endogenous infection. Consequently, it has been suggested that knowledge of these
resistance levels may improve the success of initial antibiotic therapy [2], A number of
surveys examining antimicrobial resistance in selected healthy volunteers have recently
been reported [1-6]. In clinical isolates, the levels of antibiotic resistance are
significantly higher in the developing world than in the developed world [7], This may
also be true of the carriage of antibiotic resistance in commensal flora [5,6], In
particular, the incidence of ampicillin resistance in both areas is high. The genetic and
biochemical mechanisms of resistance to (3-lactam agents have been extensively
investigated in clinical isolates and it has been shown that resistance to (3-lactam
agents in Gram-negative bacteria is most commonly mediated by the TEM-1 (3-
lactamase [8-12], This is especially true for transferable resistance where the TEM-1
gene has been shown to account for up to 80% of all plasmid-mediated resistance [10].
Although the significance of the commensal flora as a reservoir for resistance
determinants is increasingly realised, there have been few studies as yet to address the
resistance mechanisms involved in such isolates. This study establishes the levels of
resistance to various antimicrobial agents in the healthy population in Edinburgh and
then examines the genetic and biochemical basis for the ampicillin resistance identified
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Materials and Methods
Sample population
A total of 100 faecal specimens were collected from three separate healthy populations
in Edinburgh between January - June 1991 No volunteer was allowed to participate in
the study if they had received any antimicrobial treatment in the three weeks prior to
sampling. The study group consisted of office workers and members of the university
chaplaincy centre (42), patients of a general practice in Loanhead (34) and medical
students at the University of Edinburgh (24).
Sample collection and processing
The carriage of antibiotic resistance was assessed following the protocol established
for such studies and described previously [5]. The fresh faecal samples were collected
in sterile plastic bottles and transported to the laboratory the same day. Each specimen
was plated onto Oxoid MacConkey agar (Oxoid, Basingstoke, U.K.) plates containing
either ampicillin (lOmg/L), ceftazidime (2mg/L), nalidixic acid (lOmg/L), ciprofloxacin
(lmg/L), gentamicin (4mg/L), tetracycline (lOmg/L) or no antibiotic. In addition, the
specimens were also plated onto a modified Mueller Hinton Agar (Difco, Michigan,
U.S.A.) containing trimethoprim (lOmg/L) [13], The plates were incubated at 37°C
for 24h. Non-mucoid, lactose-fermenting colonies were recorded and purified onto
media containing the same antibiotics as in the initial isolation.
Identification ofampicillin resistant isolates
All ampicillin resistant isolates were identified by the API 20E system.
Transfer of ampicillin resistance determinants
All the ampicillin resistant isolates were investigated for their ability to transfer their
resistant determinants to an isogenic background Transfers were carried out in
nutrient broth at 37°C for 18h employing E.coli K-12 strain J62-2 as the recipient
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strain [14] The mating mixture was washed and resuspended in Davis and Mingioli
(DM) minimal medium [15], before they were plated onto a selective medium
containing ampicillin (lOmg/L) and rifampicin (25mg/L) [13] The auxotrophic
requirements of the transconjugants were checked on DM minimal media plates
containing L-proline, L-histidine and L-tryptophan (each at 50mg/L) and also on
similar plates lacking L-histidine in order to confirm their status
Plasmid and restriction endonuclease analysis
Plasmid DNA was isolated by the method of Takahashi and Nagano [16], Restriction
analysis was carried out with Eco R1 (Boeringer Mannheim, Sussex, U K.) according
to the manufacturer's instructions.
Minimum inhibitory concentration and antibiogram analysis
All the ampicillin resistant organisms isolated were investigated further. The minimum
inhibitory concentration (MIC) of each ampicillin resistant bacterium was determined
by diluting an overnight nutrient broth culture in DM minimal medium. Approximately
104 cfu was inoculated onto the surface of Diagnostic Sensitivity Test Agar (Oxoid)
(DSTA) plates containing doubling concentrations of amoxycillin, amoxycillin plus
clavulanic acid in a 2:1 ratio, cefuroxime, cefotaxime and ceftazidime. The plates were
incubated aerobically at 37°C for 24h. The MIC was taken as the lowest concentration
which gave no visible growth. The antibiogram of each transconjugant was obtained by
following the same method as for the MIC except one fixed concentration of antibiotic
was incorporated into the test plates.
^-lactamase identification
Sonicated (3-lactamase extracts were prepared as described previously [17] The
enzymes were identified by analytic isoelectric focusing by comparison with known P-
lactamases isolated from control strains [17,18] and visualised by staining with
nitrocephin (lO'^M). ^-lactamase activity was measured by spectrophotometry assay
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(A. 2 UV/V1S Spectrophotometer) of the hydrolysis of nitrocephin (10~4) at 384nm
(sodium phosphate buffer pH7 0, 37°C) and the specific activity was obtained with
reference to the protein concentration measured by the method ofWaddell [19]
Results
%
Incidence of antibiotic resistance in the commensal faecal flora
A total of 100 faecal specimens were obtained from healthy populations in Edinburgh
The sex distribution of the volunteers consisted of 46 males, 45 females and 9
unknown. The carriage rates of resistance identified in the faecal strains is shown in
Table 1. The highest incidence of resistance was against ampicillin as 42% of the
specimens contained aerobic bacteria not susceptible to the drug. However, no
resistance was found to the third generation cephalosporin, ceftazidime. Little
resistance was detected to nalidixic acid (2%) and none to ciprofloxacin. Resistance to
gentamicin was low (1%) while 27% of all volunteer's specimens contained bacteria
resistant to tetracycline. Trimethoprim resistance was 12%. There was no significant
difference in the levels of resistance found from the different populations.
Identification of ampicillin resistant isolates
Identification of the ampicillin resistant isolates demonstrated that E.coli was the most
common isolate (Table 2). Other strains identified were Klebsiella, Citrobacter and
Hafnia spp.
Sensitivity ofampicillin resistant strains to ^-lactam antibiotics
The 42 ampicillin resistant isolates were examined for their resistance to a range of (3-
lactam agents. The minimum inhibitory concentration (MIC) of the strains was
determined for amoxycillin, amoxycillin in combination with clavulanic acid (2:1 ratio),
cefotaxime, ceftazidime and cefiiroxime (Table 3) Isolates with a high MIC of
amoxycillin (MIC > 512mg/L) were predominantly E.coli Amongst the E.coli there
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was almost universal sensitivity to cefotaxime and ceftazidime (MIC < 2mg/L) and the
addition of clavulanic acid reduced the MIC to amoxycillin to below 32mg/L in all but
two cases Cefuroxime resistance amongst the E.coli (MIC > 4mg/L) was 15%
Those isolates identified as Klebsiella spp had lower MICs of amoxycillin and
amoxycillin plus clavulanic acid than the E.coli and universal sensitivity to cefuroxime,
cefotaxime and ceftazidime. The small number of Citrobacter and Hafnia spp
identified showed variable resistance to amoxycillin, amoxycillin/clavulanic acid and
cefuroxime but no resistance to ceftazidime and cefotaxime.
Examination of transferable ampicillin resistance
Amongst the ampicillin resistant strains, the ability to transfer the resistant
determinants by conjugation to the standard bacterial strain E. coli J62-2 was exhibited
in 14 of the 42 isolates (33%). Those strains which were able to transfer their
ampicillin resistance determinants were all identified by API 20E system as E. coli
Each transconjugant was examined for its plasmid content and the plasmids were
characterised by their size and resistance profile (Table 4). Although three
transconjugants contained more than one plasmid, the remainder of the transconjugants
contained only a single plasmid. The plasmids were investigated further by restriction
analysis with Eco R1 (Figure 1). Plasmids with closely related restriction digest
patterns were assigned to the same category; that is they did not differ by changes in
no more than two bands. However, if the profiles differed by three bands or more, the
plasmids were assigned to a separate group. In addition, the antibiogram of the
plasmids was established by testing the sensitivity to various antibiotics at given
breakpoints (Table 4). The results from the restriction analysis revealed a number of
different plasmid types (9) were present Amongst the transconjugants, a common
plasmid type was isolated on five occasions (Tracks 1,2,9,13 and 14) conferring
resistance to amoxycillin, cephaloridine, cefuroxime, streptomycin and spectinomycin
Another plasmid was present on two occasions (Tracks 5 and 12) and appeared to be
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related to the common plasmid because, although the restriction digest profile differed
by three bands, there was a number of common bands, and the antibiograms were
identical The remaining seven plasmids each occurred on a single occasion and
although the restriction digest was quite different for each, the antibiogram showed
that, in common with the other plasmids isolated, resistance was mediated to similar
agents.
Distribution of 0—lactamases
The prevalence of different ^-lactamase was determined by iso-electric focusing
(Table 3). Amongst E.coli the TEM-1 ^-lactamase predominated as only two 0-
lactamase producers did not mediate this enzyme, in one isolate no 0-lactamase was
detected whilst in the second only chromosomal 0-lactamase was observed. All the
E.coli that could transfer ampicillin resistance were TEM-1 producers. Greater
heterogeneity in 0-lactamase production was observed with the Klebsiella isolates with
TEM-1, SHV-1 and K-l all present. In a single isolate no 0-lactamase was detected.
The Citrobacter and Hafiiia isolates produced only chromosomally encoded and TEM-
1 0-lactamases The specific activity of the TEM-1 0-lactamase was determined for
the ampicillin resistant transconjugants. No significant difference could be identified
between the plasmid type and the specific activity of the enzymes.
Discussion
The incidence of antibiotic resistance amongst clinical isolates is ofworldwide concern
and has been extensively studied [20,21], Much less attention has been paid to the
carriage ofantibiotic resistance genes in the normal non pathogenic aerobic gut flora of
healthy individuals. However recent studies indicate that this group may represent an
important pool of resistant organisms demonstrating significant carriage rates ofE.coli
resistant to commonly used antimicrobials [1,2,4]. Amongst clinical isolates the levels
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of antibiotic resistance in the Third World are considerably higher than those found in
the West [7] This would also appear to be the case with resistance in commensal
faecal flora In South India there is almost unive sal carriage of ampicillin (96 8%) and
trimethoprim (96 8%) resistant strains in the normal healthy population [5] In South
African townships there is also a high carriage rate of resistant organisms to ampicillin
(88 6%) and trimethoprim (74 2%) [6] In this study in Edinburgh the carriage rate of
antibiotic resistance amongst 100 healthy volunteers was 42 0%, 27 0% and 12.0% for
ampicillin, tetracycline and trimethoprim respectively. No resistance was detected to
the third generation cephalosporin ceftazidime and only a low level of resistance to
gentamicin perhaps reflecting the restricted use of these compounds to hospitals only
There was only a low level of resistance to the quinolone antibacterials, this has been
noted before in surveys of resistance in commensal faecal flora [5] and may result from
the lack of plasmid mediated resistance to these agents. In common with other surveys
of the carriage of resistance in commensal faecal flora the highest carriage rate of
resistance in the Edinburgh population was to ampicillin. Ampicillin has been the most
widely used antibiotic worldwide and this may partly explain the high levels of
resistance encountered. In addition ampicillin is poorly absorbed from the gut
facilitating the selection of resistant gut flora [22], Further examination of the
ampicillin resistant isolates for their resistance to other (3-lactam agents revealed that
amongst the E.coli there was complete sensitivity to the later generation
cephalosporins cefotaxime and ceftazidime and in addition clavulanic acid was
effective in restoring the sensitivity to amoxycillin (MIC < 32mg/L) in 96% of cases
This resistance pattern results from the fact that the TEM-1 ^-lactamase predominates
as the mediator ofampicillin resistance in these strains.
The genetic and biochemical basis for the development and spread of resistance is well
documented in clinical settings [20,21] Unfortunately few of the studies on normal
E.coli have proceeded to examine the mechanisms of resistance in the strains isolated
The value of such studies is obvious to establish whether the resistance genes and
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plasmids in the normal flora are indeed the progenitors of those encountered in clinical
isolates In this present study the ^-lactamases responsible for transferable ampicillin
resistance and the genetic carriers for such resistance have been determined
Restriction endonuclease fingerprinting of the transconjugant plasmids showed that
there were nine different plasmid types The fact that one plasmid type not only
occurred on five occasions but was also isolated from each of the different sample
groups and another, very similar, plasmid type occurred on two occasions may indicate
the presence of an epidemic plasmid in the community. Although spread of epidemic
plasmids in hospitals is well reported [23-2S] this study represents the first indication
that this may also happen amongst the healthy community. Examination of the (3-
lactamases produced by the transconjugants demonstrated that ampicillin resistance
resulted from the presence of the TEM-1 ^-lactamase in all cases, this is similar to a
recent study in India which demonstrated that production of the TEM-1 (3-lactamase
predominated as the mechanism of ampicillin resistance amongst normal E.coli [26].
This would suggest that the situation in normal E.coli is the same as in the clinical
setting where TEM-1 is by far the most commonly produced ^-lactamase in clinical
isolates [10,21],
This study has demonstrated significant carriage of antibiotic resistant strains in the
healthy population in Edinburgh. In particular, there is a high carriage rate of resistance
to ampicillin. The widespread presence of the TEM-1 ^-lactamase on specific plasmids
throughout the community is of concern. The TEM-1 ^-lactamase is the progenitor of
many extended-spectrum ^-lactamases [20], The presence of the TEM-1 ^-lactamases
in the healthy community may therefore not only complicate current therapy but may
also act as potential source of novel adapted (3-lactamases as newer agents are
introduced into general practice.
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FIGURE I Restriction digest of the ampicillin resistant transconjugants
Eco R1 restriction endonuclease digests of plasmids isolated from the
ampicillin resistant transconjugants.
1) ES20, 2) ES59, 3) ES60, 4) ES62, 5) ES63, 6) ES64, 7) ES65, 8)
ES67, 9) ES68, 10) ES69, 11) ES72, 12) ES73, 13) ES75, 14) ES76, \5)X
phage restricted with Eco Rl, 16) X phage restricted with Hin dill
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TABLE 1 Proportion of volunteers with antibiotic resistant bacteria in
their commensal faecal flora
Antimicrobial agent Concentration mg/L Percentage volunteers
Ampicillin 10 42
Ceftazidime 2 0
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TABLE 2 Identification of ampicillin resistant isolates
Organism No. of isolates Percentage
Escherichia coli 28 67
Klebsiella spp 9 21
Citrobacter spp 4 10
Hafnia spp 1 2
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TABLE 3 Minimum inhibitory concentrations of (J-lactam antibiotics and the
production of (^-lactamase in the original isolates





•275 1 1024 16 2 2 4 E.coli TEM-1
•277 2 1024 16 2 2 2 E.coli TEM-1
•279 3 >1024 16 2 2 4 E.coli TEM-1
♦283 4 1024 16 2 2 4 E.coli TEM-1
295 5 1024 8 2 2 E.coli TEM-1
12 6 1024 8 2 2 2 E.coli TEM-1
♦17 7 1024 16 2 2 4 E.coli TEM-1
19 8 >1024 16 2 2 2 E.coli TEM-1
27 9 1024 32 2 8 32 E.coli CHRM
•31 10 1024 16 2 2 2 E.coli TEM-1
43 11 >1024 16 2 2 4 E.coli TEM-1
♦47 12 >1024 16 2 2 2 E.coli TEM-1
•503 13 512 16 2 2 2 E.coli TEM-1
•512 14 1024 16 2 2 4 E.coli TEM-1
•516 15 >1024 16 2 2 2 E.coli TEM-1
•520 16 1024 16 2 2 2 E.coli TEM-1
526 17 512 2 2 2 2 E.coli TEM-1
•529 18 >1024 16 2 2 4 E.coli TEM-1
530 19 32 2 2 2 2 E.coli ND
302 20 >1024 16 2 2 4 E.coli TEM-1
305 21 1024 8 2 2 4 E.coli TEM-1
•307 22 >1024 16 2 2 2 E.coli TEM-1
319 23 1024 8 2 2 4 E.coli TEM-1
•320 24 1024 16 2 2 4 E.coli TEM-1
322 25 >1024 16 2 2 4 E.coli TEM-1
327 26 1024 8 2 2 E.coli TEM-1
332 27 256 32 2 2 16 E.coli TEM-1
336 28 16 2 2 2 4 E.coli CHRM
293 29 64 2 2 2 2 K.pneumoniae SHV-1
35 30 64 2 2 2 2 K.oxytoca SHV-1
40 31 64 2 2 2 2 K.oxytoca ND
42 32 32 2 2 2 2 K.oxytoca SHV-1
508 33 64 4 2 2 2 K.oxytoca SHV-1
522 34 32 2 2 2 2 K.oxytoca TEM-1
308 35 32 2 2 2 2 K.oxytoca SHV-1
312 36 32 2 2 2 2 Kpneumoniae SHV-1
318 37 64 2 2 2 2 K.oxytoca K1
285 38 1024 8 2 2 2 C.freundii TEM-1
290 39 256 64 2 2 2 C.freundii CHRM
21 40 256 64 2 2 4 C.freundii CHRM
50 41 16 16 2 2 16 C.diversus TEM-1
3 42 32 16 2 2 2 H.alvei TEM-1
Amox Amoxycillin





ND No detectable ^-lactamase
* Strain carries a self-transmissible plasmid
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TABLE 4 Plasmid analysis of the TEM-1 (3-lactamase-producing transconjugants
Transconjugant No. of Size Restriction Specific Antibiogram
No. plasmids Kb pattern
group
activity*
ES20 1 809 A 2.2 Ap Cf Sm Sp
ES59 3 809 A 19 3 Ap Cf Sm Sp
ES68 1 809 A 5.2 Ap Cf Sm Sp
ES75 1 84 1 A 3 4 Ap Cf Sm Sp
ES76 1 82.9 A 2.8 Ap Cf Sm Sp
ES60 1 87.9 B 6 8 Ap Cf Sm Sp Cm Tc
ES62 1 870 C 12.7 Ap Cf Sm Sp Tc
ES63 81 9 D 289 Ap Cf Sm Sp
ES73 1 81.9 D 5.7 Ap Cf Sm Sp
ES64 1 85.7 E 17.7 Ap Cf Sm Sp
ES65 121.5 F 18 1 Ap Cf Sp
ES67 1 46 5 G 35.5 Ap Cf Sm Sp Tp
ES69 1 54.8 H 4.2 Ap Cf Sm Sp
ES72 1 46.1 I 3.1 Ap Cf Sm Sp
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476 REDUCED SYNTHESIS OF LACTAMASE BY /•>,-
tcrobaclcriaccac UNDER ANAEROBIC CONDITION'S.
Murchcsc A* Dcbbia E.A.. and Schito G.C.
Institute of Microbiology, University of Genoa, Italy.
It is known that under anaerobic conditions the expression of several genes is
reduced while that of others is increased. Since different Authors have reported
that the bactericidal activity of various new oral third generation cephalosporins
against /^-lactamase producing Entcrohactcriaccac is affected by the analytical
techniques adopted, in litis study we have evaluated the extent of /3-Iactamasc
synthesis and the susceptibility of some gram-negative enteric bacteria to the
aforementioned drugs under aerobic and anaerobic conditions. MIC values obtait-
aincd with Ii.coli and K./pneumoniae differed widely by microliter, macromcthod,
and under anaerobic environment in comparison to those noted in cultures main¬
tained under vigorous aeration. In particular, tests conducted in acrobiosis
showed MIC values tS-fold higher than those observed in the anaerobic assays.
The same findings were noted with P.mirabilis, S.marccsccns, and E. cloacae in
experiments that included cefdinir and ccfuroximc. On the other hand, a reference
noil/3-Jaclamasc producing Jicoli strain exhibited the same MIC values in all the
experimental conditions examined. Under anaerobic conditions /3-Jactamasc
production by E.coli and fCpneumoniae, as assessed by a colorimctric method,
was reduced (63 and 77% respectively) in comparison with the amounts found in
acrobiosis. These findings suggest that in vivo, where low oxygen tensions exist
in several infected sites, the sluggish rate of /^-lactamase synthesis by some
gram-negative pathogens might render the threat of inactivation of these antibiot¬
ics negligible, thus improving their therapeutic margin.
EXTENDED-SPECTRUM 13-LACTAMASES
CONFERRING RESISTANCE TO THIRD-
GENERATION CEPHALOSPORINS AND
CEPHAMYCINS IN KLEBSIELLA
Ann PNEUMONIAE CLINICAL ISOLATES.
"
' ' Pagani.L. Ronza.P.. '(iiacobone.L. Roiikto.K. •
islilulo di Microbiclocin I'nivcrsilh tiedi .-'hrJi Tavia
Uboratorio Anulisi Microbioiosiciic IRCCe S Matteo
Pavia.
The exlended spectrum 6-lactamases (ESBs) have been reported with
increasing frequency mainly in MpaeuiilOJlise and have been recognized as a
serious threat to current 6-lactam therapy. ISO producing strains are involved
in epidemic spreads throughout institutions particularly in Europe. *e have-
studied twenty isolates of Jupj]£lMlQliia5 from patients in intensive care units,
resistant to cefotaxime, ceftazidime, aztreonam .and cefoxitinc. The
lactamases extracted from unninduccd and induced strains have been studied
bv isoeieclro focusing. Plasmid DNA obtained by alkali-lysis has bf-e:i
eicctrophcresed in agarose gels. Transfer of resistance markers 10 h.coii :.; a
has been also carried out. All strains produced a P>-lactamase with pi <G. four
strains produced a B-iactamase with pi 5.5 and three strains produced a
lactamase with pi 8.4. All strains showed a common plusmid of about 31.7 M
«!al and three strains another one slightly smaller.
CONCLUSION: The clinical isolates showed a similar extended-spectrum
lactamases and plasmid pattern supporting the impression that the oulbrc:-..-:
was caused by dissemination of a simgie organism throughout Ike iiospitai
A CARBAPENEM-HYDROLYSING (J-LACTAMASE
FROM ENTEROBACTF.R CLOACAE
A n O SEQUENCE ANALYSIS AND REGULATION
H / 0 T. Naas', S. Marioitc-. P. Nordmann**-
' Biozcntrum of Basel University. Basel, Switzerland and
-Paris-Oucst Medical School, Pans. France.
As previously reported (ICAAC. 1990). a clinical isolate of Entcrobactcr cloacae
produces a carbapcncmasc alone with an AmpC ccphalosponnasc. From this
strain, a 5.2 kb Snu3A genomic DNA fragment containing the carbapcncmasc
gene was cloned into pACYCl84 plasmid in E. coli. Analysis of the deduced
protein from iLs determined DNA sequence revealed that the protein (NOR -BLA)
is a 30 kDa Ambler class A ^-lactamase. It shares 50% homology with
chromosomal (Vlactama.se from Klebsiella oxvtoca. Deletion experiments of the
5' upstream sequences of the carbapcncmasc gene lead to a decrease in carbapcncm
resistance level, therefore suspecting the existence of regulatory elements. In the
opposite orientation from the NOR-bla promoter. an overlapping and divergent
promoter was detected along with an open reading frame which encoded for a 32
kDa protein (NOR-R). NOR-R sequence displayed homology with the LysR
regulatory family proteins including, in particularly, the conserved residues
nearby the Nib end which arc thought to be involved in their DNA binding
functions. NOR-R homology was 23 % with AmpR of the inducible
ccphalosponnasc system of E. cloacae. Protein fusion of NOR-bla with the (3-
galactosidasc gene revealed thai NOR-BLA expression was (t) strongly decreased
in ihc absence of NOR-R, (li) and induced in presence of NOR-R with 6-
aminopcnicilloic acid (500 pg/ml). imipcncm (0.1 uc/ml) and ampicillin (100
ug/mi).
CONCLUSION This is the first report of a carbapcncmasc sequence in
Entcrohactcriaccac. As opposed to the carbapcncmascs previously sequenced (IT
I'tacilis. IT. ccrcus) NOR-BLA is a serine jMaetamasc and not a inctallo-cnzymc.
Moreover, its biosynthesis is regulated by a LysR-type protcin^vhich acts as a
jxisitivc regulator and which is required for NOR-BLA induction
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INCIDENCE OF THE TEM-1 jiETA-LACTAMASE
IS COMMENSAL FAECAL FLORA.
PMA Shanahan*, CJ Thomson and SCB
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EFFECT OF AMOXYCILLIN" CHALLENGE ON
jl-LACTAMASE TRC-l.
CJ Thomson* & 5GB Anyes, Univer
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COMPARISONFRESISTANCEINCOMME SAL BACTERIAINRI AINDINDIA.
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